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INTRODUCTION
In the Netherlands between 179.000 and 204.000 children were born annually during the 
last ten years. Congenital anomalies occur in 1 in 33 births. Th e most frequent anomaly 
involves the heart with a prevalence of 1 in 150 births (66.7 per 10.000 births). Th e ven-
tricular septal defects occur the most frequent (30.0 per 10.000 births) (Central Bureau 
of Statistics Netherlands, European Registration of Congenital Anomalies, National 
Neonatology Registration). A rare congenital anomaly is craniosynostosis, aff ecting 1 in 
2.500 births. 
Th e newborns cranial vault is composed of seven individual bones separated by sutures. 
Th is arrangement accommodates transient skull distortion during birth and permits 
future growth of the brain, the volume of which quadruples during the fi rst two years 
of life. Th ere are six major cranial sutures: the metopic, two coronal, the sagittal, and 
two lambdoid sutures. Six additional sutures are considered minor: two frontonasal, two 
temporosquamosal, and two frontosphenoidal. At the anterior of the skull, the sagittal, 
coronal, and metopic sutures meet to form the anterior fontanelle. Th e posterior fontanelle 
is formed by the intersection of the sagittal and lambdoid sutures. Th e sutures function 
as growth centres. In the center of a suture lie undiff erentiated, proliferating cells. A part 
of these cells undergo osteogenic diff erentiation and migrate to the borders of the bone 
sheets. After diff erentiation in osteoblasts growth of the sheets occurs by apposition1.
At two months of age, the posterior fontanelle closes, followed by anterior fontanelle 
closure at approximately two years of age2. While the metopic suture typically closes within 
the fi rst year of age, all remaining cranial sutures close in adulthood, although they are no 
longer involved in skull growth after approximately the age of six. Th en skull growth takes 
place by apposition of bone at the outer side of the skull and resorption at the inner side.
SYNDROMIC CRANIOSYNOSTOSIS
Craniosynostosis is characterized by the premature fusion or agenesis of calvarial sutures, 
which usually happens at 15 weeks of gestation for the metopic suture, at 16 weeks for 
the coronal and lambdoid sutures and at 18 weeks for the sagittal suture3. Due to the 
craniosynostosis normal growth of the skull related to the aff ected suture is restricted. In 
order to accommodate the growing brain, compensatory skull growth occurs in the other 
directions resulting in cranial deformation: this is categorized as scaphocephaly in case of 
involvement of the sagittal suture, as frontal plagiocephaly in case of one coronal suture, 
as brachycephaly in case of both coronal sutures, as trigonocephaly in case of the metopic 
suture, and as pachycephaly in case of synostosis of one lambdoid suture. In about 40% 
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General introduction
of the cases (1:6.250) the craniosynostosis is part of a syndrome, such as Apert, Crouzon, 
Pfeiff er, Muenke or Saethre-Chotzen syndrome4. 
Apert syndrome is an autosomal dominant syndrome caused in >98% of the cases by one of 
the two FGFR (fi broblast growth factor receptor) 2 mutations on chromosome 10, S252W 
and P253R with full penetrance5, 6, very rare is S252F4. Recently, two rare mutations were 
found, a partial large FGFR 2 gene deletion and an Alu element insertion into the FGFR 
2 gene5. Th e syndrome is characterized by symmetric complex syndactyly (involving both 
soft tissues and bone) of hands and feet, bicoronal synostosis, exorbitism, hypertelorism 
and midface hypoplasia. Th e intelligence varies from near normal to mentally retarded 
with a mean IQ of 62 to 747-9. Apert is the most severe type of syndromic craniosynostosis. 
Crouzon syndrome occurs in 1 in 25.000 births and is an autosomal dominant syndrome 
predominantly caused by mutations in FGFR 2 on chromosome 10 with variable expres-
sion10, but the FGFR 3 mutation, A391E has also been reported in individuals with Crou-
zon syndrome and acanthosis nigricans11. Crouzon syndrome is characterized by midface 
hypoplasia, exorbitism and various forms of craniosynostosis, which may have a postnatal 
onset. Th e intelligence of patients with Crouzon syndrome is overall signifi cantly better 
than the intelligence of patients with Apert syndrome, with an average IQ of 84 to 929, 12.
Pfeiff er syndrome is an autosomal dominant syndrome but most cases are sporadic. Th e 
syndrome is mainly caused by mutations in FGFR 2 on chromosome 10, but the P252R 
mutation in the FGFR 1 gene on chromosome 8 have also been described incidentally4, 13, 14. 
Th e phenotype of this syndrome is characterized by craniosynostosis (bilateral coronal or 
pansynostosis), midface hypoplasia and broad thumbs and great toes. With the discovery 
of the genetic background in syndromic craniosynostosis the same genotype in Pfeiff er 
syndrome was found as in Crouzon syndrome. Th e clinical presentation is also very similar 
to Crouzon syndrome besides the characteristically hand and foot anomalies. So there is 
an overlap between both syndromes and they can be considered as phenotypic variations 
of the same genetic defect15.
Muenke syndrome is an autosomal dominant disorder with incomplete penetrance, caused 
by the P250R mutation of the FGFR 3 gene on chromosome 4, discovered in 199716. It is 
one of the most commonly found mutations in the human genome, but does not always 
result in craniosynostosis17. Th e phenotype associated with this syndrome incorporates 
macrocephaly, uni- or bilateral coronal synostosis, hearing loss and developmental and 
language delay18, 19. Th e cognitive function seems to be normal with a mean IQ of 9320.
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Saethre-Chotzen syndrome is an autosomal dominant syndrome with incomplete pen-
etrance, predominantly caused by mutations or deletions in the TWIST gene on chromo-
some 7. Th e syndrome is characterized by coronal synostosis, upper eyelid ptosis, external 
ear anomalies and limb abnormalities, such as brachydactyly, syndactyly, clinodactyly or 
broad halluces. Most patients with Saethre-Chotzen have a normal intelligence21, 22, with 
the exception of patients with TWIST deletions who have a higher frequency of mental 
retardation23.
In a signifi cant number of patients one of the above-mentioned genetic mutations is 
found. FGFR’s and their ligands the fi broblast growth factors (FGF’s), play a central 
role in the growth and diff erentiation of mesenchymal and neuroectodermal cells21, 24. 
FGFR binds FGF and plays a substantial role in signal transduction. FGFR’s regulate cell 
proliferation and diff erentiation and are thus involved in cranial suture fusion24-26. Also the 
TWIST gene encodes for a basic transcription factor that is responsible for mesenchymal 
cell development during cranial neuralization18. 
But not in all patients with a phenotypically syndromic craniosynostosis a mutation can 
be found. Complex craniosynostosis is defi ned as fusion of two or more cranial sutures 
without known FGFR or TWIST mutation4, 18. In the future new mutations are likely to 
be found in this group of patients with complex craniosynostosis27.
INTRACRANIAL PRESSURE
Pathophysiology
Th e skull protects the intracranial compartment consisting of brain parenchyma (80%), 
cerebrospinal fl uid (10%) and blood (10%). Because of the rigid structure of the skull with 
a fi xed internal volume once growth is completed, intracranial pressure (ICP) is a function 
of the volume and the compliance of each component of the intracranial compartment. 
An increase in the volume of one component or the presence of pathologic components 
results in displacement of other structures, an increase in ICP, or both. In severe cases it 
can diminish the cerebral blood fl ow resulting in ischemia, cell injury and death28. Th e 
relationship between intracranial volume and pressure is not linear. An initial increase in 
volume results in a small increase in ICP due to compensation, but once the compensation 
mechanism is overcome, a further increase in volume results in a steep rise in ICP29. 
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General introduction
Factors involved in elevated intracranial pressure
Traumatic brain injury is the most common risk factor to develop elevated ICP. A brain 
tumour, hematoma or hydrocephalus can result in elevated ICP, just as cerebral edema due 
to an infection, tumour, head injury or stroke.  
Patients with syndromic craniosynostosis are at risk for elevated ICP. Factors suggested 
to contribute to elevated intracranial pressure in craniosynostosis are craniocerebral dis-
proportion, ventriculomegaly or hydrocephalus, venous hypertension and obstructive 
sleep apnea. 
a. Craniocerebral disproportion
Due to premature fusion of calvarial sutures, the intracranial pressure may be elevated if 
the brain grows more rapidly than the skull30. In healthy children the intracranial volume 
does not increase linear with age. Th e growth is most rapid in the fi rst 5 years of life; by the 
age of 2 years 77% of the intracranial volume observed at the age of 15 is reached and by 
5 years 90% of the volume31. In children with syndromic craniosynostosis the intracranial 
volumes seem to be signifi cantly smaller at birth with an increase to the normal growth 
curve before the age of one32. Except for Apert syndrome, in these children the intracranial 
volume is in the normal range at birth, but at 6 months of age much higher than the 
norm32-36. Th e explanation remains unclear. In Apert syndrome this increased intracranial 
volume was not related to cranial decompression or ventriculomegaly35. Posnick et al.36 also 
found greater intracranial volumes than the mean in patients with Crouzon syndrome in 
contrast with Gault et al.34. 
Children with elevated ICP, due to their craniosynostosis, also had a signifi cantly lower 
intracranial volume, but a lower intracranial volume did not result in elevated ICP in each 
case37. However, in a study from London no relationship between elevated intracranial 
pressure and decreased intracranial volume was found in children with craniosynostosis38. 
b.  Ventriculomegaly or hydrocephalus
Ventricular dilatation is a common fi nding in patients with syndromic craniosynostosis. 
Th e increase in ventricular size can result in elevated ICP due to an increase in cerebrospi-
nal fl uid volume. Enlarged ventricles are defi ned as hydrocephalus when the condition is 
progressive and as ventriculomegaly when it is non-progressive39. Ventricular dilatation of 
either origin is reported in 30 to 70% of the patients with Crouzon or Pfeiff er syndrome 
with frequently true hydrocephalus and in 40 to 90% of the patients with Apert syndrome, 
which mainly concerns ventriculomegaly. In Muenke and Saethre-Chotzen syndrome 
ventricular dilatation is rare, but specifi c literature for these syndromes is rare39. 
In craniosynostosis, hydrocephalus can hypothetically result from cerebrospinal fl uid 
outfl ow obstruction due to constriction of the posterior fossa, malabsorption due to ve-
nous sinus hypertension39 or increased cerebrospinal fl uid production40. Ventriculomegaly 
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seemed to be associated with primary brain maldevelopment or sometimes with secon-
dary brain atrophy. Other less common causes of hydrocephalus are basilar invagination, 
aqueductal stenosis and compression by the midline occipital bone crest41.
c. Venous hypertension 
Venous hypertension is also common in syndromic craniosynostosis and another factor 
contributing to elevated ICP30, 42. It can be caused by anomalous venous drainage and 
anatomical vascular variations resulting in development of collateral veins30, 43. Abnormal 
intracranial venous drainage seems to be present in patients with severe stenosis of the 
sigmoid sinus- jugular bulb and jugular segment (intraosseous part of the jugular sinus) 
complex. Th ese patients are more likely to show earlier signs of elevated ICP, mostly before 
the age of 3. Presence of elevated ICP due to the eff ects of venous hypertension is unusual 
after six. After this age the collateral venous drainage will likely become suffi  cient to allow 
the ICP to normalize43.
Early fusion of the lambdoid sutures in combination with the petro-occipital synchon-
droses can be associated with stenosis of the jugular foramen41. And in presence of a small 
posterior fossa this stenosis is possibly related to venous hypertension39, 41, 44. Jugular fora-
men stenosis is suggested to result in a rise of the sagittal sinus pressure, which increases 
the cerebrospinal fl uid pressure44. 
d.  Obstructive sleep apnea
Forty percent of the patients with syndromic craniosynostosis will develop obstructive 
sleep apnea45. During invasive ICP monitoring, plateau waves of elevated ICP are recog-
nized to be associated with obstructive apneas and desaturations. Obstructive sleep apnea 
results in hypoxia and hypercapnia with subsequent vasodilatation and an increase of 
the cerebral blood fl ow resulting in elevated ICP42. In the next part of this introduction 
obstructive sleep apnea will be discussed extensively.
Prevalence of elevated intracranial pressure
In isolated, single-suture craniosynostosis the frequency of elevated ICP before vault 
expansion diff ers for the various types of craniosynostosis46-48. In patients with syndromic 
craniosynostosis, either Apert or Crouzon syndrome, elevated ICP before vault expansion 
is seen in 45% and 63% respectively7,49. Regular screening with visual evoked potentials 
(VEP) for signs of elevated ICP prior to vault expansion, demonstrated an incidence of 
elevated ICP of 83% in children with Apert syndrome with a mean age of 18 months (range 
1 month- 4 years 5 months)50. In the diff erent types of craniosynostosis the frequencies of 
elevated ICP (≥ 15 mm Hg), invasively measured before surgery, are shown in table 17, 18, 
37, 46-49, 51, 52. 
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General introduction
Recurrent elevated intacranial pressure 
Despite early treatment elevated ICP may still reoccur or persist after early cranial expan-
sion43, 53. Late-presenting children with a smaller intracranial volume than normal have 
a higher chance to develop recurrent elevated ICP due to craniocerebral disproportion 
with a need for reoperation32. Information on the frequency of this problem, however, 
is limited54. In Saethre-Chotzen syndrome the postsurgical rate of elevated ICP raised to 
42% after 5 years of follow-up53. In Apert syndrome 35% will develop a second episode of 
elevated ICP on average 3 years and 4 months after vault expansion50.
Diagnostic methods
Elevated ICP can be diagnosed in diff erent ways, either through direct measurement or 
through indirect methods. Th e classic clinical symptoms of acute elevated intracranial 
pressure are headache, vomiting and disturbed consciousness. Gradually development of 
elevated ICP seen in craniosynostosis is diffi  cult to recognize with more subtle features as 
deterioration in schoolwork and sight, and change in behavior29. 
Th e ‘gold standard’ for measuring ICP is an invasive overnight measurement during at 
least 12 hours with direct monitoring of the intracranial pressure. An intraparenchymal 
device is most commonly used in daily practice. A drawback of the ICP monitoring is the 
need for a surgical procedure, hospital admittance and the risk of complications such as 
haemorrhage, cerebrospinal fl uid leak and infection29, 54. 
Th e analysis of ICP measurements includes the identifi cation of the baseline ICP and 
the presence of wave patterns. Th ere are three waveforms. C-waves are a normal variation 
in ICP related to the cardiac cycle. B-waves are rises in pressure to a level between 20 
and 50 mm Hg during 5 to 10 minutes with decline to the baseline afterwards. Th ey can 
be normal, especially during sleep. A-waves are abnormal plateau waves present in the 
acute phase of elevated ICP due to traumatic brain injury for example. Loss of cerebral 
autoregulation results in these waves with a sudden rise in pressure above 50 mm Hg 
during at least 20 minutes without recurrence to the baseline29. 
Table 1: Frequencies of elevated intracranial pressure per type of craniosynostosis
Type of craniosynostosis Frequency of elevated ICP (range, %)
Trigonocephaly 0-33
Scaphocephaly 13-24
Frontal plagiocephaly 6-22
Brachycephaly 31-50
Complex craniosynostosis 47-64
Apert syndrome 39-50
Crouzon/ Pfeiff er syndrome 63-65
Muenke syndrome 0
Saethre-Chotzen syndrome 29-43
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In children, a baseline pressure below 10 mm Hg is considered as a normal ICP. An 
upper limit of the baseline pressure between 10 and 15 mm Hg is borderline elevated. 
A baseline pressure of 15 mm Hg or more and/ or at least four B-waves during at least 5 
minutes during sleep is considered to be elevated29, 49.
Indirect methods to screen for elevated ICP are palpation of the fontanelle in infants and 
measurement of the head circumference. Th e head circumference growth curve can form 
a notion of the growth of the skull, although it does not take growth in upward direction 
(turricephaly) into account. A decline of the curve can be associated with elevated ICP.
Radiological evaluation for screening on elevated ICP consists of a skull radiograph, 
a computed tomography (CT) angiography scan or magnetic resonance imaging (MRI) 
scan. A skull radiograph might demonstrate a beaten-copper pattern, also known as digital 
impressiones, which correspond to the gyral pattern of the underlying brain. Th ese radio-
graphic changes are visible as markings in the skull of the gyri in presence of elevated ICP. 
To screen for elevated ICP this method is insensitive55. A CT angiography scan of the brain 
can show ventricular dilatation or signs of venous hypertension39, 55. 
A reliable symptom of elevated ICP, although rather late in onset, is papilledema56. 
If fundoscopy reveals papilledema, it is a sure sign for elevated ICP after exclusion of 
hyperopia, which can resemble papilledema without being a sign of elevated ICP, so-
called pseudopapilledema57. Th e specifi city of papilledema is 98%, but the sensitivity is 
age-dependent. Above eight years the sensitivity is 100%, but in younger children absence 
of papilledema does not exclude the presence of elevated ICP and thus fundoscopy is 
likely to result in an underestimation of the incidence of elevated ICP56. Ocular cohe-
rence tomography can measure the retinal nerve fi bre layer thickness. Th e thickness is 
increased if severe papilledema is present. But it is not eff ective to diff erentiate between 
mild papilledema and pseudopapilledema58. Visual evoked potentials (VEP) can be used 
if neurophysiologic expertise is available. Prolongation of the N2 wave latency period is 
correlated with elevated ICP59. 
Treatment of elevated intracranial pressure
Treatment of elevated ICP is dependent on the causal factor. In craniosynostosis the fi rst 
treatment or prevention of elevated ICP is surgical decompression to expand the skull 
within the fi rst year of life48. Other options can be the insertion of a ventriculoperitoneal 
shunt or treatment of obstructive sleep apnea.
Consequences of untreated elevated intracranial pressure
If left untreated, elevated ICP may lead to irreversible visual loss caused by optic nerve 
dysfunction, mental impairment or tonsillar herniation41, 48, 60, 61. Visual loss is a very rare, 
but severe complication. In our hospital visual loss is described in three cases with Crou-
zon and in one case with Apert syndrome in presence of papilledema but without other 
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General introduction
symptoms of elevated ICP60. Renier et al.48 mentioned an observed frequency of optic 
atrophy in 10% of the Crouzon cases and no optic atrophy was observed in the other 
syndromes. Regularly screening of sight and the presence of papilledema can possibly 
prevent these severe complications. 
Vault expansion done after the age of 1 results in a higher risk to develop elevated ICP. 
Th e mental development seems to be better after early surgical treatment done before the 
age of 148. Possibly there is an association between elevated ICP and the mental develop-
ment. Another study found no correlation between the mental development and the age 
at surgery8. So, the association between craniosynostosis, age at surgery, untreated elevated 
ICP and mental impairment is not clear yet. 
Elevated ICP appears to cause herniation of the cerebellar tonsils through the fora-
men magnum. More than one third of the patients with tonsillar herniation will develop 
symptoms or syringomyelic cavities, but in most craniosynostosis patients it remains 
a symptomatic. Chronic tonsillar herniation can cause suboccipital pain, compression of 
the lower brainstem and upper cervical spinal cord (respiratory problems) and deforma-
tion of the fourth ventricle41. 
Tonsillar herniation of the cerebellum is also known as Chiari malformation and is com-
monly observed in Crouzon and Pfeiff er syndrome (73%) and rarely in Apert syndrome 
(2%). In Crouzon syndrome 20% will develop symptoms of chronic tonsillar herniation 
before the age of 20. In these sydromes the herniation is not present at birth, but acquired 
after. It seems to be related to an abnormally small posterior fossa, in particular after 
fusion of the lambdoid sutures within the fi rst two years of life39, 41. In Crouzon syndrome 
the sagittal and lambdoid sutures fuse signifi cantly earlier than in Apert syndrome, which 
can explain the diff erent occurrence. Another factor that may explain the diff erence is 
hydrocephalus. All patients with Crouzon syndrome and hydrocephalus show a Chiari 
malformation. Of the Crouzon patients with a Chiari malformation 53% do not have a 
hydrocephalus41. 
OBSTRUCTIVE SLEEP APNEA
Defi nition and pathophysiology
Obstructive sleep apnea (OSA) is a clinical syndrome due to partial or complete upper 
airway obstruction characterized by diffi  culties in breathing, snoring and apneas during 
sleep resulting in sleep fragmentation, hypoxia and hypercapnia. Other features of OSA 
are restless sleep, mouth breathing, sweating, and daytime sleepiness62, 63. Between inspira-
tion and expiration a substantial change in the size of the airway is shown, which is 
most apparent in the rhinopharynx64. Collapse occurs when the pressure surrounding the 
airway becomes greater than the pressure within the airway. 
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OSA can result in development of elevated ICP. Th e causal relationship and the exact 
underlying mechanism between airway obstruction and elevated ICP are not fully clear. 
A possible hypothesis is that the muscular tone of the pharyngeal dilators, who maintain 
the patency of the airway, reduces during active sleep. Th is causes accumulation of carbon 
dioxide and reactive vasodilatation, followed by a rise in ICP. With the elevated ICP 
the cerebral perfusion pressure decreases resulting in more vasodilatation. A vicious cycle 
exists, which can be broken by an arousal resulting in correction of the blood gases and 
the airway obstruction30, 42, 65. 
Causes of obstructive sleep apnea
Th e upper airway obstruction is due to an anatomically small upper airway and/ or to a 
decreased neuromuscular tone of the pharyngeal dilators during sleep. Anatomic factors 
along the upper airway, such as nasal obstruction, enlarged tonsils and adenoids, pha-
ryngeal collapse or fat deposition by obesity can decrease the airway size or stability, and 
may therefore contribute to the development of OSA. Also endocrine disorders, such as 
hypothyroidy or acromegaly, and neuromuscular factors, such as hypotonia or hypertonia 
can result in OSA. Medicaments, such as analgesics or muscle relaxants can aff ect the 
neural control or collapsibility of the airway or reduce the size of the upper airway66.  
Also craniofacial anomalies, such as midface hypoplasia, retro- or micrognathia, skull 
base anomalies or a narrow maxillary arch can lead to a decrease in the size of the rhino-
pharynx, oropharynx, or hypopharynx, and can predispose to obstructive sleep apnea67, 68. 
Prevalence of obstructive sleep apnea
Obstructive sleep apnea exists in 2 to 5 percent of the healthy children, which can occur at 
any age with a peak incidence between three and six years of age62. At that age adenotonsil-
lar hypertrophy is the major risk factor for development of OSA, because the tonsils and 
adenoid are the largest in relation to the oropharynx62, 69.
Th e risk to develop OSA is 40% in children with Apert, Crouzon and Pfeiff er syndrome 
mainly during the fi rst six years of life45, 68, 70. Beside the anatomical anomalies in these 
syndromes they also develop adenotonsillar hypertrophy. In Muenke and Saethre-Chotzen 
syndrome and complex craniosynostosis the incidence of OSA is unknown. 
In 1982, Schafer described upper airway obstruction and sleep disorders in children with 
craniofacial anomalies71. Up till then, little attention was paid to respiratory diffi  culties in 
syndromic craniosynostosis. Only the severe OSA patients are recognized and the initial 
treatment was a tracheostomy72. However, in the last years due to the familiarity with the 
risk to develop OSA in presence of syndromic craniosynostosis also the moderate and mild 
cases are diagnosed. 
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Diagnostic methods
A questionnaire on presence of symptoms can be helpful to screen for obstructive sleep ap-
nea. Th is questionnaire is developed and validated for normal, otherwise healthy children 
and consists of three questions about the presence of diffi  culty in breathing during sleep, 
observed apneas and snoring. From this questionnaire the Brouillette score is calculated 
which is related to the likelihood of having OSA73. 
Another tool to estimate the presence of OSA is observation of the child during sleep. 
Th e parents’ observation includes diff erent items: eff ort of respiration (diffi  culty in brea-
thing), apneas during breathing, snoring, retractions, sleep position, hyperextension of the 
neck, restless sleep and mouth breathing. 
Th e gold standard to diagnose presence and severity of OSA is polysomnography (PSG). 
Polysomnography can be done at the hospital or ambulatory at home. A lot of studies to 
diagnose OSA and to analyze PSG’s are done in adults. Much fewer studies are performed 
in children and diff erent defi nitions for duration and severity of OSA are used. Th e degree 
of OSA is expressed in an obstructive apnea hypopnea index (OAHI), the number of ob-
structive and mixed apneas and hypopneas followed by desaturation per hour. An OAHI 
> 1 is defi ned as OSA. Also an oxygenation desaturation index (ODI) is measured by the 
number of desaturations (≥ 4% decrease with respect to the baseline) per hour. A score 
< 1 is considered to be normal, between 1-5 is defi ned as mild OSA, between 6 and 25 as 
moderate OSA, and > 25 as severe OSA62, 63, 74, 75. 
Treatment of obstructive sleep apnea
According to its severity and cause or level of obstruction, OSA can be treated phar-
macologically (e.g. with nasal corticosteroid spray or antibiotics), surgically (e.g. with 
a denotonsillectomy (ATE) or midface advancement), or non-surgically (e.g. with noc-
turnal oxygen or continuous or bi-level positive airway pressure (CPAP or BiPAP))67, 69, 76. 
Because of the associated midface hypoplasia in children with Apert, Crouzon or 
Pfeiff er syndrome, midface advancement appears to be the treatment of choice for OSA 
in syndromic craniosynostosis77. But on long-term mixed respiratory results of midface 
advancement in patients with syndromic craniosynostosis are reported78. It is unclear how 
long and to which level the improvement in breathing lasts, and which factors are predic-
tors of respiratory outcome. It is known that growth of the maxilla in anterior direction is 
very limited in Apert, Crouzon and Pfeiff er syndrome, so if surgical advancement of the 
maxilla is performed at an early age further advancement at adult age will be needed79, 80.
Consequences of untreated obstructive sleep apnea
If OSA is not treated suffi  ciently, disturbed sleep patterns may result in major physical 
and functional impairment, for instance failure to thrive, recurrent infections, feeding 
diffi  culties, disturbed cognitive functions, delayed development, cor pulmonale or sudden 
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death81. Because of the major consequences of untreated OSA early recognition is manda-
tory70.  Specifi c attention for upper airway obstruction during follow-up is needed. 
QUALITY OF LIFE AND BEHAVIOR
Quality of life 
Quality of life is a method to describe the impact on daily functioning of a disorder. 
International standardised quality of life questionnaires are available and there are two 
diff erent types of quality of life, the general health-related quality of life (Infant Toddler 
Quality of Life questionnaire (ITQoL) or Child Health Questionnaire (CHQ)) and the 
disease-specifi c (OSA-18)82-85. With the health-related quality of life questionnaires several 
domains are examined and a general reproduction of the impact of the sickness of the 
child is given on the physical and psychosocial aspects of the health of the child, parent 
and family. With the disease-specifi c questionnaire special domains associated with a 
disease are evaluated to show the impact of this specifi c disease.
In diff erent fi elds the health-related quality of life is assessed, such as in children with 
cancer, meningococcal septic shock and cleft lip and palate86-88. For obstructive sleep apnea 
the OSA-18 survey is developed to use in healthy children with a history of snoring and 
disrupted sleep for three months or longer due to adenotonsillar hypertrophy. A signifi cant 
correlation between the mean OSA-18 score and the severity of OSA is found82. 
Warschausky et al.89 reported health-related quality of life in children with craniofacial 
anomalies. Th ey compared 27 children with primary cleft lip and/ or palate with 28 chil-
dren with other craniofacial diagnoses, including only 5 children with Apert, Crouzon or 
complex craniosynostosis. Th ey found signifi cant perceived general health concerns in the 
second group, but no specifi c physical or mental health concerns.
Health-related and disease-specifi c quality of life in a selected group of children with 
syndromic or complex craniosynostosis is not studied before. 
Behavior 
Behavior, attention and concentration are important aspects in the development of chil-
dren. Th ese aspects are possibly impaired in children with craniosynostosis that is associ-
ated with developmental delay and lower intelligence in some syndromes. Problems can 
be assessed with the Child Behavior Checklist (CBCL), a widely used norm-referenced 
measure90, 91. 
Boltshauser et al.92 evaluated behavior and quality of life in 30 patients with isolated 
sagittal craniosynostosis. Parents reported the behavior of their children in the normal 
range and the health-related quality of life was comparable with the norms, except lower 
scores on positive emotional functioning. 
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Th e amount of behavioral and emotional problems in children with syndromic or 
complex craniosynostosis is unknown. 
HYPOTHESIS AND OBJECTIVES
Th e aim of this thesis is to assess the importance and impact of obstructive sleep apnea in 
children with syndromic or complex craniosynostosis. Th e topics of interest are the preva-
lence, diagnostics and treatment outcome of obstructive sleep apnea and the infl uence on 
prevalence of papilledema, health-related quality of life and general behavior. 
Hypothesis
Obstructive sleep apnea is an important feature in children with syndromic and complex 
craniosynostosis, which requires regular screening and aff ects daily functioning.
Objectives
Th e risk for developing obstructive sleep apnea in children with syndromic craniosy-
nostosis is known for a few years, but the prevalence and consequences in these children 
are unknown. Diagnostic methods and treatment modalities need to be evaluated. Th e 
objectives of this thesis are:
1. To determine the prevalence, evaluate screening tools, diagnostic methods and determi-
nants of obstructive sleep apnea in children with syndromic and complex craniosynostosis
2. To assess the respiratory outcome of midface advancement for treatment of obstructive 
sleep apnea and to determine the factors contributing to its effi  cacy
3. To describe the prevalence of functional problems in children with syndromic cranio-
synostosis 
4. To assess the health-related and disease-specifi c quality of life and behavioral problems 
in these children.
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ABSTRACT
Objective
Obstructive sleep apnea (OSA) is a clinical syndrome characterized by snoring, apneas and 
diffi  culty in breathing. Th ese symptoms can be rated and a risk score (Brouillette score) can 
be calculated to estimate the likelihood of OSA. Th is study aimed at establishing the pre-
dictive value of the Brouillette score and observation by parents at home in children with 
syndromic or complex craniosynostosis, compared with ambulatory polysomnography.
Methods
Th is prospective study included 78 patients (37 boys, mean age 7.3 years). Sensitivity and 
negative predictive values were calculated. 
Results
Polysomnography showed clinically signifi cant OSA in 11 children. Th e Brouillette score 
had a negative predictive value of 90% and a sensitivity of 55% in comparison with poly-
somnography. More than three quarters of all patients snored. Th e single question ‘Is there 
diffi  culty with breathing during sleep?’ showed a sensitivity of 64% and a high negative 
predictive value of 91%. 
Conclusion
Th us, asking parents whether the child has diffi  culty in breathing during sleep can exclude 
the presence of clinical signifi cant OSA and avoid polysomnography in children with 
syndromic and complex craniosynostosis.
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INTRODUCTION
Obstructive sleep apnea (OSA) is a clinical syndrome characterized by diffi  culty in 
breathing, snoring and apneas during sleep resulting in sleep fragmentation, hypoxia and 
hypercapnia. Other features of OSA are restless sleep, mouth breathing and sweating. 
Th e ‘gold standard’ for diagnosing the presence and severity of OSA is polysomnography 
(PSG), but a feasible alternative is a questionnaire about the presence of symptoms. After 
discriminant analysis Brouillette et al. developed an OSA score, known as Brouillette 
score, to predict the presence of OSA with a high sensitivity1. Th is score is calculated from 
a respondent’s rating on three items (fi gure 1). Some studies showed that the Brouillette 
score could not reliably distinguish between the presence of OSA and simple snoring2-5 
and that its sensitivity and specifi city were not suffi  cient for affi  rming OSA6. 
Children with syndromic or complex craniosynostosis have a 40% risk of developing 
OSA due to midface hypoplasia and collapse of the pharynx. Th ey must be screened for 
OSA from birth on. Th is is usually done by PSG, as the value of the Brouillette score 
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Figure 1: Items of the questionnaire and observation for calculating the Brouillette score
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as a screening tool in these children has not been established. An earlier study by the 
authors found a discrepancy between the high prevalence of OSA as established by the 
questionnaire and analysis of the medical records7. Th e present study aimed to determine 
the reliability of the Brouillette score and parents’ observation at home compared with 
ambulatory PSG to predict clinically signifi cant OSA in children with syndromic or 
complex craniosynostosis. 
METHODS
Study design
A prospective cohort study was carried out at the authors’ hospital. All patients between 
0 and 18 years with syndromic or complex craniosynostosis registered at the Dutch 
Craniofacial Center were invited to participate in the study between January 2007 and 
March 2008. Syndromic craniosynostosis included Apert, Crouzon, Muenke, Pfeiff er and 
Saethre-Chotzen syndromes. Complex craniosynostosis was defi ned as fusion of two cra-
nial sutures or more without known fi broblast growth factor receptor (FGFR) or TWIST 
gene mutation. 98 of the eligible 111 patients (88%) were included after informed consent. 
Th is study at home had three components. Th e parents rated the three items of the 
Brouillette score (breathing diffi  culty, apnea and snoring) with regard to the sleep brea-
thing pattern of their child over the previous 3 months. Th e parents observed their child 
at home during sleep for one period of 30 minutes and rated the items of the Brouillette 
score every 5 minutes and recorded any mouth breathing. Th e children underwent a 
cardiorespiratory polysomnography at home for one night. 
Th e data were incomplete for 20 patients. Questionnaires on two patients and observa-
tion forms on 15 were not completed for various logistic reasons. During PSG the total 
sleep time was below 360 minutes for three patients, which was too short for analysis. Th e 
data from 78 patients were analyzed: 37 boys and 41 girls with a mean age of 7.3 ± 5.4 years 
(SD) at the time of PSG.
From the questionnaire and the observation form a Brouillette score (Br score 1) and 
observation score (Br score 2) were calculated using the equation 1.42 D + 1.41 A+ 0.71 
S – 3.83 (fi gure 1)1. OSA is likely if the score is above –1 and is thought to be absent if 
the score is below –1. Mouth breathing was considered as continuous if parents observed 
mouth breathing during the whole observation. 
Ambulatory PSG was carried out with Embletta Portable Diagnostic System and analyzed 
with Somnologica for Embletta software 3.3 ENU (Medcare Flaga, Reykjavik, Iceland). 
Th oracic and abdominal movements, nasal fl ow, saturation, and pulse were monitored. A 
minimum of 360 minutes total sleep time was required. Obstructive apnea was defi ned as 
absence of airfl ow (measured by a nasal cannula) or as out-of-phase movement of thorax 
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and abdomen (scored as X fl ow). Hypopnea was defi ned as ≥ 50% reduction in nasal fl ow 
signal amplitude or X fl ow signal amplitude, both for more than two breaths6, 8, 9. Th e X 
fl ow signal was the sum of the amplitudes of the thoracic and abdominal movements8, 9 
and was used when nasal airfl ow was insuffi  cient. Mixed apnea was defi ned as a type of 
obstructive apnea with a central component that mostly preceded the obstructive pattern, 
for more than two breaths. Central apneas were not included in this study. Desaturation 
was defi ned as ≥ 4% decrease with respect to the baseline value. Th e severity of OSA was 
expressed in an obstructive apnea hypopnea index (OAHI), which consisted of: the hourly 
number of obstructive and mixed apneas; and the hourly number of hypopneas followed 
by desaturation. 
A score of ≤ 5 is considered to be of no clinical signifi cance with no necessity to treat, 
between 6 and 25 as moderate OSA, and > 25 as severe OSA10, 11. 
For statistical analysis, contingency tables were made and the sensitivity (sens) and nega-
tive predictive value (NPV) with accessory 95% confi dence intervals (CI) were calculated. 
Th e sensitivity of the questionnaire and observation (the number of Br scores ≥ -1 that 
correctly identifi ed OSA) was tested in comparison with the results of the PSG. Th e nega-
tive predictive value (the number of Br scores < -1 that correctly diagnosed the absence of 
OSA) of the two scores was calculated.
RESULTS
For 52 of the 78 patients (67%) the Brouillette score (Br score 1) was < -1. For 57 of the 78 
patients (73%) the observation score (Br score 2) was < -1. Continuous mouth breathing 
was observed in 23 patients. Th e X fl ow was used in 15 of them, for whom the nasal fl ow 
registration was insuffi  cient. Eleven PSG’s were clinically signifi cant and scored as OSA, 
based on OAHI.
Th e predictive results for the presence of clinical signifi cant OSA are shown in table 1. 
Th e questionnaire had a high negative predictive value of 90% and a sensitivity of 55% 
when related to PSG. Combining the questionnaire with the parents’ observation gives 
a slight improvement of predicting OSA (sensitivity 64% and negative predictive value 
Table 1: Questionnaire and observation as tools for predicting clinically signifi cant OSA (OAHI >5)
Questionnaire Observation
Br score 1
< -1
Diffi  culty in 
breathing +
Apnea + Snoring + Br score 2
< -1
Sens (%)
95% CI
6/ 11 (55%)
[0.23-0.83]
7/ 11 (64%)
[0.31-0.89]
3/ 11 (27%)
[0.06-0.61]
10/ 11 (91%)
[0.59-1.00]
4/ 11 (36%)
[0.11-0.69]
NPV (%)
95% CI
47/ 52 (90%)
[0.79-0.97]
40/ 44 (91%)
[0.78-0.97]
54/ 62 (87%)
[0.76-0.94]
17/ 18 (94%)
[0.73-1.00]
50/ 57 (88%)
[0.76-0.95]
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91%). In 89% of the observations the fi ndings of the parents for the observed 30 minutes 
corresponded with those for the matching PSG period.
For the questionnaire the sensitivity and negative predictive value for prediction of OSA 
were calculated per item of the Brouillette score (table 1). Only asking about diffi  culty in 
breathing during sleep (with the answer ‘yes’ or ‘no’) resulted in a sensitivity of 64% and a 
high negative predictive value of 91%. Snoring is very sensitive (91%), but not specifi c due 
to its high prevalence (77% 60/ 78). 
DISCUSSION
Children with syndromic or complex craniosynostosis can be screened for the presence or 
absence of clinically signifi cant OSA using a questionnaire administered at the outpatient 
clinic. Th e sensitivity of this questionnaire is relatively low, whereas its negative predictive 
value is high. Th is means that in the absence of positive answers on questions related to 
the child’s breathing pattern, clinically signifi cant OSA is highly unlikely. If the single 
question ‘Has the child diffi  culty in breathing during sleep?’ was answered negatively, the 
presence of OSA could also be excluded. Similar observation by parents at home for 30 
minutes did not give a higher predictive value for OSA compared with the questionnaire.
Th e sensitivity of the questionnaire according to the Brouillette score for OSA was 
relatively low at 55%. In two earlier studies on normal healthy children sensitivities of 
89% and 80% were reported1, 12. Th e Brouillette score was developed as a screening tool 
for normal, healthy children with OSA, related to adenotonsillar hypertrophy and not to 
craniofacial abnormalities1. A specifi c fi nding in children with syndromic and complex 
craniosynostosis is that nearly all snore (in this study 77%) due to a narrow nose and mid-
face hypoplasia. In this specifi c population the question about snoring did not have any 
additional value. On the contrary, if there was no diffi  culty in breathing during sleep as 
reported by the parents, OSA can almost be excluded and additional PSG is not necessary. 
In this study, the parents’ observation during 30 minutes at home proved not to be a 
more sensitive test for OSA than the questionnaire. In a similar study, in children up to the 
age of 14 years and referred to a pediatric chest clinic, parents’ observations at home did 
not reliably predict the severity of OSA8. PSG was needed for this assessment, although 
higher incidences of cyanosis, obstructive apnea and extremely loud snoring were reported 
for these children with severe OSA8.
Th e present study is the fi rst study to compare the results of ambulatory PSG with 
parental observation at home and a questionnaire. Ambulatory PSG was successful in 
this group of children in contrast to a previous study in healthy children scheduled for 
adenotonsillectomy11. As a possible explanation, children with syndromic or complex 
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craniosynostosis may be more familiar with examinations due to frequent check-ups and 
their parents may be more motivated. 
A limitation of ambulatory PSG is the lack of various signals, such as nasal fl ow, which 
are gathered during a clinical registration. In 15 patients the nasal fl ow signal was insuf-
fi cient and obstructive apneas needed to be analyzed using the X fl ow. A possible reason is 
the continuous mouth breathing commonly observed in these children.
In conclusion, the answer ‘no’ to the question ‘Has the child diffi  culty in breathing during 
sleep?’ is helpful to exclude OSA in children with syndromic and complex craniosynostosis. 
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ABSTRACT
Objective
Children with syndromic or complex craniosynostosis are at risk to develop obstructive 
sleep apnea due to midface hypoplasia and collapse of the pharynx. Th e golden standard 
to diagnose OSA is polysomnography. Th e aim of this study is to analyze the feasibility of 
a home cardiorespiratory monitor in children with syndromic or complex craniosynostosis 
and to analyze whether oximetry alone or the sum of the amplitudes of the thoracic and 
abdominal movements (X fl ow) are valuable alternative assessments to diagnose obstruc-
tive sleep apnea at home, when complete recording was not achieved. 
Methods
We performed a prospective study in 129 children and analyzed 200 diff erent ambulatory 
polysomnographies. 
Results
In 41% of the measurements a complete analysis of the obstructive apnea hypopnea index 
was possible based on adequate recording of all sensors. Oximetry in comparison with 
polysomnography had a positive predictive value of 82% and negative predictive value of 
79% for diagnosing obstructive sleep apnea. Moderate obstructive sleep apnea could be 
excluded with a negative oximetry. Comparing the X fl ow and the nasal fl ow signals the 
hypopneas were adequately recorded in 86% and the obstructive apneas in 55%, resulting 
in an underestimation of the severity of OSA in 10%.
Conclusion
In children with syndromic or complex craniosynostosis the home cardiorespiratory 
monitoring is feasible to diagnose obstructive sleep apnea. Oximetry alone can be used as 
a rough estimate screening and with a negative test moderate OSA can be excluded. X fl ow 
can be helpful to diagnose OSA in absence of nasal fl ow. 
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INTRODUCTION
Children with syndromic or complex craniosynostosis are at risk to develop obstructive 
sleep apnea (OSA) due to midface hypoplasia and collapse of the pharynx1. Regular 
scree ning of these patients for the presence of OSA is indicated. Th e golden standard 
to diagnose OSA is polysomnography (PSG) in a hospital setting. In 2003, Poels et al.2 
evaluated the feasibility of the home cardiorespiratory recording device during a single-
night to assess OSA in children who snore, between the ages of two to seven. Only 29% 
of the recordings that were performed in 24 children were classifi ed as successful. Possible 
explanations for this low percentage of successful studies were the limited tolerance of the 
patients for the sensors and the fact that caregivers had to apply the device themselves with 
the help of a written instruction. 
In contrast to the healthy children studied by Poels et al.2 children with syndromic or 
complex craniosynostosis undergo medical examinations regularly and might therefore 
tolerate application of the device better. With a successful use of home cardiorespiratory 
monitoring the number of the visits and admissions to the hospital for routine polysomnog-
raphy can be reduced, which is of particular interest for these children and their families. 
Home cardiorespiratory monitoring can be analyzed in the same way as polysomnogra-
phy in a hospital setting, but the use of defi nitions for apnea and hypopnea in children is 
not uniform2-5. Th e aim of our study is to analyze the feasibility of a home cardiorespira-
tory monitor in children with craniosynostosis and to analyze whether oximetry alone or 
the sum of the amplitudes of the thoracic and abdominal movements (X fl ow) are valuable 
alternative assessments to diagnose OSA at home, when complete recording of all the 
sensor signals was not achieved.
METHODS
Patients and study design
In a prospective longitudinal study children with a craniosynostosis syndrome or complex 
craniosynostosis were included. Syndromic craniosynostosis included children with Apert, 
Crouzon, Muenke, Pfeiff er and Saethre-Chotzen syndrome. Complex craniosynostosis is 
defi ned as fusion of two cranial sutures or more without a known mutation in fi broblast 
growth factor receptor (FGFR) 1, 2, 3 or TWIST gene.
After informed consent the child underwent a polysomnography at home. Th is proce-
dure was repeated annually. When treatment for OSA was needed the PSG was repeated 
three months after starting the treatment.
Th e institutional medical ethics committee of the Erasmus Medical Center Rotterdam 
approved the study protocol (MEC-2005-273). 
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Equipment
Polysomnography was done ambulatory with Embletta Portable Diagnostic System 
(Medcare Flaga, Reykjavik, Iceland). Th oracic and abdominal movements were registered 
by elastic trace belts. Nasal fl ow was measured by a nasal cannula (pressure transducer), 
oxygen saturation and heart rate (pulse) were recorded by a pulse oximeter. Th e signals 
from the sensors were displayed and analyzed with Somnologica for Embletta software 3.3 
ENU (Medcare Flaga, Reykjavik, Iceland). 
Procedure of ambulatory polysomnography
Th e recording devices were transported to the children by a courier. Caregivers were 
instructed to apply the sensors and start the recording by connecting the adapter to the 
device at the usual bedtime. A manual was supplied. Th e next morning the recording was 
ended and the courier brought the device back to the hospital.  
Criteria for analysis
1. Feasibility was assessed in terms of the number of adequate performed recordings (i.e. 
recordings during a minimal total sleep time) and the number of successful recordings 
(i.e., recordings with suffi  cient artefact-free signals of the various determinants to allow 
scoring of the PSG). 
2. Defi nitions of the various determinants. 
a. Nasal fl ow as tool for the registration of respiration was used to diff erentiate between an 
obstructive or central character of the apnea or hypopnea. 
b. Th e minimum duration of total sleep time for overnight recordings on sleep apnea 
evaluation in adults and children is 360 minutes6-8. In this study in children with cranio-
synostosis a measurement was also considered adequately performed and successful if a 
minimal total sleep time of 360 minutes with artefact-free signals of the various determi-
nants was available. 
c. Obstructive apnea was defi ned as absence of airfl ow (measured by a nasal cannula) and 
hypopnea as reduction by ≥ 50% in nasal fl ow signal amplitude, both for more than two 
breaths8-10. Mixed apnea was defi ned as a type of obstructive apnea with a central compo-
nent that mostly preceded the obstructive pattern, for more than two breaths. A central 
apnea was defi ned as the absence of airfl ow without eff ort of thorax and abdomen for more 
than two breaths and was considered pathologic if it was followed by a desaturation. A 
desaturation was defi ned as ≥ 4% decrease in saturation with respect to the baseline. 
Criteria for diagnosis
Th e degree of OSA was expressed in an obstructive apnea hypopnea index (OAHI), the 
number of obstructive and mixed apneas with or without desaturation in combination 
with hypopneas followed by desaturation per hour. An OAHI score < 1 is considered to 
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be normal, between 1 and 5 is defi ned as mild OSA, between 6 and 25 as moderate OSA, 
and > 25 as severe OSA2, 8, 9, 11. A central apnea index (CAI) was calculated as the number 
of central apneas followed by desaturation per hour. An abnormal central apnea index was 
defi ned as ≥ 1. A combined obstructive apnea hypopnea index and central apnea index 
(OAHCAI) was calculated. Th e similar scores for gradation of the index were used. 
Alternative assessments 
1. Oximetry. 
An oxygenation desaturation index (ODI) was determined, based on the number of 
desaturations per hour. A negative oximetry was defi ned as an ODI < 1. 
2. X fl ow. 
Th e X fl ow is the sum of the amplitudes of the thoracic and abdominal movements and 
in case of obstruction out-of-phase movement of the thoracic and abdominal movements 
is present. Within the group of successful recordings a comparison was made between the 
obstructive apneas and hypopneas determined with the nasal fl ow and the X fl ow. Th e 
correlations between nasal fl ow and X fl ow were determined with intraclass correlation 
with the accessory 95% confi dence interval (CI)12. In the recordings in which nasal fl ow 
was absent the X fl ow was used to determine obstructive apneas and hypopneas. 
Statistical analysis 
For statistical analysis contingency tables were made to calculate the positive (PPV) and 
negative predictive value (NPV) for oximetry in comparison with polysomnography. A 
p-value of < 0.05 was considered to be statistically signifi cant. All numbers are expressed 
as median and range. 
RESULTS
Of 150 eligible children 129 (86%) participated in the study, of whom 50% were boys. 
Th eir median age at the moment of PSG was 6.2 years (range 2.5 mnths-20.3 yrs). In this 
group 200 diff erent polysomnographies were performed. Overall, 81 (40.5%) recordings in 
65 children were suitable for calculating an OAHI (fi gure 1) with all signals being present. 
Of the remaining 119 recordings an oxygen saturation profi le was available in 83 (41.5%), 
the oxygen saturation recording was too short in 3 (1.5%), and the recording was not 
adequately performed in 33 (16.5%) because the total sleep time was too short (n = 28, 14%) 
or the child did not co-operate (n = 5, 2.5%).  
Th e analysis of the 81 successful recordings demonstrated 26 recordings (32%) in 21 
children with mild OSA and 8 (10%) recordings in 7 children with moderate OSA, based 
on OAHI (table 1). 
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
44
Ambulatory PSG in children
Central apneas
An abnormal central apnea index was seen in 14 recordings in 12 children. Th e number 
of pathologic central apneas varied from one to six per hour (median of two per hour). 
Th ere was a signifi cant diff erence (p= 0.000) in age between children diagnosed with or 
without an abnormal central apnea index (1.5 versus 9.0 years). A combined obstructive 
apnea hypopnea and central apnea index (OAHCAI) resulted in 42 (52%) recordings in 
33 children in a mild index (between 1 and 5) and in 11 (14%) recordings in 9 children in a 
moderate index (between 6 and 25).
Oximetry
Analysis of the oxygenation desaturation index in the 81 successful recordings in 65 children 
showed a negative ODI in 53 recordings in 49 children (table 1). In these 53 recordings a 
positive OAHI despite of the negative oximetry was found in 11 measurements (negative 
predictive value of 79%). A negative oximetry never resulted in missing of moderate OSA; 
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Figure 1: Analysis of 200 polysomnography recordings in 129 children
Table 1: Overview of the results of 81 successful polysomnographies
Polysomnographies
n = 81 (65 children)
TST (min) 557 (360-900)
Mean saturation 97.5 (sd 1.1)
Nadir saturation 89.8 (sd 5.1)
Mean respiratory rate 17.2 (sd 4.3)
Mean heart rate 80.2 (sd 20.1)
OAHI < 1 47 (37 children)
OAHI 1-5 26 (21 children)
OAHI 6-25   8 (7 children)
CAI ≥ 1 14 (12 children)
OAHCAI < 1 28 (23 children)
OAHCAI 1-5 42 (33 children)
OAHCAI 6-25 11 (9 children)
ODI < 1 53 (49 children)
ODI 1-5 20 (16 children)
ODI 6-25   8 (6 children)
sd standard deviation
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so the negative predictive value for moderate OSA was 100%. Of the 28 recordings with a 
positive ODI also a positive OAHI was found in 23 (positive predictive value 82%). 
Of the 83 recordings in 65 children with only an available oximetry signal 40 recordings 
(48%) in 34 children showed OSA based on ODI; 30 mild OSA in 26 children, 9 moderate 
OSA in 7 children and 1 severe OSA.
X fl ow
Comparison of nasal fl ow with the X fl ow in successful recordings showed overall that 86% 
of the hypopneas recorded with nasal fl ow were also scored with the X fl ow, whereas 55% of 
the obstructive apneas recorded with nasal fl ow were also scored with the X fl ow. However, 
after comparison the degree of OSA in no, mild or moderate measured by nasal and X fl ow 
in these patients, in 10% the severity of OSA was underestimated. 
In the 81 recordings with all signals the intraclass correlation of 0.77 between nasal fl ow 
and X fl ow was good (95% confi dence interval [0.65-0.86]). Of the 83 recordings with only 
an available oximetry signal in absence of nasal fl ow the X fl ow was analyzed in 69 (34.5%) 
recordings in 56 children. Th ese showed OSA in 33 recordings in 29 children; 23 mild in 
20 children and 10 moderate in 9 children. 
Analysis of the oxygenation desaturation index in these 69 recordings showed a negative 
ODI in 36 recordings in 35 children. In these 36 recordings a positive OAHI despite of 
the negative oximetry was found in 10 measurements (negative predictive value of 72%). 
A negative oximetry resulted in missing of one moderate OSA; so the negative predictive 
value for moderate OSA was 97%. Of the 33 recordings with a positive ODI also a positive 
OAHI was found in 23 (positive predictive value 70%). Using X fl ow as screening method 
raised the overall success rate from 40.5 to 75% (table 2). 
Table 2: Diagnosis of obstructive sleep apnea based on OAHI measured by nasal fl ow or X fl ow and based on 
ODI
OSA OAHI nasal fl ow 
n = 81 (65 children)
OAHI X fl ow
n = 69 (56 children)
ODI
n = 83 (65 children)
Mild 32% (21 children) 33% (20 children) 36% (26 children)
Moderate/ severe 10% (7 children) 14% (9 children) 12% (8 children) 
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DISCUSSION 
In children with syndromic or complex craniosynostosis the use of home cardiorespira-
tory monitoring resulted in 40.5% successful recordings. Th is result is better than the 
previously mentioned study in ‘healthy’ children scheduled for adenotonsillectomy by 
Poels et al.2 with a successful recording rate of only 29%. Th e higher number of successful 
recordings might be explained by the fact that parents of children with a serious medical 
condition were more motivated and maybe these children were more cooperative due to 
their frequent medical investigations. Th e fi rst explanation seems to be confi rmed by the 
high participation rate of 86% in this study, compared to 45% in the study of Poels et al.2 
Of the recordings 59.5% were not successful due to absence of nasal fl ow, technical failure 
or too short registration of the signals. Only 2.5% of the children did not accept the device. 
Th e most logical reason for the absence or decreased presence of nasal fl ow was the shift 
of the nasal cannula during sleep, or the fact that children did not tolerate the nasal can-
nula. We expected that children below the age of one and older children who understand 
the aim of the recording would accept the nasal cannula better, but this was not seen in 
this study. In these children with syndromic or complex craniosynostosis we speculate that 
the main reason for the failing signal of the nasal cannula is the absence of nasal passage 
due to the severe anatomical malformations of the nasal cavity, leading to almost complete 
obstruction of the upper airway and as a consequence preferred mouth breathing13. Th is 
problem might be solved using a mouth thermistor to record oral fl ow but this application 
is not (yet) used at home. 
In our defi nition of the OAHI we did not account for pathologic central apneas whereas 
in some previous studies this was done2. A combined OAHCAI showed a 20% increase 
of the children with an index between 1 and 5 and a 4% increase of the children with an 
index between 6 and 25. Th e high number of pathologic central apneas found in the very 
young children was especially related to central irregularity of breathing14, 15. It is however 
important to notice that in patients with severe OSA, which was not the case in this 
study, an increase of central apneas can be found due to ventilatory control instability16, 
17. Th erefore when central apneas are taking into account in the analysis of OSA the AHI 
can be considerably higher. Based on this study in children with syndromic or complex 
craniosynostosis we recommend excluding the pathologic central apneas in the AHI for 
defi ning OSA. 
Concerning the defi nitions for the apnea hypopnea index we used the criteria stated in 
2005 by the American Academy of Sleep Medicine17. Brouillette et al.3 advocated using 
oximetry alone to show OSA in healthy children. A high positive predictive value of 97% 
was found if desaturations were recorded, but a negative oximetry could not rule out OSA. 
Children with a negative oximetry had a 47% probability of having OSA on full poly-
somnography in the hospital. In our study we compared within the successful recordings 
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oximetry with the other signals and found compared with the study of Brouillette et al.3 a 
lower positive predictive value for oximetry (82%) and a higher negative predictive value 
(79%). However, if only moderate OSA is considered to be clinical signifi cant a negative 
oximetry never resulted in missing a case of moderate OSA. Overall, we concluded that 
oximetry can be used as a rough estimate screening tool but with limited accuracy. In 
the 83 recordings in 65 children in which only an oximetry signal was present we found a 
negative test in 43 recordings in 31 children.
Th e use of X fl ow might be an alternative method in absence of the nasal fl ow. Previ-
ously Ciftci et al.18 showed in a clinical setting in 90 symptomatic adult patients with an 
apnea hypopnea index > 5 that hypopneas monitored by only the eff ort amplitude of tho-
racoabdominal movements without regard for airfl ow amplitude had a sensitivity of 97% 
and a specifi city of 84% to distinguish between OSA and non-OSA. Th ey concluded that 
thoracoabdominal movements can be useful in situations when the nasal fl ow is diffi  cult 
to interpret18. We are the fi rst to report the use of X fl ow in ambulatory polysomnography 
in children in absence of a nasal fl ow measurement. Comparing the X fl ow and the nasal 
fl ow signals we found using the X fl ow that in 86% the hypopneas were recorded and in 
55% the obstructive apneas. It was remarkable that hypopneas were detected better with 
X fl ow than obstructive apneas because obstructive apneas will result in a more extensive 
out-of-phase movement of thorax and abdomen. A possible explanation for the fact that 
this out-of phase movement was less well recorded could be the positioning of the trace 
belts during the recordings. Due to shifting of the trace belts, the same registration of 
movements of either the abdominal or thoracic movements could occur. On the contrary, 
the measurement of hypopnea is less dependent on the correct position of the trace belts 
and the defi nition itself is more fl exible than the defi nition of an obstructive apnea. How-
ever, the underestimation of the degree of OSA is limited with 10%. In 69 recordings in 56 
children using the X fl ow in absence of nasal fl ow OSA was showed in 33 recordings (48%) 
in 29 children. Th e negative (72%) and positive (70%) predictive value for oximetry were 
lower in comparison with nasal fl ow, but a negative oximetry resulted in missing of only 
one case of moderate OSA. If X fl ow was used as additional screening method the overall 
success rate for ambulatory polysomnography recordings would rise from 40.5 to 75%.  
Overall, comparing the presence of OSA using the complete recording of all the sensor 
signals, oximetry or X fl ow, an almost similar percentage of 34% was found for mild OSA 
and 12% for moderate OSA in this patient group. 
Several limitations are to be noticed in this study due to the use of ambulatory polysom-
nography in an uncontrolled environment. Parents were instructed by a written form to 
apply the sensors by themselves and due to inexperience not all sensors might be applied 
suffi  ciently. We tested the X fl ow measurements using these home recordings whereas 
we were not informed if the abdominal and thoracic belts were at the appropriate place. 
Furthermore only one of the researchers (Bannink N.) scored the signals whereas it should 
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be better to have two diff erent scorers looking each at the same recording, one analyzing 
all signals with nasal fl ow and the other analyzing all signals minus nasal fl ow based on 
X fl ow. Even more ideal would be to apply the ambulatory polysomnography sensors in 
the hospital together with the sensors of regular full polysomnography to test the X fl ow 
for validity. However, despite these limitations we think that X fl ow can be helpful in the 
diagnosis of OSA in absence of nasal fl ow. 
In conclusion, in children with syndromic or complex craniosynostosis the home cardio-
respiratory monitoring is feasible to diagnose obstructive sleep apnea. Oximetry alone 
can be used as a rough estimate screening and with a negative test moderate OSA can be 
excluded. X fl ow can be helpful to diagnose OSA in absence of nasal fl ow. 
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Respiratory outcome of midface advancement 
ABSTRACT
Objective
Almost 50% of patients with Apert, Crouzon or Pfeiff er syndrome develop obstructive 
sleep apnea (OSA), mainly due to midface hypoplasia. Midface advancement is often the 
treatment of choice, but the few papers on long-term outcome reported mixed results. 
Th is paper aimed to assess the long-term respiratory outcome of midface advancement in 
syndromic craniosynostosis with OSA and to determine factors contributing to its effi  cacy. 
Methods
A retrospective study was performed on 11 patients with moderate or severe OSA, re-
quiring oxygen, continuous positive airway pressure (CPAP), or tracheostomy. Clinical 
symptoms, results of polysomnography, endoscopy and digital volume measurement of 
the upper airways on CT scan before and after midface advancement were reviewed. 
Results
Midface advancement had a good respiratory outcome in the short term in 6 patients and 
was ineff ective in 5. In all patients without respiratory eff ect or with relapse, endoscopy 
showed obstruction of the rhino- or hypopharynx. Th e volume measurements supported 
the clinical and endoscopic outcome. 
Conclusion
Despite midface advancement, long-term dependence on, or indication for, CPAP or 
tracheostomy was maintained in 5 of 11 patients. Pharyngeal collapse appeared to play a 
role in OSA. Endoscopy before midface advancement is recommended to identify airway 
obstruction that may interfere with respiratory improvement after midface advancement. 
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INTRODUCTION
Craniosynostosis is a congenital disorder aff ecting in 1 in 2.500 births; it is characterized 
by the premature fusion of calvarial sutures. Th is fusion restricts normal growth of the 
skull, brain, and face, and necessitates surgical correction. In about 40% of the cases it 
is part of a syndrome such as the Apert, Crouzon, Pfeiff er, Muenke or Saethre-Chotzen 
syndrome1.
Almost 50% of children with Apert, Crouzon or Pfeiff er syndrome develop obstructive 
sleep apnea (OSA), mainly during the fi rst 6 years of life.2-4 Th ese patients are at risk for 
OSA due to midface hypoplasia, but other factors such as adenotonsillar hypertrophy, 
and mandibular hypoplasia may be involved as well.4, 5 According to its severity and cause, 
OSA can be treated pharmacologically, surgically (e.g. with adenotonsillectomy, midface 
advancement or tracheostomy), or non-surgically (e.g. with nocturnal oxygen or continu-
ous positive airway pressure (CPAP)).5, 6 If OSA is not treated suffi  ciently, disturbed sleep 
patterns may result in major physical and functional impairment, for instance failure to 
thrive, recurrent infections, disturbed cognitive functions, delayed development, cor pul-
monale or sudden death.7 As midface hypoplasia is the main cause of OSA in syndromic 
craniosynostosis, midface advancement appears to be the treatment of choice.8 
In the long-term, mixed respiratory results were reported following midface advance-
ment in patients with syndromic craniosynostosis.9 It is unclear how long and to which 
level the improvement in breathing lasts, and which factors are predictors of respiratory 
outcome. To assess the respiratory outcome of midface advancement for moderate to 
severe OSA and to determine predictive factors, the authors carried out a retrospective 
study in patients suff ering from Apert, Crouzon or Pfeiff er syndrome.
METHODS
Study group
Over 100 patients with Apert, Crouzon and Pfeiff er syndrome have been treated at the 
Dutch Craniofacial Center since 1983. For this study, the authors were only interested in 
the 14 patients with moderate or severe OSA, requiring treatment with nocturnal oxygen, 
CPAP, nasopharyngeal tube (NPT), or tracheostomy, who presented between 1987 and 
2006. Th eir records were analyzed for clinical symptoms of OSA, results of polysomnogra-
phy (PSG) and endoscopy of the upper airways, and the diff erent treatment modalities for 
OSA. CT-scans were used to measure the airway volume before and after midface advance-
ment. For this case series, suffi  cient data and follow-up were available in 11 patients. 
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Obstructive sleep apnea
Th e clinical symptoms of OSA were snoring, diffi  culty in breathing, apnea during sleep, 
perspiration, and daytime sleepiness. PSG was carried out ambulatory or during admis-
sion to hospital and the following criteria for analysis were used. Apnea was defi ned as 
absence of airfl ow for more than two breaths and hypopnea as reduction by ≥ 50% in nasal 
fl ow signal amplitude for more than two breaths. Th e analysis was expressed in an apnea 
hypopnea index (AHI), the number of obstructive apneas in combination with hypopneas 
followed by desaturation per hour, and an oxygenation desaturation index (ODI), the 
number of desaturations (≥ 4% decrease with respect to the baseline) per hour. A score < 
1 is considered to be normal, 1-5 is defi ned as mild OSA, 6-25 as moderate OSA, and > 25 
as severe OSA.10-13 
Respiratory outcome of midface advancement
Th e timing, type and outcome of the following interventions were evaluated: oxygen, 
NPT, CPAP, adenotomy and tonsillectomy, tracheostomy and midface advancement. 
Th e diff erent interventions in each patient were added to evaluate the total number of 
procedures carried out to improve the breathing. 
Th e effi  cacy of treating OSA was determined on the basis of clinical symptoms and 
PSG before and after midface advancement. Midface advancement was considered to be 
eff ective on respiration, in the short term, if oxygen, CPAP, NPT or tracheostomy were 
discontinued within 1 year after midface advancement. Relapse of OSA was defi ned as the 
need for respiratory support again. Long-term eff ectiveness was defi ned as independence 
of respiratory support at least 2 years after midface advancement. 
Endoscopy of the upper airway
Endoscopies were carried out under general anesthesia in a supine position. In 2 patients 
an additional endoscopy was done at the outpatient clinic in a sitting position. Th e endos-
copies were carried out to identify the possible level of obstruction including anatomical 
malformations in the rhino- and hypopharynx.
Volume measurements of the upper airway
A software program (MevisLab) was used to import and analyze the CT scans by means 
of a custom-designed tool. Preoperative and postoperative scans were analyzed on trans-
versal slices. Th e maxillary, ethmoidal, frontal and sphenoidal sinuses, concha bullosa and 
the oral cavity were manually excluded. Th e respiratory active air-holding cavities were 
segmented using semi-automatic region growing. Th e volumes of 2 separate anatomically 
defi ned areas were measured in mm3, taking the scale into consideration: nasal cavity and 
rhinopharynx (defi ned to range from the most caudal point of the frontal sinus to the 
cranial point where the soft palate transformed into the uvula); and the oro- and hypo-
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pharynx (ranged from the most cranial point where the soft palate transformed into the 
uvula, to the most caudal point of the hyoid bone). Th e total volume is being calculated 
by adding the volumes of the 2 areas. All patients were scanned according to a protocol, 
using the same CT scan, and the thickness of the transversal slices was similar.
Statistical analysis
Th e results were analyzed using SPSS 14.0 for Windows 2000. All numbers are expressed 
as median and range. 
RESULTS
Eleven patients with Apert (n = 3), Crouzon (n = 6) or Pfeiff er (n = 2) syndrome who had 
moderate or severe OSA, requiring treatment with nocturnal oxygen, CPAP, NPT, or tra-
cheostomy, were included. Four of the 11 patients were boys (36%), aged 14.9 years (range 
4.1-23.1 years). All patients had midface hypoplasia. Six of the 11 patients underwent PSG 
before the start of treatment for OSA; this showed moderate OSA in 3 patients and severe 
OSA in 3 (median ODI 25, range 10-66). In the other patients, no PSG was performed due 
to the severity of the respiratory distress at presentation, which necessitated instant airway 
management, namely intubation or insertion of a tracheostomy. Airway treatment after 
diagnosis of OSA involved tracheostomy in 4 patients, oxygen in 3, CPAP or NPT in 3, and 
monobloc with NPT in 1. All patients underwent a midface advancement with distraction 
followed by a control PSG; in 3 a monobloc was performed; and in 8 a le Fort III. 
In 10 of the 11 patients an endoscopy of the upper airway was performed to identify 
the level of obstruction; this was done preoperatively in 5, postoperatively in 1, and both 
in 4. In 4 patients, a CT scan, carried out before and after midface advancement, was 
available. After advancing the midface for at least 20 mm the occlusion was corrected 
from class III in class II with overcorrection in all patients (fi gure 1). Clinically, a suffi  cient 
advancement of the midface was achieved in all patients. Final adjustment of the level of 
occlusion is performed in patients aged 18 or older. So far, an additional le Fort I has been 
performed in 2, no patient underwent mandibular correction. Th e follow-up time after 
midface advancement was 3.5 years (range 2.4-11.4 years, mean 5.7 years). 
Respiratory outcome of midface advancement
Th e follow-up of the 11 OSA patients at diff erent ages is shown in fi gure 2. Th e respiratory 
outcome of each treatment option was considered. Adenotomy and tonsillectomy had a 
temporary benefi cial eff ect on respiration in 1 of 5 patients, and no eff ect in 4. 
In 6 of the 7 patients, oxygen and CPAP or NPT were eff ective in bridging time to the 
midface advancement. In the other patient, tracheostomy was required despite monobloc 
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and NPT. Midface advancements were carried out in three diff erent modes: monobloc 
with and without distraction, and le Fort III with distraction. 
Th e patients with moderate or severe OSA underwent a median number of 5 (2-8) 
invasive or non-invasive treatment procedures to improve their breathing. Midface ad-
vancement in the short term had a good or improved respiratory outcome in 6 patients 
(patients 1, 2, 8, 10, 11 and patient 9, respectively), and was unsatisfactory in 5 (patients 3, 
4, 5, 6, and 7) (table 1). In 2 patients (patients 1 and 11) OSA relapsed. In the long term, 
4 of the 11 patients (patients 3, 4, 6 and 7) were still dependent on CPAP (2.5, 8.1 and 8.2 
years after advancement) or tracheostomy (10.6 years) in spite of a surgically successful 
midface advancement and 1 (patient 11) had severe OSA without treatment following a 
parental decision. 
Endoscopy and volume measurements of the upper airway 
Anatomical malformations of the rhino- and hypopharynx were a common feature in 
nearly all patients, causing a functional obstruction at this level. Only 1 patient did not 
have this feature and had a good respiratory outcome after midface advancement. All 
patients had a narrow nasal cavity. 
Th e volumes of the upper airway on CT scan before and after midface advancement 
were calculated in patients 1, 4, 6 and 8 (table 2). In fi gure 3 the changes in these volumes 
are shown. In patient 1 the CT scan 4 months post-surgery showed an increase in airway 
volume (1.4 times), mostly in the region nasal cavity and rhinopharynx (1.6 times). One 
year after midface advancement the CT scan illustrated the narrow hypopharynx seen 
with endoscopy, with a volume decrease in the region oro- and hypopharynx (0.7 times). 
Th e CT scans of patient 4, made 7 months before and 1 year after midface advancement, 
showed no increase in the total volume of the upper airway. Th e volume of the oro- and 
hypopharynx increased 1.2 times. Patient 6 showed no change in total volume of the 
Figure 1: Suffi  cient correction was achieved in all patients; after advancing the midface for 20 mm the occlusion 
changed from class III to class II including the overcorrection
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Figure 2: Follow-up of OSA in 11 patients at diff erent ages
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Respiratory outcome of midface advancement 
upper airway 4 months after midface advancement in comparison with 1 year before, 
which matches the clinical presentation. After midface advancement the nasal cavity and 
rhinopharynx volume increased, but the oro- and hypopharynx region was 0.7 of the 
volume before. In patient 8, with a clinical good result, the volume of the upper airway 
increased by a factor of 1.6, 13 months after midface advancement in comparison with 3 
months before. Th e volume of the nasal cavity and rhinopharynx increased 1.6 times and 
the volume of the oro- and hypopharynx was 1.7 times larger. 
DISCUSSION
In the general population, adenotonsillectomy is the treatment of choice, as adenotonsillar 
hypertrophy is an important cause of OSA.13, 14 In this study, in patients suff ering from 
Apert, Crouzon or Pfeiff er syndrome with moderate or severe OSA, neither tonsillectomy 
nor adenotomy had a signifi cant eff ect on respiration.
In patients with syndromic craniosynostosis, midface hypoplasia is generally considered 
to be the major cause of upper airway obstruction.4 All children in this study also had mid-
face hypoplasia. Although, midface advancement seemed to be a good treatment modality 
for compromised airways at the level of the midface4, 15, in this study 6 of 11 patients (55%) 
had a favourable eff ect in the short term after monobloc or le Fort III with distraction. 
Witherow et al.16 found an improvement in all patients suff ering from Apert, Crouzon or 
Table 1: Respiratory outcome of midface advancement in the short term 
Treatment Number of treatments Eff ect Insuffi  cient eff ect
Monobloc without distraction 3 1 2
Monobloc with distraction 3 2 1
Le Fort III with distraction 8 4 4
Total view (N patients) 14 (11) 7 (6) 7 (5)
Table 2: Measurements of airway volume on CT scan before and 4 months and/or 1 year after midface 
advancement in mm3
Patient Nasal cavity and rhinopharynx
Before          After 1      After 2
Oro- and hypopharynx
Before          After 1        After 2
Total airway volume
Before         After 1         After 2
1 20.109        32.850       33.544 13.287         14.772        9.620 33.396        47.622        43.164
4 35.909        33.166   6.408           7.913 42.317        41.078
6 19.639        20.327   9.166           6.252 28.804        26.578
8 20.147        32.671   3.683           6.081 23.830        38.751
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Figure 3: Volume measurements of the upper airway before and after midface advancement
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Pfeiff er syndrome with abnormal PSG after monobloc with external distraction. Of the 
14 patients with severe OSA, treated with tracheostomy or CPAP, OSA was resolved after 
surgery in 6 (43%). Th e other 8 patients remained dependent on tracheostomy or CPAP. 
Th e mean follow-up was 24 months.16 Arnaud et al.17 showed a respiratory improvement 
measured by oxygen level in 14 of 16 patients with Apert, Crouzon or Pfeiff er syndromes 
after monobloc with internal distraction. In the severe cases, removal of tracheostomy 
was possible in 4 of 6 (67%). In 1 patient a tracheostomy was needed 6 months after 
removal of distractors because of relapse of OSA. Th e mean follow-up after surgery was 2.5 
years.17 Nelson et al.9 studied 18 patients with syndromic bilateral coronal synostosis and 
OSA, in 15 of them a tracheostomy or CPAP was required before midface advancement. 
After midface advancement, 5 patients were decanulated and in 6 CPAP was discontinued 
(73%). Th e mean time of follow-up was 3.2 years. In these 3 studies, midface advancement 
did not result in good respiratory outcome in all (similar to the present study). Th ese 
studies and the present one showed that respiratory outcome after midface advancement 
in syndromic craniosynostosis patients who need it the most is not as successful as is 
generally thought. Inclusion of patients with mild OSA in other studies has given the 
impression that midface advancement with distraction gives a guaranteed improvement 
of OSA.
Endoscopy of the upper airway can show the level of obstruction and the dynamic 
infl uence of breathing. In the 4 patients with persistent OSA after advancement and in 
the patient with a relapse of OSA an obstruction of the rhino- or hypopharynx was seen. 
In Apert, Crouzon and Pfeiff er syndrome, the anatomy of the upper airway is diff erent 
and there seems to be a dynamic function problem regarding the airway, possibly related 
to the mutation of the fi broblast growth factor receptor.1 Th e nasal cavity is narrow in 
all patients; this is common in these syndromes. Collapse of the pharynx is a dynamic 
problem that may or may not improve with midface advancement. In the non-responders, 
the pharyngeal walls collapsed with each breath, and resulted in an airway obstruction. 
So the advancement did not result in a larger airway volume and could not overcome 
the tendency of the pharyngeal walls to collapse. Th e changes in airway volume on CT 
scan after midface advancement were similar to the results of endoscopy, and thus seem 
to illustrate the dynamic situation of the airway, including the level of obstruction. An 
improvement of airway volume on CT correlated with a good respiratory outcome. Th e 
authors consider that the degree of functional obstruction of the rhino- or hypopharynx 
correlates with respiratory outcome after midface advancement: a mild tendency for 
collapse can be overcome with the midface advancement. Th is hypothesis could not be 
substantiated in this retrospective analysis. 
Measurement of airway volume on CT scan has some limitations, in particular the diffi  -
culty of manually defi ning the borders of the nasal cavity because of anatomical anomalies. 
A cold can aff ect the thickness of the mucosa and the size of the tonsils, and the position 
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and respiration state of the patient in the CT scan can infl uence the volume of the airway 
at the moment of scanning. Th e infl uence of growth in volume changes is not likely 
in patients with syndromic craniosynostosis since they have growth retardation of the 
maxilla18 and restriction of normal transverse growth of the mandible, possibly secondary 
to cranial base abnormalities.19 
Previous studies on airway changes after advancement were based on tracing of cepha-
lograms.20, 21 Ishii et al.20 studying 16 patients with Apert or Crouzon syndrome found an 
improvement on cephalogram in the nasopharyngeal airway after le Fort III osteotomy, 
but no change in hypopharyngeal airway was found. In 12 ‘normal’ adults who underwent 
maxillary and mandibular advancement for OSA Li et al.21 found an increase in the airway 
dimension after surgery measured by cephalometric imaging. Fiberoptic nasopharyngo-
scopy with Müller maneuver (take a breath while the mouth is closed and the nostrils 
are plugged) showed a decrease in collapsibility of the upper airway, mostly the lateral 
pharyngeal wall. Th ey suggested a reduction of the thickness of the muscular wall. Man-
dibular advancement seemed to be needed to enlarge the pharyngeal airway. In the present 
study group no mandibular advancement was carried out. Mandibular advancement is 
generally not considered in children with syndromic craniosynostosis to treat their OSA, 
although this may be an option in patients with disappointing results following midface 
advancement and remaining obstruction at the hypopharynx. 
Th is study showed that moderate or severe OSA in children with syndromic cranio-
synostosis is a major problem and diffi  cult to treat. It is not only directly correlated with 
midface hypoplasia. Endoscopy showed anomalies at diff erent levels throughout the up-
per airway. Dynamic pharyngeal collapse can aff ect the respiratory outcome of midface 
advancement; endoscopy of the upper airway before midface advancement may predict 
respiratory improvement. It may be possible to treat obstructions at another level with 
other procedures, such as widening of the palate to enlarge the nose and mandibular 
advancement to create more space at the level of the hypopharynx. Long-term follow-up 
is important because OSA may relapse.
To implement these fi ndings and to improve the prognostic information on respiratory 
outcome after midface advancement, the authors recommend performing an endoscopy 
of the upper airway before midface advancement to identify all levels of obstruction (also 
stated by Nelson et al.9). Treatment of OSA will then be better focussed on its cause. Th e 
volume measurements of the upper airway will be continued in further research as a tool 
to investigate the eff ect of midface advancement on airway volume and to specify the level 
of largest gain on respiration.
 
In conclusion, despite midface advancement, long-term dependence on, or indication 
for, CPAP or tracheostomy was maintained in 5 of 11 patients in whom Apert, Crouzon 
or Pfeiff er syndrome was combined with moderate or severe OSA. In the patients with 
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persistence of OSA despite optimal surgical treatment, pharyngeal collapse appeared to 
play a role in obstruction of the airway. Endoscopy makes it possible to identify a static or 
dynamic airway obstruction that may interfere with respiratory improvement, enabling a 
prediction of respiratory improvement and treatment to be adapted to the specifi c level of 
obstruction. Long-term follow-up is needed, because of the chance of relapse.
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ABSTRACT
Objective
Patients with syndromic craniosynostosis are at risk for elevated intracranial pressure 
because of various physiologic and anatomic abnormalities. Th e aims of this study were 
to determine the prevalence of papilledema in syndromic craniosynostosis, to evaluate the 
results of the treatment, and to examine the risk factors.
Methods
Th is is a retrospective study on 84 patients with Apert, Crouzon, or Pfeiff er syndrome. 
Papilledema was defi ned as blurring of the margins of the optic disk. Th e association 
between clinical symptoms, beaten-copper pattern on skull radiograph, ventricular dilata-
tion on computed tomography scan, and papilledema was assessed.
Results
Papilledema was present in 51% of the patients. No relation between specifi c clinical 
symptoms and papilledema was found. Th e signifi cant associations were complex cranio-
synostosis, exorbitism, and ventricular dilatation.
Conclusion
Th e prevalence of papilledema in patients with Apert, Crouzon, or Pfeiff er syndrome is 
high, not only before cranial decompression but also after vault expansion. Annual fun-
doscopy is recommended to screen for papilledema. We consider that early decompressive 
surgery (within the fi rst year of age) prevents the development of papilledema and, most 
likely, elevated intracranial pressure.
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INTRODUCTION
Craniosynostosis is a congenital disorder, arising in 1 in 2500 births, characterized by the 
premature fusion of calvarial sutures. Th is fusion restricts the normal growth of the skull, 
brain, and face and needs surgical correction. In about 40% of cases (1:6250), craniosynos-
tosis is part of a syndrome, such as Apert, Crouzon, Pfeiff er, Muenke or Saethre-Chotzen 
syndrome1. 
Due to fusion of calvarial sutures the intracranial pressure (ICP) may be elevated. In 
isolated, single-suture craniosynostosis, the frequency of elevated ICP before vault ex-
pansion diff ers according to the site of the aff ected suture (e.g., 8% in trigonocephaly, 
13% in scaphocephaly and 16% in frontal plagiocephaly)2-4. Th e reported frequency of 
elevated ICP is 31% in brachycephaly (bilateral coronal synostosis) and 47% in complex 
craniosynostosis (combination of 2 sutures, e.g., coronal and sagittal suture synostosis)4. 
In patients with either Apert or Crouzon syndrome, elevated ICP before vault expansion 
is seen in approximately 45% and 63%, respectively5,6. Untreated, elevated ICP may lead to 
irreversible visual loss caused by optic nerve dysfunction and mental impairment4,7. Th ere-
fore, surgical decompression is recommended within the fi rst year of life4. Unfortunately, 
elevated ICP may still persist after early cranial expansion8. Information on the frequency 
of this problem, however, is limited9. 
Clinically, it is diffi  cult to recognize signifi cantly elevated ICP in these children because 
symptoms can be vague. Th e classic symptoms of elevated ICP -vomiting and disturbed 
consciousness- are typically absent. A skull radiograph and a computed tomography 
(CT) scan of the brain might be helpful in diagnosing signs of elevated ICP10,11. A reliable 
symptom, although rather late, is papilledema12. Th e criterion standard for measuring ICP 
is an invasive measurement. A drawback is the risk of complications such as haemorrhage, 
cerebrospinal fl uid leak, and infection9.
We have undertaken a retrospective study in patients with Apert, Crouzon, or Pfeiff er 
syndrome to determine the prevalence of papilledema before and after vault expansion. 
We have also assessed the risk factors for papilledema, and the results of surgery on pap-
illedema.
METHODS
Study group
Th e records of all patients with Apert, Crouzon, and Pfeiff er syndrome (n = 90) who were 
treated at the Dutch Craniofacial Center between 1983 and 2006 were reviewed. Patients 
with Saethre-Chotzen syndrome or Muenke syndrome (P250R mutation in FGFR3 gene) 
were not included. On the basis of genetic analysis, Crouzon and Pfeiff er syndrome 
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often cannot be distinguished from each other1. Th erefore, in this study, these clinical 
syndromes are considered to be a homogeneous group. Th e records were analyzed for 
clinical symptoms of elevated ICP, beaten-copper pattern on skull radiograph, results of 
fundoscopy, and CT scan. 
Papilledema
All fundoscopies were performed by an ophthalmologist by indirect ophthalmoscopy after 
mydriasis of the pupil with phenylephrine 2.5% and tropicamide 0.5%. Papilledema was 
defi ned as blurring of the margins of the optic disk (fi gure 1). If this was seen, objective re-
fraction (skiascopy) was performed to exclude hyperopia, which can resemble papilledema 
without being a sign of elevated ICP, so-called pseudopapilledema13. Papilledema was 
defi ned as persistent when it was still present 1 year after surgical intervention. Relapse of 
papilledema was defi ned as a recurrence of papilledema after at least 1 normal fundoscopy 
examination. Th e presence of papilledema on at least 1 occasion is included for analysis. 
Invasive ICP measurements were not reported because of the small amount.
Figure 1: Fundus photograph showing papilledema in the right eye of a girl with Crouzon syndrome
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Signs of elevated ICP
1. Clinical symptoms of elevated ICP.
Clinical symptoms suggestive of elevated ICP were taken as headache, vomiting, and 
changes in vision, and/or behavior. 
2. Beaten-copper pattern on skull radiographs.
Beaten-copper pattern on skull radiographs were assessed until the age of 7 years. Only 
digital radiographs were evaluated, and these were available for 28 patients. Th e area of 
beaten-copper pattern was graded as mild (<33%), moderate (33-66%), and severe (66-
100%)11 using Image J software (Wayne Rasband, National Institute of Mental Health, 
Bethesda, MD). Th e ratio of the area with beaten-copper pattern to the total area of the 
skull, defi ned the gradation (J.J.N.M. van der Meulen, et al., unpublished data, 2007). 
3. Ventricular dilatation on CT scan.
Ventricular dilatation was defi ned by an enlargement of the ventricles on CT scan, accor-
ding to the radiology report10. 
Effi  cacy of treatment to resolve papilledema
Th e effi  cacy of cranial surgery for resolving papilledema was determined by fundoscopy 
during follow-up. Th e surgical intervention was considered to be eff ective if papilledema 
disappeared or if no papilledema developed within the fi rst year after surgery.
Risk factors for elevated ICP
Potential risk factors for elevated ICP were the age at vault expansion, the number of fused 
sutures (with complex craniosynostosis defi ned as fusion of ≥ 2 sutures), midface hypo-
plasia, exorbitism, severe obstructive sleep apnea (OSA) -requiring supplemental oxygen, 
continuous positive airway pressure, nasopharyngeal tube or tracheal cannula14-16 - and 
ventricular dilatation on CT scan. 
Statistical analysis
Th e results were analyzed using SPSS 14.0 for Windows 2000. All numbers are expressed 
as median and range. Comparisons of categorical variables between patients with and 
without elevated ICP were performed using Fisher exact test. Logistic regression analysis 
with backward elimination was used to determine variables independently predictive of 
elevated ICP. Variables with a p-value < 0.20 after univariate analysis were used in a logistic 
regression model. Signifi cance was defi ned as a p-value < 0.05.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
72
Papilledema in Apert, Crouzon, and Pfeiff er syndrome
RESULTS
Six of the 90 patients were excluded because there was no information on the level of 
papilledema (i.e., no fundoscopy was performed). Th erefore, 84 patients with Apert (n = 
33), Crouzon (n = 43), or Pfeiff er (n = 8) syndrome underwent full analysis. Th ere were 
44 boys (52%) and the patients were aged 11.4 years (range 5 months to 23.5 years) at the 
time of review. 
Papilledema 
Preoperatively, 66 patients were examined and 25 had papilledema (38%; 95% confi dence 
interval 26-51%). Th e age at presentation with papilledema was 12 months (range 2-64 
months) in the Crouzon/ Pfeiff er group (n = 23), and in 2 children with Apert syndrome, 
it was 8 and 12 months (fi gure 2).
Postoperatively, 70 patients underwent fundoscopy, and 30 patients had papilledema 
(43%; 95% confi dence interval 31-55%), 7 with persistent papilledema after skull surgery, 
5 with a relapse, and 10 with a fi rst presentation after surgical decompression. In the 
remaining 8 patients, there was no preoperative fundoscopy. Two patients with Apert 
syndrome had pseudopapilledema due to hyperopia and were thus considered to have no 
papilledema. Another 7 patients with Apert syndrome and 2 with Crouzon syndrome had 
hyperopia and also true papilledema. 
In total, 43 (51%) of the 84 patients had papilledema on at least 1 occasion.
Signs of elevated ICP (table 1)
1. Clinical symptoms of elevated ICP.
Headache, vomiting, changes in vision and/or changes in behavior were recorded in 10 
(24%) of 42 patients with papilledema, which was not signifi cantly diff erent with the 9 
(27%) of 33 patients with normal fundoscopy (table 1). 
Table 1: Predictive variables of papilledema after univariate analysis 
Papilledema (n = 43) Normal fundoscopy (n = 41) p-value
Diagnosis Crouzon/Pfeiff er 31/ 43 20/ 41 0.044*
Complex craniosynostosis 31/ 42 20/ 40 0.040*
Midface hypoplasia  39/ 42 33/ 41 0.116
Exorbitism 42/ 43 34/ 39 0.097
Hyperopia 11/ 41 12/ 29 0.302
Headache, vomiting, 
changed vision and/or 
changed behavior
10/ 42 9/ 33 0.793
Impressiones 15/ 17 6/ 11 0.076
Severe OSA 8/ 41 3/ 31 0.331
Ventricular dilatation 26/ 40 8/ 36 0.000*
* p < 0.05
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Figure 2: Papilledema before and after vault expansion
VP ventriculoperitoneal
ATE adenotonsillectomy
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2. Beaten-copper pattern on the skull radiograph.
Th ere were 28 children younger than 7 years with available digital skull radiographs. 
Fifteen (88%) of 17 with papilledema and 6 (55%) of 11 with normal fundoscopy had 
beaten-copper pattern. Th ere was no signifi cant diff erence between these 2 groups. Th e 
gradation in the fi rst group was 27% mild, 20% moderate, and 53% severe, and in the 
second group, 67% mild and 33% severe. 
3. Ventricular dilatation on CT scan.
Ventricular dilatation on CT scan was seen in 26 (65%) of 40 patients with papilledema, 
whereas it was present in only 8 (22%) of 36 patients with normal fundoscopy (p ≤ 0.001). 
Effi  cacy of treatment to resolve papilledema (fi gure 2)
Vault expansion
All 25 children with papilledema before surgery were treated with decompressive surgery 
within 2 months of the problem being diagnosed. In 8 patients, skull expansion was 
combined with midface surgery because of severe airway obstruction in 4 patients (one 
received supplemental oxygen and one had a tracheostomy), severe exorbitism in 1 patient, 
and severe midface hypoplasia in 3 patients. After decompressive surgery, papilledema dis-
appeared in 10 (59%) of 17 patients for at least 1 year after surgery, it persisted in the other 7 
patients (41%). Th e results were unknown 1 year after surgery in 8 patients. Th irty of the 41 
patients without papilledema before decompressive surgery were screened postoperatively, 
and 2 (7%) of 30 developed papilledema within 1 year after surgery. Of the 18 patients with 
unknown preoperative state, papilledema was seen within 1 year of surgery in 2 (11%) of 
18 patients (fi gure 2). 
Fifty-four (83%) of the 65 patients did not have papilledema 1 year after surgery. No 
papilledema was seen preoperatively and postoperatively in 28 (93%) of 30 patients. After 
surgical treatment papilledema was eliminated in 10 (59%) of 17 patients. 
More than 1 year after vault expansion 70 patients were screened, and papilledema was 
seen in 30 patients (43%); papilledema persisted in 7 patients; it relapsed after 2.5 years 
(range, 14 months to 4.5 years) in 5 patients, and it developed postoperatively in 18 patients 
(including 8 patients within 1 year). In 20 (67%) of the 30 patients with postoperative 
papilledema, secondary surgery (vault expansion, monobloc, or le Fort III, ventriculoperi-
toneal shunting, revision of shunting and adenotonsillectomy) was performed, and it was 
eff ective in treating papilledema in 14 patients (70%). In 6 patients, papilledema persisted, 
and the known risk factors for elevated ICP were evaluated. In 4 of them, complementary 
treatment (vault surgery and non-invasive OSA treatment) was necessary; in the other 
2, the known risk factors were excluded. All patients were followed up on regular basis. 
Th e remaining 10 untreated children had papilledema, which occurred incidentally at 
1 or 2 follow-up examinations. In them, no symptoms of elevated ICP were present; 
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hydrocephalus and OSA could be ruled out. In these patients no surgical treatment was 
performed, and they were followed up intensively, and in at least 9 cases papilledema 
disappeared. 
Ventriculoperitoneal shunt
In the study group of 84 patients, 10 (12%) had a ventriculoperitoneal shunt; 6 because of 
hydrocephalus and 4 because of hydrocephalus and papilledema. Papilledema persisted in 
1 patient and relapsed in 2 patients.   
Risk factors for elevated ICP 
Premature fusion of calvarial sutures was seen in all patients; in 7% of the patients 1 
suture was fused; in 54%, 2 sutures; and in 39%, more than 2 sutures. Th e age at vault 
expansion in the children with preoperative papilledema was 20 months (range, 2 months 
to 5.5 years). In the group without papilledema, the age of vault expansion was 7 months 
(range, 2 months to 9 years). Th is diff erence is statistically signifi cant (p = 0.007). In 11 
patients, severe OSA was present. Papilledema was present before OSA treatment in 4 
patients, absent in 4, and unknown in 3. After OSA treatment, papilledema disappeared 
in 1 patient, persisted in 1, relapsed in 2, and developed in 3; no control examination was 
done in 4 patients. 
Univariate analysis revealed that the diagnosis of Crouzon/ Pfeiff er, complex craniosy-
nostosis, and ventricular dilatation are statistically signifi cant predictive variables for the 
presence of papilledema (table 1). Multivariate analysis showed that complex craniosynos-
tosis, exorbitism, and ventricular dilatation were predictive of papilledema (table 2).
DISCUSSION
Th ere are 2 principal fi ndings in this study of papilledema in syndromic craniosynostosis. 
First, based on fundoscopy, papilledema occurred in more than half of the patients with Ap-
ert, Crouzon, or Pfeiff er syndrome, not only before but also after vault expansion. Second, 
we did not fi nd any clinical symptoms that specifi cally indicated the presence of papilledema. 
Table 2: Predictive model of papilledema after multivariate analysis
Odds ratio 95% CI lower 95% CI upper p-value
Complex 
craniosynostosis
6.119 1.549 24.179 0.010*
Exorbitism 18.800 1.376 256.916 0.028*
Ventricular dilatation 12.659 3.179 50.408 0.000*
* p < 0.05
CI confi dence interval
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In this study, we have used the presence of papilledema as a surrogate marker of elevated 
ICP. A major limitation of this approach, however, is that we may have underestimated 
the extent of elevated ICP in our population because the absence of papilledema does 
not defi nitely exclude elevated ICP12. Despite this limitation, the high prevalence of 
papilledema in our study is similar to that observed in previous studies4,5, and we found 
that before vault expansion, it was particularly common in patients with Crouzon and 
Pfeiff er syndrome (~ 50%). Cases of Apert syndrome had a lower incidence of this fi nding 
(~ 10%). Th is observation diff ers from the study reported by Renier et al. in which 45% of 
patients with Apert syndrome had preoperative elevation in ICP4,5. A possible explanation 
for the lower percentage in our Apert group was the younger age at which fundoscopy was 
performed (3 versus 6 months)5. 
Because the absence of papilledema does not exclude elevated ICP12, we also examined 
whether clinical symptoms commonly associated with elevated ICP might reliably indi-
cate the presence of papilledema. In this study, they did not. It is possible that elevated 
ICP might still have been present in those with symptoms had we measured it invasively. 
However, our fi nding is consistent with the study reported by Tuite el al.12, where only 8 
of 41 patients with elevated ICP had clinical symptoms. Beaten-copper pattern on skull 
radiograph was seen more often in children with papilledema. 
Treatment to resolve papilledema
Overall, within 1 year of primary surgery no papilledema was present in 83% of the patients. 
On follow-up of children with no preoperative papilledema, 93% remained papilledema-
free after surgery. In respect to the timing of primary vault expansion, the children with 
no preoperative papilledema were 6 months younger at surgery compared with those who 
had preoperative papilledema. Th is signifi cant diff erence suggests that decompressive 
surgery at a younger age prevents the development of papilledema in craniosynostosis. 
After surgical treatment, papilledema disappeared in 59% of the patients, but in a few 
specifi c instances, it persisted, or developed within 1 year, after decompression. Possible 
reasons for this fi nding were insuffi  cient decompression, presence of ventricular dilatation, 
or residual papilledema after correction of ICP. More than 1 year after vault expansion, 
papilledema was seen in 43% of the patients. In 67% of these patients, secondary surgery 
was performed, and it was eff ective in treating papilledema in 14 of the 20 patients. Th e re-
maining patients were treated conservatively despite the incidental fi nding of papilledema 
on intensive follow-up with repeated fundoscopy.
Ventricular dilatation is a common fi nding in patients with craniosynostosis. Its con-
tribution to elevated ICP may be diffi  cult to establish. In our study, ventricular size was 
signifi cantly increased in patients with papilledema, compared with those without (65% 
versus 22%). In one third of the patients with ventricular dilatation, a shunt was needed 
in addition to vault expansion. 
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Th ese fi gures are comparable with a previous study reported by Collmann et al.10, where 
it was found that papilledema could persist, relapse, or develop more than 1 year after 
vault expansion and placement of a ventriculoperitoneal shunt. Th us, annual fundoscopy 
is highly recommended until adulthood.
Risk factors for papilledema
We found that complex craniosynostosis, exorbitism, and ventricular dilatation were fac-
tors associated with papilledema. Th e fi rst 2 of these variables were also reported in the 
study by Gupta et al17. Signifi cant correlations were found between optic nerve damage 
from papilledema and multiple suture craniosynostosis and exorbitism17. Tuite et al.11 
showed that hydrocephalus had low sensitivity (40%), but high specifi city (80%), for 
elevated ICP. 
Other factors, which result in elevated ICP, are OSA and venous hypertension18,19. In a 
study of 13 patients with syndromic craniosynostosis, a signifi cant correlation was found 
between the severity of upper airway obstruction and elevated ICP in active sleep15. In our 
study 11 patients had severe OSA. However, they all had this problem treated, and thus, 
association (or causation) with elevated ICP could not be shown. In addition, the retro-
spective design of our study meant that we could not obtain information about venous 
hypertension and stenosis of the jugular foramen as causes of elevated ICP20. 
In conclusion, in syndromic craniosynostosis, the prevalence of papilledema is high, 
not only before cranial decompression but also after vault expansion. Given the high 
prevalence of papilledema, annual review is highly recommended until adulthood. In our 
hospital, fundoscopy is the fi rst choice, given its feasibility and low risk. We consider that 
early decompressive surgery (within the fi rst year of age) prevents the development of 
papilledema and, most likely, elevated ICP. Th e origin of papilledema may be complex and 
diffi  cult to establish. It is therefore important to check all known risk factors to identify 
the specifi c cause(s) and plan optimal treatment. Hence, management of these patients 
should be multidisciplinary and focussed in specialized centers. 
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ABSTRACT
Objective
Little is known about the long-term prevalence of elevated intracranial pressure (ICP), 
obstructive sleep apnea (OSA), level of education, language and motor skills, impaired 
sight and hearing in craniosynostosis syndromes. Th e objective of this study was to defi ne 
the prevalence per syndrome of elevated ICP, OSA, impaired sight and impaired hearing. 
Methods
A retrospective study was undertaken on 167 consecutive patients diagnosed with Apert, 
Crouzon, Pfeiff er, Muenke or Saethre-Chotzen syndrome, aged 1-25 years and treated 
between 1983 and 2008. Th e mean age at time of referral and review was 1 years and 2 
months and 10 years and 3 months, respectively.
Results
Patients with Apert and Crouzon/ Pfeiff er syndrome had the highest prevalence of elevated 
ICP (33% and 53%, respectively) and OSA (31% and 27%, respectively), while Saethre-
Chotzen syndrome was also associated with a fair risk for elevated ICP. Th e prevalence of 
impaired sight (61%) and hearing (56%) was high in all syndromes. 
Conclusion
Based on these data a syndrome specifi c risk profi le with suggestions for screening and 
treatment is presented.
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INTRODUCTION
Syndromic craniosynostosis is a complex disease with a broad spectrum of problems. 
Elevated intracranial pressure (ICP) has a high prevalence in patients with Apert and 
Crouzon/ Pfeiff er syndrome1, 2, but its prevalence in Muenke or Saethre-Chotzen syn-
drome is unclear. One of the factors that is related to elevated ICP is obstructive sleep 
apnea (OSA)3, 4. OSA is a known problem in children with craniosynostosis but little is 
known about the prevalence among the diff erent syndromes5. Other problems that are 
often seen are ocular and hearing defi cits, with the most frequent ocular problems being 
strabismus and refractive errors6-8. Hearing defi cits are conductive in most cases caused 
by recurrent otitis media that occurs during their entire life9, 10. A retrospective study was 
undertaken to determine the prevalence of these problems per syndrome. Based on these 
data, guidelines for follow-up of patients per syndrome are suggested.
METHODS
Study group 
A retrospective study on all consecutive patients with Apert, Crouzon, Pfeiff er, Muenke 
or Saethre-Chotzen syndrome treated at the Dutch Craniofacial Center between 1983 and 
2008 was performed. Crouzon and Pfeiff er syndrome often cannot be distinguished from 
each other genetically, and were therefore considered to be a homogeneous group in this 
study. Th e only exclusion criterium was an age of less than 12 months at the time of review, 
leaving a total of 167 patients were included. 
Protocol for intake, treatment and follow-up
Patients who were referred to our center were assessed by a multidisciplinary team, which 
consisted of a plastic surgeon, neurosurgeon, maxillofacial surgeon, clinical geneticist, 
orthodontist, ophthalmologist, otolaryngologist, paediatrician, radiologist, psychologist, 
and a nurse practitioner. All patients were off ered a genetic analysis. Depending on their 
phenotype, exons of FGFR 1, 2 and 3 and TWIST were tested. Routine diagnostic tests, 
besides a complete physical examination, were skull X-rays, cephalograms, photographs, 
fundoscopy, and a three-dimensional computed tomography (3D-CT) scan of the skull. 
In case of anamnestic respiratory problems, a polysomnography was done either at home 
or at the clinic. Th e day before surgery fundoscopy was repeated. 
Vault remodelling is scheduled at the age of 6-9 months or as soon as possible if patients 
were already older at time of referral. During the period under review, a fronto-orbital 
advancement was performed routinely as primary vault remodelling. A monobloc was 
only done in the very young in case of severe OSA or severe exorbitism. Le Fort III or 
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monobloc was preferably postponed until adult age, unless functional problems neces-
sitated an earlier intervention. Psychosocial functioning and the wish for correction of 
patient and parents were also taking into account in timing the midface advancement. If 
for these reasons the midface advancement was performed between the ages of 9 and 12, 
the necessity for le Fort I osteotomy at 18 is the resulting consequence.
Follow-up visits of these patients are scheduled once every 3-6 months during their fi rst 
2.5 years. Th ereafter, check-ups are scheduled once a year, up to the age of 9, after which 
the frequency drops to once every 3 years until the age of 18 for those patients who have 
no functional problems requiring extra attention. During follow-up visits, patients and 
their parents were specifi cally asked about complaints suggestive for elevated ICP, respira-
tory problems, ocular problems, and hearing diffi  culty. Skull circumference was measured 
and facial features were assessed. Skull X-rays were checked for impressiones, progressive 
sutural synostosis, sutural widening, vascular impressions, and deepening of the sella.
Ophthalmologic and audiologic tests were regularly repeated. CT scans were taken 
on indication only, such as anamnestic complaints suggestive of elevated ICP, decline in 
growth curve of skull circumference, presence of papilledema or indication for surgery 
(e.g. vault remodelling, le Fort III or monobloc). 
Functional assessment
Intracranial pressure 
Papilledema was used as an indicator of elevated ICP. A paediatric ophthalmologist per-
formed all fundoscopies after pharmacological pupillary dilation with a combination of 
phenylephrine 2.5% and tropicamide 0.5%. Papilledema was diagnosed when blurring of 
the optic disc margins was present. Pseudopapilledema, which can resemble papilledema 
without being a sign of elevated ICP, was excluded. To diff erentiate papilledema from 
pseudopapilledema, objective refraction was performed to rule out high hyperopia. If 
papilledema was still present 1 year after surgery it was defi ned as persistent, and a relapse 
was defi ned as reappearing papilledema following at least one normal fundoscopy. All 
patients with papilledema were considered to have elevated ICP11. 
ICP measurements were performed with an intraventricular catheter or with an intrapa-
renchymal device (Camino or Codman). Invasive ICP measurements were recorded for at 
least 24 hours. Elevated ICP was defi ned as an average of 15 mmHg or higher and/or more 
than three plateau waves of 35 mmHg lasting more than 5 minutes12. For the analysis the 
term elevated ICP refers to the presence of papilledema and/or elevated ICP on invasive 
measurement. Invasive ICP measurement was not done routinely, but only in specifi c 
cases such as severe OSA, headache or persisting papilledema after surgery.  
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Obstructive sleep apnea 
OSA was diagnosed based on a nocturnal pulse oximetry, which measures the oxygen satu-
ration13. Th is was usually done ambulatory, with an Embletta Portable Diagnostic System 
using a Nonin Oximeter and analyzed with Somnologica for Embletta software 3.3 ENU 
(Medcare Flaga, Reykjavik, Iceland). From this oxygen saturation profi le the oxygenation 
desaturation index (ODI) was calculated. Th e ODI was defi ned as the average number 
of oxygen desaturations of 4% or more, below the baseline level, per hour. Patients were 
classifi ed as having mild OSA with an ODI of 1-5, moderate OSA with an ODI of 6-25 
and severe OSA with an ODI higher than 2514, 15. 
Sight and hearing
Sight was assessed based on the test results done by an orthoptist or ophthalmologist. It 
was scored as normal, myopic, hyperopic, astigmatic, anisometropic or blind. 
Hearing was assessed based on the results of hearing tests performed by an otolaryngolo-
gist or audiologist. Hearing was scored as normal or loss due to conductive, sensorineural 
or mixed cause.
Statistical methods
Statistical analyses were performed using SPSS 14.0 for Windows 2000 (SPSS, Inc., Chi-
cago, IL, USA). All numbers are expressed as mean and range. Th e Pearson’s chi-square 
was used or when a table contained numbers smaller than 5 the Fisher’s exact test was used 
to compare proportions. A two-sided p-value of 0.05 or less was considered signifi cant.
RESULTS
Baseline
Of the 167 patients who were included, 36 had Apert, 55 had Crouzon/ Pfeiff er, 38 had 
Muenke and 38 had Saethre-Chotzen syndrome. Th e mean age at time of referral and 
review was 1 year and 2 months and 10 years and 3 months, respectively. Of the 167 
patients, 81 (48%) were boys and 123 (74%) diagnoses were confi rmed genetically (table 1). 
Of the 43 in whom no mutation was found, 12 were not tested, because parents did not 
give consent or they were tested in another hospital but no information was available. In 
the Apert patients 24 were tested, 16 had the S252W mutation and eight the P253R muta-
tion. In nine of the tested patients with Crouzon/ Pfeiff er syndrome, no mutation was 
found. No TWIST mutation or deletion was found in 11 patients with Saethre-Chotzen 
syndrome, in whom a FGFR 2 or 3 mutation was excluded. In these patients, we adhered 
to the clinical diagnoses made by the geneticist. All patients with the Muenke syndrome 
had the FGFR 3 P250R mutation. 
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Table 1: Overview of genetic diagnosis
Apert
n = 36
Crouzon/ Pfeiff er   
n = 55
Muenke
n = 38
Saethre-Chotzen
n = 38
FGFR 2
S 252 W 16  
P 253 R 8
C 342 Y 4 
C 342 W 1
C 342 T 1 
C 278 F 4
Y 105 C 1
Y 340 H 3
F 276 V 2
G 271 V 1
G 338 R 1 
Q 289 P 3 
S 351 C 2 
S 354 C 1
S 267 P 3 
W 290 R 3 
A 362 T 3 
C 342 R 2 
C 342 W 1 
K 641 R 1
1084+3a>g 1
FGFR 3
A 391 E 1
P 250 R 38
TWIST
Y103X 2
D157A 1
N114S 1
R116G 1
P136S 1
P136H 1
R749C 1
T137M 1
7p21 1
165ins10 2
417dup21 1
CA-repeat 1
Unilateral deletion 
TWIST region chr. 7 3
Deletion region 7p21 3
No mutation found 10 11
Not tested 12 8 7
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Th e type of primary surgery is described in table 2. No surgery was performed in 14 
patients because they were relatively old at time of referral and did not have signs of 
elevated ICP or because their parents did not give their consent. Th e mean age at primary 
vault expansion was 14 months (range: 2 months to 9 years). A total of 92 (55%) patients 
underwent surgery before the age of 1 year. Th e main reason for performing primary skull 
remodelling after the age of 1 year was a delay in referral. In 22 of the 167 (13%) a second 
vault expansion was needed, and in 1 a third vault expansion was needed. Th e indication 
for this secondary surgery was elevated ICP in eight, scheduled fronto-orbital surgery after 
initial occipital expansion without any sign of elevated ICP in one, and in fi ve patients 
because of unsatisfactory aesthetic eff ect of the fi rst vault expansion. Of the 22 patients 
with a second vault expansion result, three patients were referred for a second opinion fol-
lowing initial vault surgery that was performed by a surgeon who was inexperienced with 
the treatment of syndromic craniosynostosis. In 29 patients (12 Apert and 17 Crouzon/ 
Pfeiff er syndrome) 37 midface advancements were conducted. Complications caused by 
midface advancement were previous described by Nout et al.16. Th e type and timing of the 
midface advancements are described in table 3. A ventriculoperitoneal shunt was placed 
in 13 patients (three Apert, nine Crouzon/ Pfeiff er, and one Muenke syndrome) because 
progressive ventricular dilatation was present and intracranial volume was more than ap-
propriate. 
ICP
A complete fundoscopic assessment was performed in 164 patients; of these 55 (33%) were 
diagnosed with elevated ICP on at least one occasion. Th e mean age at the fi rst diagnosis 
of elevated ICP was 3.5 years (range: 5 months to 18.3 years). Forty-two were diagnosed 
based on the presence of papilledema and 13 based on the presence of papilledema and a 
positive invasive ICP measurement. Invasive measurements were made when papilledema 
Table 2: Overview of surgery per syndrome
Syndrome Primary vault expansion Secondary vault expansion Midface advancement
Apert 35 (97%) 5 (14%) 16 (44%) 
Crouzon/ Pfeiff er 46 (84%) 10 (18%) 21 (38%) 
Muenke 38 (100%) 2 (5%) 0
Saethre-Chotzen 34 (89%) 5 (15%) 0
Total 153 (92%) 22 (13%) 37 (22%)
Table 3: Type and timing of fi rst midface advancement
Mean age fi rst midface 
advancement (years)
Apert 
(n = 12)
Crouzon/ Pfeiff er 
(n = 17)
Monobloc 2.3 5 6
Le fort III 10.3 6 9
Le fort II 10.3 1 2
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was present without any clinical or radiological evidence for elevated ICP. Th e prevalence 
of papilledema varied strongly before and after fi rst vault expansion and among diff erent 
syndromes (table 4). Th e 1-year cumulative incidence (CI) of fi rst occurrence of papill-
edema varied strongly between diff erent syndromes and in time (fi gure 1). 
OSA
Because of a high suspicion for respiratory problems (e.g., snoring, diffi  culty in breathing 
during sleep or apneas during sleep) in 66 patients, a screening for OSA with nocturnal 
pulse oximetry was done. In 30 (18%) of the 167 patients, OSA was diagnosed. Patients 
with Apert and Crouzon/ Pfeiff er syndrome had a much higher prevalence of OSA than 
patients with Muenke and Saethre-Chotzen syndrome, and if OSA was present in patients 
with Muenke and Saethre-Chotzen syndrome it was only mild (table 5). 
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Figure 1: 1-year cumulative incidence (CI) of fi rst occurrence of papilledema per syndrome* 
* includes only patients checked for papilledema at least once every 3 years, Apert syndrome n = 32, Crouzon/ 
Pfeiff er syndrome n = 47, Muenke syndrome n = 36, Saethre-Chotzen syndrome n = 36
Table 4: Prevalence of papilledema before and after the fi rst vault expansion
  Preoperative1 Postoperative2 Total
Apert 2/ 22 (9%) 11/ 31 (35%) 12/ 36 (33%)
Crouzon/ Pfeiff er 24/ 45 (53%) 8/ 40 (20%) 29/ 55 (53%)
Muenke 1/ 28 (4%) 1/ 24 (4%) 2/ 38 (5%)
Saethre-Chotzen 5/ 26 (19%) 4/ 24 (17%) 8/ 38 (21%)
1 Number of patients with papilledema divided by the number of patients tested for papilledema
2 Includes new onset and recurrent cases of papilledema
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Sight
In 132 patients information of sight was available. Refractive errors were reported in 69 
(52%) patients, 18 were myopic and 51 hyperopic (table 6). In 48 (70%) patients it was 
corrected with glasses. Astigmatism was reported in fi ve (4%), anisometropia in fi ve (4%), 
and severe visual loss in four (3%). Th e four patients with severe visual loss were previ-
ously reported by Bartels et al.17. Strabismus was diagnosed in 81 patients. Patients with 
Apert syndrome had signifi cantly (p < 0.001) more strabismus than all patients with other 
syndromes (table 6).
Hearing
Hearing loss was reported in 78 of 140 (56%) patients. Conductive hearing loss was re-
ported in 62 (44%), sensorineural hearing loss (SNHL) in six (4%) and mixed hearing 
loss was reported in 10 (7%) of the patients. Th e prevalence was the highest in Apert and 
Muenke syndrome (table 6). Of the 16 patients with SNHL, four had Apert syndrome, 
fi ve had Crouzon/ Pfeiff er syndrome and seven had Muenke syndrome. Conductive hear-
ing loss was present in 20 patients with Apert syndrome, in 19 patients with Crouzon/ 
Pfeiff er syndrome, in 20 patients with Muenke and in 13 patients with Saethre-Chotzen 
syndrome. Eighteen of the 140 (13%) patients needed a hearing aid: four patients with 
Apert syndrome, nine with Crouzon/ Pfeiff er syndrome, three with Muenke syndrome 
and two with Saethre-Chotzen syndrome
Table 5: Number of patients with OSA per syndrome
Mild Moderate Severe Total
Apert 4 (11%) 3 (8%) 4 (11%) 11/ 36 (31%)
Crouzon/ Pfeiff er 8 (15%) 4 (7%) 3 (5%) 15/ 55 (27%)
Muenke 2 (5%) 0 0 2/ 38 (5%)
Saethre-Chotzen 2 (5%) 0 0 2/ 38 (5%)
Table 6: Prevalence of refractive errors, strabismus and impaired hearing
Refractive error Strabismus Impaired hearing
Apert 22/ 29 (76%) 27/ 29 (93%)* 21/ 29 (72%)
Crouzon/ Pfeiff er 16/ 41 (39%) 27/ 43 (63%) 20/ 40 (50%)
Muenke 17/ 35 (49%) 14/ 36 (39%) 24/ 36 (67%)
Saethre-Chotzen 14/ 27 (52%) 13/ 35 (37%) 13/ 35 (37%)
* statistical signifi cant compared to all other syndromes
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DISCUSSION
Th is study highlights the high prevalence of elevated ICP in patients with Apert, Crouzon/ 
Pfeiff er and Saethre-Chotzen syndrome. OSA is prevalent in Apert and Crouzon/ Pfeiff er 
syndrome and hearing and visual problems are frequent in all of the syndromes. Th is 
retrospective description of our population guides us to a diagnosis-specifi c screening and 
treatment protocol (table 7).
Table 7: Overview of diagnosis-specifi c screening and treatment protocol
Clinical diagnosis Apert Crouzon/ Pfeiff er Muenke Saethre-Chotzen Comment
Genetic research FGFR 2 FGFR 2 1st P250R 
FGFR 3
2nd TWIST
1st TWIST
2nd P250R 
FGFR 3
No FGFR 1 analysis 
included
Fundoscopy Yearly up till 
6 years
Yearly up till 6 
years. 
In patients without 
craniosynostosis 
every 3 months 
during the fi rst 2 
years
At age of 2 
years
Yearly up till 6 
years
At fi rst visit and pre-
surgery in all patients.
Papilledema without 
clinical or radiological 
symptoms: invasive ICP 
measurement
Polysomnography 
and/or pulse-
oximetry
Yearly till 6 years. For older patient 
only if anamnestic breathing 
diffi  culties are present. Yearly after 
surgical treatment of moderate or 
severe OSA
If anamnestic 
breathing 
diffi  culties are 
present
If anamnestic 
breathing 
diffi  culties are 
present
If OSA is diagnosed: 
inspection of tonsils 
and endoscopy of upper 
airway 
Hearing Otoscopy and tympanometry at all ages. Otoacoustic Emission (OAE) till 4 years. Pure tone 
audiometry in patients of 4 years and older. If a hearing defi cit is found on OAE or pure tone 
audiometry, Brainstem Response Audiometry is indicated.
Sight At fi rst visit: screening for strabismus, if present; further ophthalmic work up is needed. When 
possible given child’s development, information about visual acuity is required.
(3D-)CT scan Prior to any craniofacial surgery in all patients 
MRI At age 0 and 4                                                                                                                                     
If papilledema is present
First cranial vault 
remodelling
Occipital expansion between 6 and 
9 months (if synostosis is present). 
If severe OSA or severe exorbitism 
is present: monobloc + distraction
Fronto-orbital 
advancement 
between 9 and 
12 months
Fronto-orbital 
advancement 
between 6 and 9 
months
Elevated ICP in 
follow-up
Occipital expansion with 
distraction or biparietal widening 
based on shape of skull
Occipital remodelling
Midface 
advancement
(monobloc or 
le Fort III with 
distraction)
Relative indication: between age 
9 and 12 (and le Fort I at 18) or 
at 18
Not indicated  
Psychological 
testing
At the age of 1.5; 3.5; 6; 8; 12; 15 and 18 years
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All patients need genetic analysis to establish the diagnosis, for selective screening on 
related abnormalities, genetic counseling and research. Given the fact that we never en-
countered a mutation in the FGFR 1 gene, we have now stopped routine analysis of this 
gene (table 1).
In general, all patients undergo vault expansion within their fi rst year of life18, 19, but 
surgery is scheduled earlier whenever papilledema is detected. According to our current 
protocol, initial vault expansion in patients with Apert or Crouzon/ Pfeiff er syndrome 
is occipital remodelling. Th is way we leave the fronto-orbital area untouched, which 
facilitates a monobloc at a later stage. In Muenke and Saethre-Chotzen syndrome, we 
choose to perform a fronto-orbital advancement, to expand the cranial volume and restore 
the appearance of their upper face. Given the very low risk on elevated ICP in Muenke 
syndrome and reports on the disappointing aesthetic results requiring additional surgery 
20-22, we suggest to postponement of surgery for these patients (table 7). 
A monobloc with distraction is chosen as primary surgery whenever patients suff er from 
severe OSA and/or severe exophthalmus. 
Some patients with Crouzon/ Pfeiff er syndrome may not develop craniosynostosis at 
all or postnatal. Th ese patients should be seen at an interval of 3 months within the fi rst 2 
years and vault surgery is indicated whenever elevated ICP is detected.  
Despite early vault expansion, the prevalence of postoperative new onset elevated ICP 
remained high in our and other studies especially for patients with the Apert, Crouzon/ 
Pfeiff er and Saethre-Chotzen syndrome18,23. Th e craniofacial group from London has 
presented similar fi ndings in patients with the Apert syndrome2, in whom vault expansion 
was only performed once signs of elevated ICP were detected. Despite surgery at a later 
age, these patients experienced a similar risk on re-occurrence of elevated ICP at about 5 
years of age. Apparently, expansion of the skull does prevent and treat elevated ICP for a 
few years. Th e second episode with elevated ICP about the age of 4-5 years is not related to 
a craniocerebral disproportion because most of the brain growth has already taken place. 
Other possible factors that can cause the second rise in ICP are OSA4, hydrocephalus and 
venous hypertension. 
To diagnose elevated ICP, we recommend yearly fundoscopy in Apert, Crouzon/ Pfeiff er 
and Saethre-Chotzen syndrome up to the age of 6 and for Muenke up to the age of 2. 
If papilledema is present, a computed tomography (CT) or magnetic resonance imaging 
(MRI) is indicated to exclude progressive ventricular dilatation. 
In this study, we probably have an underestimation of the prevalence of OSA due to 
measuring only a selected group of patients with anamnestic breathing diffi  culties and due 
to the use of pulse-oximetry instead of polysomnography. Pulse-oximetry is a diagnostic 
test for straightforward OSA, but a negative pulse-oximetry cannot rule out OSA13. Ta-
king into account these limitations, we found OSA in more than 25% of the suspected 
children with the Apert and Crouzon/ Pfeiff er syndrome and 5% in the children with 
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Saethre-Chotzen or Muenke syndrome. Because the high prevalence of OSA in Apert 
and Crouzon/ Pfeiff er syndrome, we advocate yearly screening for OSA with polysom-
nography. Children with Saethre-Chotzen or Muenke syndrome should be tested when 
diffi  culties in breathing during sleep are reported. Once the presence of OSA is confi rmed, 
additional work-up is indicated including inspection of the size of the tonsils and endos-
copy of the upper airways to determine the level(s) of obstruction. In a previous study 
we have demonstrated that OSA in syndromic craniosynostosis can be caused by airway 
obstruction at various levels and is therefore not always cured by a midface advancement 
(Bannink 2009, submitted). Treatment of OSA should be individualized for each specifi c 
patient, depending on severity of OSA, level of obstruction, contributing factors to OSA, 
age of the patient and additional functional or psychosocial problems. Treatment may 
consist of adjusting the sleeping position, nasal spray with steroids, respiratory support 
(for instance with nocturnal oxygen, continuous positive airway pressure (CPAP) or 
tracheal cannula), (adeno)tonsillectomy, maxillary or even mandibulary advancement or 
a monobloc procedure.
Th is retrospective study showed that impaired sight and hearing had a high prevalence 
in all syndromes and should therefore be an integral part of follow-up. Regular screening 
is therefore indicated. 
Genetic analysis is necessary for counseling and screening on syndrome-specifi c anoma-
lies and functional defi cits. Follow-up by a multidisciplinary team is needed till the age of 
18 years to guarantee the best possible outcome.
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ABSTRACT
Objective
Syndromic craniosynostosis is a congenital disorder characterized by premature fusion of 
calvarial sutures combined with other anomalies. Th e facial appearance is diff erent and 
patients may show physical impairment, mental or developmental disabilities, elevated 
intracranial pressure and obstructive sleep apnea. Th e impact of this condition on daily 
functioning has not been studied before. Th e aim of this study is to assess the health-related 
quality of life in children and adolescents with syndromic or complex craniosynostosis and 
to determine the impact of these syndromes on parents. 
Methods
A prospective study was performed in 111 children. Health-related quality of life was 
measured by international standardised quality of life questionnaires, the Infant Toddler 
Quality of Life Questionnaire (ITQoL), Child Health Questionnaire Parental Form 50 
(CHQ-PF50), Child Health Questionnaire Child Form 87 (CHQ-CF87) and the Short 
Form Health Survey (SF-36). For comparison, we used Dutch population norms of 
health-related quality-of-life-scores. 
Results
Parents’ scores for patients with syndromic or complex craniosynostosis were signifi cant 
lower than those for the norm population. Apert syndrome had the largest impact on the 
diff erent domains. Scores on the CHQ-PF50 scales for ‘physical functioning’, ‘parental 
impact emotional’ and ‘family activities’ for these patients were signifi cantly lower than 
scores for patients with other syndromes, possibly due to the complexity of the syndrome, 
which includes complex syndactyly, cognitive impairment and behavior problems. Parents 
reported a reduced health-related quality of life for themselves, mostly psychosocial with 
clearly signifi cantly lower general health perceptions.
Conclusion
Syndromic craniosynostosis has a large impact on the health-related quality of life of these 
children and their parents, both physical and psychosocial. 
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INTRODUCTION
Craniosynostosis, characterized by premature fusion of calvarial sutures, is a congenital 
anomaly that occurs in 1 in 2500 births. In about 40% of cases, craniosynostosis is part 
of a syndrome, such as Apert, Crouzon, Pfeiff er, Muenke or Saethre-Chotzen syndrome1. 
Fusion of two cranial sutures or more without a known fi broblast growth factor receptor 
(FGFR) 1, 2, and 3, TWIST, or ephrin-B1 (EFNB1) mutation1-3 is defi ned as complex 
craniosynostosis. 
Patients are at risk of elevated intracranial pressure (ICP), obstructive sleep apnea, hea-
ring and visual disorders, and delayed motor and language development4. All these could 
aff ect the daily life of these patients and of their parents; however the impact has not been 
studied so far. 
Th e facial appearance of children with syndromic or complex craniosynostosis is clearly 
diff erent and they may show physical, mental or developmental disabilities. Th is study 
aimed at assessing the health-related quality of life in children with syndromic or complex 
craniosynostosis and additionally at determining the impact of these syndromes on the 
daily functioning of their parents. 
METHODS
Study population
A prospective study was performed at the Erasmus MC-Sophia Children’s Hospital, a 
tertiary care university hospital. All patients between 2 and 18 years with syndromic or 
complex craniosynostosis registered at the Dutch Craniofacial Center were invited be-
tween January 2007 and September 2008 to participate, along with their parents. 
Health-related quality of life questionnaires
Health-related quality of life of the past 4 weeks was measured with international stan-
dardized quality of life questionnaires. For children between the ages of 2 and 4 years, the 
parents completed the Infant Toddler Quality of Life (ITQoL)5, and for children between 
4 and 18 years the Child Health Questionnaire Parental Form 50 (CHQ-PF50)6 was used. 
Children aged between 12 and 18 years completed the Child Health Questionnaire Child 
Form 87 (CHQ-CF87)7 themselves. Parents also completed a questionnaire on their own 
health, the Short-Form Health Survey (SF-36)8 (see appendices 1-3). 
Item scores per scale were summed up and transformed into a 0-100 score; the lower 
the score, the poorer the subjective health status. For the CHQ-PF50, a ‘physical sum-
mary score’ and ‘psychosocial summary score’ were calculated; for the SF-36, a ‘physical 
component summary score’ and ‘mental component summary score’ were calculated by 
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the sum of all scales except ‘change in health’, ‘family activity’ and ‘family cohesion’ based 
on an exploratory factor-analytic model9. Th e ‘change in health’ scale diff ers from the 
other scales in that it measures change over the past year. A score of 50 indicates no 
change and a score of 100 maximal improvement. All questions were short and closed with 
responses on Likert-scales. Th ey were phrased to avoid diffi  cult words where possible. Th e 
confi dentiality of the answers was guaranteed. 
Data of the research group were compared with Dutch healthy population norms of 
health-related quality-of-life-scores5, 7, 8. Scores for patients with the diff erent syndromes 
were also compared with the norms and between the syndromes. 
Potential predictive factors on health-related quality of life 
We compared scores for parents with and without the same craniosynostosis syndrome as 
their child to evaluate how suff ering from syndromic craniosynostosis themselves would 
eff ect reporting on their children. 
Furthermore, we determined the eff ect of obstructive sleep apnea (OSA) on health-
related quality of life. OSA was detected through a nocturnal ambulatory sleep study and 
was defi ned as an obstructive apnea hypopnea index ≥ 1 (N. Bannink et al., unpublished 
data, 2009).
Elevated intracranial pressure may have impact on health-related quality of life. It is 
detected through fundoscopy, which reveals papilledema in those cases.
Statistical analysis 
Statistical analysis was performed with SPSS 16.0 for Windows (SPSS, Chicago, IL, USA) 
and with GraphPad Prism 4.0 (GraphPad Prism Inc., CA, USA). Th e mean values of the 
diff erent domains with standard deviation were calculated. Th e independent t-test was 
used to compare the children’s and parents’ quality of life with a sample of the Dutch 
population5, 7. Th e groups were large enough to use this test. Because of the small numbers 
of patients in the syndromic subgroups, Z-scores were calculated and compared in an 
analysis of variance (ANOVA) procedure.
Signifi cant diff erences were defi ned as a p-value ≤ 0.05. All quality-of-life domains were 
expressed as mean and standard deviation. Pooled eff ect size of the diff erence between 
study population and norm population was calculated for each domain, which is measured 
by the diff erence between norm scores and patient scores divided by the pooled standard 
deviation10. 
To analyze the eff ects of OSA and ICP on each domain, multivariate analysis was per-
formed with age, sex, diagnosis, OSA and papilledema as independent variables. 
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RESULTS
Study population
A total of 136 patients with syndromic or complex craniosynostosis were approached, and 
117 (86%) children and their parents gave informed consent. Of those, 111 (95%) returned 
the questionnaires; that is, 23 patients returned the ITQoL and 88 patients the CHQ-
PF50. Twenty-nine of the 32 patients between 12 and 18 years completed the CHQ-CF87. 
Th e three other patients were unable to complete due to low mental capacity. One parent 
returned the CHQ-PF50 without answering all questions; the analysis therefore included 
87 instead of 88 questionnaires.
All 110 parents (74% mothers) completed the SF-36. Th eir median age was 39 (23-61) 
years. As many as 85% of the mothers and 84% of the fathers were born in the Netherlands. 
Th e educational level of 6% was elementary school, of 72% secondary education and of 
22% higher education or university.
Th e study group consisted of 53 boys (48%) and 57 girls. Eighteen patients had Apert 
syndrome, 26 Crouzon, 17 Muenke, 20 Saethre-Chotzen syndrome, and 29 had complex 
craniosynostosis. Th eir median age was 7 (2-18) years. A total of 95% was born in the 
Netherlands. 
Health-related consequences in children with syndromic or complex craniosynostosis 
below 4 years of age
Th e mean ITQol scores of the study population in comparison with the norm population 
scores are shown in table 1. Children under the age of 4 years were assigned signifi cantly 
lower scores on the domains such as ‘physical functioning’, ‘growth and development’, 
‘general health perceptions’ and ‘parental impact: emotional and time’. 
Health-related consequences in children with syndromic or complex craniosynostosis 
above 4 years of age
Th e mean CHQ-PF50 scores of the study population in comparison with the norm popu-
lation are also shown in table 1. Children above 4 years of age were assigned lower scores 
on all domains except ‘family cohesion’ and ‘change in health’. 
Subgroup analysis of age groups 4-12 years (n = 55) and 12-18 years (n = 32) revealed no 
statistical diff erences in the scores in any domain. Families with a lower socioeconomic 
status reported a lower health-related quality of life of their children, but only on psycho-
social domains. 
Syndrome-specifi c health-related consequences in children with syndromic or complex 
craniosynostosis 
Table 2 and fi gure 1 show the scores per syndrome in comparison with the norm popula-
tion. 
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Apert syndrome
Th e three 2- to 4-year-olds with Apert syndrome scored signifi cantly lower than the norm 
at ‘physical functioning’, ‘growth and development’, ‘general health perceptions’, ‘parental 
impact: time’, and ‘family activity’. Th ey showed a signifi cant ‘change in health’. Th e 15 
children above 4 years of age were assigned signifi cantly lower scores in each domain except 
‘family cohesion’ and ‘change in health’. Compared with children with other syndromes, 
Table 1: Th e mean health-related quality-of-life scores with standard deviation of the ITQol and the CHQ-PF50 
of our study population in comparison with the norm population 
Children with 
craniosynostosis 
Norm 
population
p-value¹ Eff ect size²
d
ITQoL (2-4 years)
Physical functioning (PF)
Growth and development (GD)
Bodily pain (BP)
Temperament and moods (TM)
General behavior (GB)
Getting along (GA)
General health perceptions (GH)
Parental impact: Emotional (PE)
Parental impact: Time (PT)
Family activity (FA)
Family cohesion (FC)
Change in health (CH)
n = 23
86.1 (23.8)
79.9 (19.7)
84.4 (18.0)
78.7 (12.6)
75.3 (15.0)
72.2 (10.0)
67.8 (22.0)
83.1 (19.7)
84.9 (24.2)
82.8 (22.5)
82.8 (23.0)
61.4 (21.4)
n = 314
97.2 (9.8)
86.5 (10.6)
83.8 (16.8)
77.2 (10.5)
72.8 (12.7)
71.4 (8.8)
79.0 (14.5)
92.1 (10.5)
93.0 (11.0)
86.2 (13.5)
75.3 (18.8)
56.1 (18.4)
<0.0001**
0.0063**
0.86
0.51
0.36
0.69
0.0007**
0.0002**
0.0018**
0.26
0.06
0.20
0.61
0.42
-0.04
-0.13
-0.18
-0.08
0.60
0.57
0.43
0.18
-0.36
-0.26
CHQ-PF50 (4-18 years)
Physical functioning (PF)
Role functioning: Emotional/behavior (REB)
Role functioning: Physical (RP)
Bodily pain (BP)
General behavior (GB)
Mental health (MH)
Self-esteem (SE)
General health perceptions (GH)
Parental impact: Emotional (PE)
Parental impact: Time (PT)
Family activity (FA)
Family cohesion (FC)
Change in health (CH)
Physical summary (PHS)
Psychosocial summary (PSS)
n = 87
90.6 (16.4)
87.2 (23.4)
87.9 (27.2)
78.8 (25.4)
73.6 (15.5)
74.9 (15.8)
73.6 (15.1)
65.8 (23.9)
72.3 (23.7)
82.6 (26.7)
80.3 (21.9)
71.1 (19.7)
56.9 (19.7)
50.9 (10.4)
52.0 (9.6)
n = 353
99.1 (4.3)
97.9 (7.2)
95.8 (15.6)
85.7 (17.2)
78.5 (13.1)
81.4 (12.1)
79.2 (11.0)
82.9 (13.4)
86.3 (15.2)
94.0 (13.0)
91.5 (11.9)
72.2 (19.4)
56.1 (18.4)
56.4 (5.7)
53.2 (6.4)
<0.0001**
<0.0001**
0.0004**
0.0044**
0.0046**
<0.0001**
0.0001**
<0.0001**
<0.0001**
<0.0001**
<0.0001**
0.81
0.58
<0.0001**
<0.0001**
0.72
0.61
0.36
0.31
0.33
0.45
0.42
0.87
0.69
0.54
0.61
0.03
-0.06
0.81
0.43
** p-value ≤ 0.01
¹ 2-sided one-sample t-test of the scale scores between study population and norm population
² pooled eff ect size d measured the diff erence in mean scores divided by the standard deviations of the parental 
group, 0.2 ≤ d < 0.5 indicated a small eff ect, 0.5 ≤ d < 0.8 a moderate eff ect, d ≥ 0.8 a large eff ect, a negative 
eff ect size meant a higher score with regard to the norm group10
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Health-related quality of life in syndromic craniosynostosis
those with Apert syndrome had signifi cantly lower scores at ‘physical functioning’, ‘paren-
tal impact: emotional’ and ‘family activity’. No correlation with age was found.
Th e nine children with a S252W mutation scored lower at each domain on the CHQ 
than the four children with a P253R mutation, and signifi cantly lower at ‘role functioning: 
emotional/ behavior’ (mean 74.1 vs. 100.0, p = 0.01), ‘mental health’ (mean 62.8 vs. 85.0, 
p = 0.03) and ‘self-esteem’ (mean 61.9 vs. 80.2, p = 0.02). 
Crouzon and Pfeiff er syndrome
Th e 2- to 4-year-olds with Crouzon or Pfeiff er syndrome scored signifi cantly lower at 
‘physical functioning’ and ‘parental impact: emotional’. Th eir scores did not diff er very 
much from the norm. Th ose above 4 years scored signifi cantly lower at ‘physical functio-
ning’, ‘role functioning: emotional/ behavior’, ‘self-esteem’, ‘general health perceptions’, 
and ‘parental impact: time’. 
Muenke syndrome
Th e under 4-year-olds with Muenke syndrome scored signifi cantly higher at ‘temperament 
and moods’ and ‘family activity and cohesion’. Scores for those above 4 years were almost 
the same as for children with Apert syndrome, apart from better scores on ‘role functio-
ning: physical’ and ‘parental impact: time’. 
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Figure 1: Th e mean health-related quality-of-life scores of the CHQ-PF50 per syndrome
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Saethre-Chotzen syndrome
Th e under 4-year-olds with Saethre-Chotzen syndrome scored according to the norm on 
all domains. Th e older children scored signifi cantly lower on ‘bodily pain’, ‘mental health’, 
‘general health perceptions’, and ‘family activity’ and signifi cantly higher on ‘family cohe-
sion’.
Complex craniosynostosis
Th e under 4-year-olds with complex craniosynostosis scored signifi cantly lower at ‘physi-
cal functioning’, ‘growth and development’ and ‘parental impact: time’. Th ose above 4 
years scored signifi cantly lower at ‘physical functioning’, ‘role functioning: emotional/ 
behavior and physical’, ‘general health perceptions’, ‘parental impact: emotional and time’ 
and ‘family activity’. 
Potential predictive factors on health-related quality of life 
Hereditary craniosynostosis
Scores of the fi ve parents of 2- to 4-year-olds who suff ered from the same syndrome as 
their child were more in agreement with the norm on all quality-of-life domains of their 
children, except ‘change in health’, than parents without the syndrome (n=18). Signifi cant 
diff erences were seen in the following domains: ‘physical functioning’ (mean 98.7 vs. 82.6, 
p = 0.02), ‘growth and development’ (mean 93.5 vs. 76.1, p = 0.02), ‘bodily pain’ (mean 
96.7 vs. 81.0, p = 0.01), ‘parental impact: emotional (mean 97.1 vs. 79.2, p = 0.004) and 
time’ (mean 99.0 vs. 81.0, p = 0.01) and ‘family activity’ (mean 96.7 vs. 78.9, p = 0.01). 
Parents of children above 4 years of age, 24 with the same syndrome and 63 without, 
showed no diff erences in this respect.
Obstructive sleep apnea
Th irty-seven of all children had OSA, of whom six suff ered from Apert syndrome (16%), 
12 from Crouzon syndrome (32%) and nine from complex craniosynostosis (24%). After 
multivariate analysis OSA was an independent predictor for the domain ‘change in health’ 
on the CHQ only. 
Elevated ICP
Nineteen children had elevated ICP, of whom 13 suff ered from Crouzon syndrome, one 
from Apert syndrome, three from Saethre-Chotzen syndrome and two from complex 
craniosynostosis. ICP was an independent predictor for the domains ‘parental impact: 
emotional, ‘family activity’ and ‘change in health’ on the ITQol and ‘physical functioning’, 
‘general behavior’, ‘general health perceptions’, ‘parental impact: time’ and ‘family activity’ 
on the CHQ.
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Health-related consequences reported by patients themselves
Th e 29 children between 12 and 18 years of age who completed the CHQ-CF87 scored 
almost similar to the norm. Th ey scored signifi cantly lower at ‘general health perceptions’ 
(mean 68.3 vs. 75.0, p = 0.03) and ‘family cohesion’ (mean 66.4 vs. 76.0, p = 0.03). In 
comparison with their parents two domains were signifi cantly diff erent. Parents reported 
more limitations due to physical health (‘role functioning: physical’) and more behavioral 
problems (‘general behavior’) than their children. 
Health-related consequences in parents
Th e results of the SF-36, completed by parents, are shown in table 3. Th ey reported more 
limitations in work or other daily activities. Th e ‘mental component summary’ score was 
lower in comparison with the norm population. Parents of the under 4-year-olds reported 
signifi cantly lower scores on ‘physical functioning’ (mean 55.0 vs. 95.8, p = 0.03) and ‘role 
limitations due to physical functioning’ (mean 45.0 vs. 78.5, p = 0.03) when they had the 
same syndrome as their child. Parents of children above the age of 4 years who suff ered 
from the same syndrome scored similar to those without any syndrome. 
DISCUSSION
In this large, selected group of children with only syndromic or complex craniosynostosis, 
health-related quality of life was signifi cantly lower than in the norm population. For all 
syndromes, scores at ‘general health perceptions’ were signifi cantly lower. Apert syndrome 
had the largest impact on the diff erent domains. Two earlier studies reported quality of 
life of a small group of children with craniosynostosis. Warschausky et al.11 compared 27 
children with primary cleft lip and/ or palate and 28 children with other craniofacial diag-
noses. Th ere were only fi ve children with Apert syndrome, Crouzon syndrome or complex 
craniosynostosis. Th e children with other craniofacial diagnoses perceived signifi cantly 
more general health concerns; but no specifi c physical or mental health concerns were 
reported. Boltshauser et al.12 evaluated behavior and quality of life in 30 children with 
isolated sagittal craniosynostosis. Parents reported behavior to be within the normal range 
and health-related quality of life was comparable with the norms, except for lower scores 
on positive emotional functioning. 
For the two age groups, 2-4 years and 4-18 years, in which we used diff erent question-
naires, we found comparably low scores in similar domains. Th ere was no signifi cant 
correlation between age and the results of questionnaires. 
Subgroup analysis for the diff erent syndromes showed that parents of 2- to 4-year-olds 
with Apert syndrome and complex craniosynostosis reported lower health-related qua-
lity of life for their children. Th e low scores on ‘physical functioning’ and ‘growth and 
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development’ might be explained by the higher complexity of these conditions than in the 
other syndromes. Whereas no scores on comparable domains diff ered between the two age 
groups and were all signifi cantly lower than the norm, the score on the domain ‘change in 
health’ did not signifi cantly diff er from the norm in the older age group. A likely explana-
tion is improved function of the hand after surgical correction of the complex syndactyly 
in the younger age group. 
Scores for the older children with Apert syndrome or Muenke syndrome diff ered most 
signifi cantly from the norms, with signifi cantly higher scores in 11 out of the 13 domains 
and 10 out of the 13 domains, respectively. Th is might be because children with Apert 
syndrome are more prone to mental retardation and behavioral problems, such as autism. 
Muenke syndrome was always considered a mild type of syndromic craniosynostosis, 
given the low risk of elevated ICP or OSA; however, in the present study, children with 
this syndrome showed many problems on physical and emotional domains, possibly re-
lated to headache and behavior problems. Furthermore, we found a relatively low impact 
on health-related quality of life for patients with Crouzon or Pfeiff er syndrome, despite 
their distinct facial features. Th ey showed better intelligence and motor development than 
children with the other syndromes and seemed to have fewer behavioral problems. On 
the other hand, they have the highest risk to develop craniosynostosis-related problems 
such as elevated ICP, OSA and tonsillar herniation13, 14. Th ese fi ndings support the assump-
tion that behavioral disturbances and lowered mental capacities in Apert and Muenke 
syndrome are inborn and not a consequence of elevated ICP. In the group with complex 
Table 3: Th e mean health-related quality-of-life scores with standard deviation of the SF-36 of the parents
Parents Norm population p-value¹ Eff ect size²
d
SF-36
Physical functioning (PF)
Role functioning: Physical (RP)
Social functioning (SF)
Bodily pain (BP)
Mental health (MH)
Role functioning: Emotional (RE)
General health perceptions (GH)
Physical component summary (PCS)
Mental component summary (MCS)
n = 110
86.5 (24.7)
74.2 (27.9)
78.0 (24.4)
82.8 (26.3)
74.0 (17.3)
76.6 (22.9)
59.9 (21.8)
50.3 (7.8)
48.0 (6.9)
n = 314
87.0 (21.8)
81.6 (30.3)
84.2 (22.5)
75.3 (22.9)
76.2 (18.2)
85.5 (39.9)
73.6 (29.6)
50.3 (8.2)
51.3 (10.3)
0.21
0.03*
0.01**
0.004**
0.28
0.03*
<0.0001**
0.26
0.01**
0.13
0.25
0.27
-0.30
0.12
0.27
0.53
0.03
0.35
* p-value ≤ 0.05  
** p-value ≤ 0.01
¹ 2-sided one-sample t-test of the scale scores between parents and the norm population
² pooled eff ect size d measured the diff erence in mean scores divided by the standard deviations of the parental 
group, 0.2 ≤ d < 0.5 indicated a small eff ect, 0.5 ≤ d < 0.8 a moderate eff ect, d ≥ 0.8 a large eff ect, a negative 
eff ect size meant a higher score with regard to the norm group10
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craniosynostosis, signifi cant higher scores were found on the domains ‘physical impair-
ment’ and ‘high parental impact’. Th ese children tend to have more associated problems 
such as developmental retardation. For all syndromes, scores on the domain ‘general 
health perceptions’ were signifi cantly lower, probably due to the chronic character of the 
syndromes and the uncertainty about future developments.   
Scores for children with Apert syndrome were also much lower than those for children 
with other syndromes. Th e children with a S252W mutation had a lower health-related 
quality of life. Th ese children had more severe skull and facial abnormalities than children 
with a P253R mutation, who are characterized by more severe syndactyly. Possibly mental 
retardation and behavior problems were important factors for the lower scores. 
Parents who suff ered from the same syndrome as their child reported better scores than 
their children at all domains. Perhaps they recognize their own character in their child and 
consider this to be normal. However, denial of the problems seen in their own child might 
be an explanation as well.
In multivariate analysis, OSA was the only independent predictor for the domain 
‘change in health’, possibly associated with its treatment. Furthermore, elevated ICP was 
an independent predictor for lower scores on several domains. Th is might be explained 
by the fact that this condition could result in behavioral changes that infl uence scores. 
Further, once it is detected, extra hospital visits are necessary, which may cause more 
parental concerns.
Interestingly, parents of children aged 12-18 years reported more problems in diff erent 
domains than their children. Children seem to cope with the disabilities, minimizing 
concerns about functioning and health15. Parents may have been infl uenced by their 
own mental health and the concerns about the syndrome of their child. Th erefore, it is 
important to collect information from both to get an impression about the health-related 
quality of life because they may have diff erent views and consequences for support are 
diff erent15, 16. 
Parents themselves also scored their quality of life lower at diff erent domains, mainly 
psychosocial. Th eir child’s condition seems to have a major impact. Th ere was a diff erence 
on physical domains between parents suff ering from syndromic craniosynostosis and those 
without, but only if their child was below 4 years. Treatment is most intense in the fi rst 
years due to vault expansion and requires very regular visits to the outpatient clinic. Th is 
might infl uence the physical condition of the parents with syndrome. 
A major strength of this study is the large study population of children with syndromic 
or complex craniosynostosis. Th e health-related quality-of-life questionnaires are standard 
measures used to assess the quality of life, but a limitation is the use of these questionnaires 
in children with syndromic or complex craniosynostosis without validation in this specifi c 
population. Another possible limitation could be that outcomes for the two age groups are 
not completely comparable because diff erent questionnaires were used. 
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In conclusion, syndromic craniosynostosis has an important impact on health-related 
quality of life of these children and their families. Th e impact is not only most obvious 
for children with Apert syndrome, but also clear-cut for children with Muenke, Crouzon, 
Pfeiff er, or Saethre-Chotzen syndrome and complex craniosynostosis. Th e impact on daily 
functioning does not diff er much at the diff erent ages between 2 and 18 years. Parents 
themselves also experienced restrictions in quality of life. 
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APPENDIX 1
ITQoL scales, items per scale and score interpretationa
Th e ITQoL consists of 103 items with 4, 5 or 6 response options. Th e items are arranged 
into 10 multi-item scales and 2 single-item scales: ‘physical functioning’, growth and de-
velopment’, ‘bodily pain’, ‘temperaments and moods’, ‘general behavior’, ‘getting along’, 
‘general health perceptions’, ‘parental impact: emotional’, ‘parental impact: time’, ‘family 
activity’, ‘family cohesion’ and ‘change in health’5.
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Scale Number 
of items
Description low score Description high score
Physical 
functioning
(PF)
10 Child is limited a lot in performing 
physical activities such as eating, sleeping, 
grasping, and playing due to health 
problems
Child performs all types of physical 
activities such as eating, sleeping, grasping, 
and playing without limitations due to 
health problems
Growth and 
development
(GD)
10 Parent is very dissatisfi ed with 
development (physical growth, motor, 
language, cognitive), habits (eating, 
feeding, sleeping) and overall temperament
Parent is very satisfi ed with development 
(physical growth, motor, language, 
cognitive), habits (eating, feeding, 
sleeping) and overall temperament
Bodily pain
(BP)
3 Child has extremely severe, frequent and 
limiting bodily pain/discomfort
Child has no pain or limitations due to 
pain/discomfort
Temperament 
and moods
(TM)
18 Child has very often certain moods 
and temperaments, such as sleeping/
eating diffi  culties, crankiness, fussiness 
unresponsiveness and lack of playfulness 
and alertness
Child never has certain moods and 
temperaments, such as sleeping/
eating diffi  culties, crankiness, fussiness 
unresponsiveness and lack of playfulness 
and alertness
General behavior 
(GB)
13 Parent believes child’s behavior is poor and 
likely to get worse
Parent believes child’s behavior is excellent 
and will continue to be so
Getting along
(GA)
15 Child very often exhibits behavior 
problems, such as not following directions, 
hitting, biting others, throwing tantrums, 
and being easily distracted, while positive 
behaviors, such as ability to cooperate, 
appear sorry, and adjustment to new 
situations are seldom shown
Child never exhibits behavior problems, 
such as not following directions, hitting, 
biting others, throwing tantrums, and 
being easily distracted, while positive 
behaviors, such as ability to cooperate, 
appear sorry, and adjustment to new 
situations are frequently shown
General health 
perceptions
(GH)
12 Parent believes child’s health is poor and 
likely to get worse
Parent believes child’s health is excellent 
and will continue to be so
Parental impact: 
Emotional 
(PE)
7 Parent experiences a great deal of 
emotional worry/concern as a result of 
child’s physical and/or psychosocial health 
and/or growth and development
Parent does not experience feelings of 
emotional worry/concern as a result of 
child’s physical and/or psychosocial health 
and/or growth and development
Parental impact: 
Time
(PT)
7 Parent experiences a lot of limitations in 
time available for personal needs due to 
child’s physical and/or psychosocial health 
and/or growth and development
Parent does not experience limitations in 
time available for personal needs due to 
child’s physical and/or psychosocial health 
and/or growth and development
Family activity
(FA)
6 Th e child’s health and/or growth and 
development very often limits and 
interrupts family activity or is a source of 
family tension
Th e child’s health and/or growth and 
development never limits and interrupts 
family activities or is a source of family 
tension
Family cohesion 
(FC)
1 Family’s ability to get along is rated ‘poor’ Family’s ability to get along is rated 
‘excellent’
Change in health
(CH)
1 Child’s health is much worse now than 1 
year ago
Child’s health is much better now than 1 
year ago
a reproduced with permission from the principal author J.M. Landgraf, 1994
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APPENDIX 2
CHQ-PF50 scales, items per scale and score interpretationa 
Th e CHQ-PF50 consists of 50 items with 4, 5 or 6 response options. Th e items are arranged 
into 11 multi-item scales and 2 single-item scales: ‘physical functioning’, ‘role functioning: 
emotional/ behavior’, ‘role functioning: physical’, ‘bodily pain’, ‘general behavior’, ‘mental 
health’, ‘self-esteem’, ‘general health perceptions’, ‘parental impact: emotional’, ‘parental 
impact: time’, ‘family activity’,  ‘family cohesion’ and ‘change in health’6.
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Scale Number 
of items
Description low score Description high score
Physical functioning
(PF)
6 Child is limited a lot in performing all 
physical activities, including self-care due 
to health 
Child performs all types of physical 
activities, including the most vigorous, 
without limitations due to health 
Role functioning:
Emotional/behavior
(REB)
3 Child is limited a lot in schoolwork 
or activities with friends as a result of 
emotional or behavior problems
Child has no limitations in schoolwork 
or activities with friends as a result of 
emotional or behavior problems
Role functioning:
Physical
(RF)
2 Child is limited a lot in schoolwork 
or activities with friends as a result of 
physical health
Child has no limitations in schoolwork 
or activities with friends as a result of 
physical health
Bodily pain
(BP)
2 Child has extremely severe, frequent and 
limiting bodily pain
Child has no pain or limitations due 
to pain
General behavior 
(GB)
6 Child very often exhibits aggressive, 
immature, delinquent behavior 
Child never exhibits aggressive, 
immature, delinquent behavior
Mental health
(MH)
5 Child has feelings of anxiety and 
depression all of the time
Child feels peaceful, happy and calm all 
of the time
Self-esteem
(SE)
6 Child is very dissatisfi ed with abilities, 
looks, family/peer relationships and life 
overall
Child is very satisfi ed with abilities, 
looks, family/peer relationships and life 
overall
General health 
perceptions
(GH)
6 Parent believes child’s health is poor and 
likely to get worse
Parent believes child’s health is excellent 
and will continue to be so
Parental impact: 
Emotional 
(PE)
3 Parent experiences a great deal of 
emotional worry/concern as a result 
of child’s physical and/or psychosocial 
health 
Parent does not experience feelings of 
emotional worry/concern as a result 
of child’s physical and/or psychosocial 
health 
Parental impact: 
Time
(PT)
3 Parent experiences a lot of limitations 
in time available for personal needs due 
to child’s physical and/or psychosocial 
health 
Parent does not experience limitations 
in time available for personal needs due 
to child’s physical and/or psychosocial 
health 
Family activity
(FA)
6 Th e child’s health very often limits and 
interrupts family activities or is a source 
of family tension
Th e child’s health never limits and 
interrupts family activities nor is a source 
of family tension
Family cohesion 
(FC)
1 Family’s ability to get along is rated ‘poor’ Family’s ability to get along is rated 
‘excellent’
Change in health
(CH)
1 Child’s health is much worse now than 
1 year ago
Child’s health is much better now than 
1 year ago
a reproduced with permission from the principal author J.M. Landgraf, 1994
Th e CHQ-CF87 consists of 87 items with 4, 5 or 6 response options. Th e items are 
arranged into 10 multi-item scales and 2 single-item scales: ‘physical functioning’, ‘role 
functioning: emotional’, ‘role functioning: behavior’, ‘role functioning: physical’, ‘bodily 
pain’, ‘general behavior’, ‘mental health’, ‘self esteem’, ‘general health perceptions’, ‘family 
activity’, ‘family cohesion’ and ‘change in health’7. 
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APPENDIX 3
SF-36: scales, items per scale and score interpretation
Th e SF-36 consists of 36 items with 3, 4, 5 or 6 response options. Th e items are arranged 
into 7 multi-item scales: ‘physical functioning’, ‘role limitations due to physical functio-
ning’, ‘social functioning’, ‘bodily pain’, ‘mental health’, ‘role limitations emotional’ and 
‘general health perceptions’8, 17.
Scale Number 
of items
Description low score Description high score
Physical 
functioning
(PF)
10 Very limited in performing all physical 
activities, including bathing or dressing 
due to health 
Performs all types of physical activities, 
including the most vigorous, without 
limitations due to health 
Role functioning:
Physical (RF)
4 Problems with work or other daily 
activities as a result of physical health
No problems with work or other daily 
activities as a result of physical health
Social functioning
(SF)
2 Extreme and frequent interference with 
normal social activities due to physical or 
emotional problems
Performs normal social activities without 
interference with normal social activities 
due to physical or emotional problems
Bodily pain
(BP)
2 Very severe and extremely limiting bodily 
pain
No pain or limitations due to pain
Mental health
(MH)
5 Feelings of nervousness and depression all 
of the time
Feels peaceful, happy, and calm all of 
the time
Role functioning:
Emotional 
(RE)
3 Problems with work or other daily 
activities as a result of emotional problems
No problems with work or other 
daily activities as a result of emotional 
problems
General health 
perceptions
(GH)
5 Evaluates personal health as poor and 
believes it is likely to get worse
Evaluates personal health as excellent 
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ABSTRACT
Objective
Obstructive sleep apnea (OSA) aff ects the child’s quality of life. Rosenfeld developed a 
quality of life questionnaire, the OSA-18, on obstructive sleep apnea for children with 
OSA not caused by specifi c craniofacial syndromes. With regard to the use of the OSA-18 
in children with syndromic and complex craniosynostosis, we assessed the internal consis-
tency, test-retest reliability and discriminative validity of the OSA-18 in these children; we 
also applied the OSA-18 in healthy children to obtain reference values.
Methods
Th e OSA-18 was translated into Dutch using the procedure of multiple forward and 
backward-translations. Test-retest reliability and internal consistency were examined. In 
a prospective study, the craniosynostosis patients underwent an ambulatory polysomno-
graphy to diagnose OSA. Th e ability of the OSA-18 to discriminate between subgroups 
of patients with or without OSA was evaluated. We compared OSA-18 scores of children 
with syndromic or complex craniosynostosis with scores in healthy children.
Results
Th e Crohnbach’s alpha was ≥ 0.70 for the total OSA-18 score and for most of the domains 
in both the craniosynostosis and general population. In the craniosynostosis group the 
test-retest intraclass correlation coeffi  cients were ≥ 0.70, except for the domain ‘physi-
cal suff ering’ with 0.69. Th e discriminative validity of the domains ‘sleep disturbance’, 
‘physical suff ering’, ‘caregiver concerns’ and total OSA-18 score was signifi cant between 
the general and craniosynostosis population. 
Conclusion
Th is study supports the reliability and validity of the OSA-18 in children with syndromic 
or complex craniosynostosis.  
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INTRODUCTION
Obstructive sleep apnea (OSA) is a clinical syndrome characterized by diffi  culty in brea-
thing, snoring and apneas during sleep due to a partial or complete obstruction of the 
upper airway. Th e gold standard for diagnosing OSA is polysomnography1. Leaving OSA 
untreated may result in major physical and functional impairment due to the disturbed 
sleep patterns, for instance failure to thrive, recurrent infections, feeding diffi  culties, dis-
turbed cognitive functions (attention defi cit, impaired concentration and memory), delay 
of development, cor pulmonale and sudden death2. 
Obstructive sleep apnea aff ects the child’s quality of life, because of fatigue during the 
day, disturbed cognitive functions and the implications of treatment. Sleep problems, 
physical symptoms related to adenotonsillar hypertrophy, behavioral aspects and fatigue 
or impaired concentration are domains of quality of life that are of particular relevance. 
R.M. Rosenfeld has developed a disease-specifi c quality of life questionnaire for healthy 
children with OSA due to adenotonsillar hypertrophy, the OSA-183. It consists of 18 age-
independent items grouped into fi ve domains: ‘sleep disturbance’, ‘physical suff ering’, 
‘emotional distress’, ‘daytime problems’ and ‘caregiver concerns’. Th e OSA-18 has been 
shown to be reliable and valid to measure the impact of OSA in American children with 
a history of snoring and disrupted sleep for three months or longer, who were referred for 
polysomnography and who had enlarged tonsils or adenoids. 
In previous studies of OSA and quality of life only children without specifi c syndromes 
were studied; children with OSA based on underlying syndromes, such as craniofacial 
abnormalities, were excluded. Th is study aims at evaluating the OSA-18 in children with 
syndromic and complex craniosynostosis. Th ese patients have a 40% risk for OSA4,5,6 
mainly during the fi rst six years of life due to midface hypoplasia and collapse of the 
pharynx, but other factors such as adenotonsillar hypertrophy and mandibular hypoplasia 
may be involved as well7,6. 
In this study we assessed the internal consistency and the test-retest reliability and the 
discriminative validity of the OSA-18 in children with syndromic or complex craniosynos-
tosis. We compared OSA-18 scores of these children with scores in healthy children.
METHODS
Before the start of this study, authorisation was granted by the medical ethics committee 
(MEC-2005-273) of the Erasmus Medical Center.
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Craniosynostosis population
A prospective study was carried out in the Erasmus MC-Sophia Children’s Hospital, a 
tertiary care university hospital in Rotterdam. Patients with syndromic (genetically con-
fi rmed) or complex craniosynostosis registered at the Dutch Craniofacial Center were 
invited to participate in the study between January 2007 and March 2009. Syndromic 
craniosynostosis included Apert, Crouzon, Pfeiff er, Muenke or Saethre-Chotzen syn-
drome and is characterized by the premature fusion of calvarial sutures with additional 
congenital malformations8. Fusion of two cranial sutures or more without a known FGFR 
(fi broblast growth factor receptor) 1, 2, 3 or TWIST gene mutation8, 9 was defi ned as 
complex craniosynostosis. 
General population
A convenience sample of parents of healthy children was approached at day-care centers, 
primary and secondary schools and sport clubs in Rotterdam, Rijswijk and Leiden in the 
Netherlands. 
OSA-18 survey
First, we translated the OSA-18 to the Dutch language with permission of R.M. Rosenfeld 
using a procedure with multiple forward and back-translations10. Th ree independent per-
sons have translated the survey from English to Dutch and thereafter we asked two native 
speakers for back-translation to English as check.
All parents were asked to complete the survey, the parent form. Th ey decided whether 
the father or the mother should do that. After several months the same survey was sent to 
a random sample of parents to be completed by the same person to assess the test-retest 
reliability. 
Th e total OSA-18 score, subdivided in 5 domains, is the sum of scores for all 18 items 
with a score ranging from 18 to 126. Th e domains ‘sleep disturbance’, ‘physical suff ering’, 
and ‘caregiver concerns’ consisted each of four items and the domains ‘emotional distress’ 
and ‘daytime problems’ of three. Each item can be answered with 1 (never) to 7 (always). 
Additionally it provided a 10-point visual analogous scale with specifi c semantic anchors 
(appendix 1). 
Additionally children between 12 and 18 years completed a child form of the question-
naire themselves. Six items of the OSA-18 were excluded in the self-report child form, 
the OSA-12. In the domain ‘sleep disturbance’ children cannot report pauses in their 
breathing and gasping sounds during sleep by themselves and therefore the domain ‘sleep 
disturbance’ consisted two items. Th e domain ‘caregiver concerns’, which consists 4 items, 
cannot be used as well in the child form. Th e total OSA-12 score ranged from 12 to 84.
An additional questionnaire was given regarding items on socio-demographic variables 
as age, sex, school performance and the presence of sickness, allergy, behavior problems, 
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
119
C
hapter 8
adenotonsillectomy, use of medication and the presence of cough and use of nose drops, 
nasal or inhalation corticosteroids in the preceding four weeks. Th ese items were needed 
to exclude OSA in the general population.
Polysomnography
Th e craniosynostosis population underwent a polysomnography to diagnose obstructive 
sleep apnea. Polysomnography was done ambulatory with Embletta Portable Diagnostic 
System and analyzed with Somnologica for Embletta software 3.3 ENU (Medcare Flaga, 
Reykjavik, Iceland). Th oracic and abdominal movements, nasal fl ow, saturation, and pulse 
were monitored. Th e minimal total sleep time was 360 minutes. Obstructive apnea was 
defi ned as absence of airfl ow (measured by a nasal cannula) or out-of-phase movement of 
thorax and abdomen (scored as X fl ow) and hypopnea as ≥ 50% reduction in nasal fl ow 
signal amplitude or X fl ow signal amplitude, both for more than two breaths1, 11, 12. Th e X 
fl ow signal was the sum of the amplitudes of the thoracic and abdominal movements11, 12 
and was used when nasal airfl ow was insuffi  cient. Mixed apnea was defi ned as a type of 
obstructive apnea with a central component that mostly preceded the obstructive pattern, 
for more than two breaths. Central apneas were not included in this study. Desaturation 
was defi ned as ≥ 4% decrease with respect to the baseline value. 
Th e severity of OSA was expressed in an obstructive apnea hypopnea index (OAHI), the 
hourly number of obstructive and mixed apneas in combination with the hourly number 
of hypopneas followed by desaturation. A score < 1 is considered to be normal, between 1-5 
is defi ned as mild OSA, between 6 and 25 as moderate OSA, and > 25 as severe OSA13, 14. 
Analysis
Reliability
Reliability refers to the stability or reproducibility of survey results. Internal consistency 
was examined per domain and for the total OSA-18 score in the craniosynostosis and 
ge neral population. Th e Crohnbach’s alpha was used to calculate this internal consistency 
and a value ≥ 0.70 was considered as adequate both in children with syndromic or complex 
craniosynostosis, as in healthy children.
Th e test-retest reliability in the sample of the craniosynostosis population was evaluated 
by applying the paired t-test of the means at the group level and by intraclass correlation 
coeffi  cients (ICC) at the individual level. ICCs ≥ 0.70 were considered as adequate. 
Validity
Validity is the degree to which the survey measures what it purports to measure3. We tested 
the discriminative validity by comparing domains and the total OSA-18 scores in the 
general and in the craniosynostosis population. We hypothesized that the craniosynostosis 
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
120
OSA-18 survey in syndromic craniosynostosis
population reported higher mean scores, i.e. a lower quality on life due to OSA than the 
general population. In addition, in the population children with syndromic or complex 
craniosynostosis we evaluated the ability of the OSA-18 to discriminate between patients 
with and without OSA; we hypothesized that OSA patients have higher mean scores than 
the non OSA patients. 
All analyses were performed with SPSS 16.0 for Windows (SPSS, Chicago, IL). Th e num-
bers were given in median and range. All domains were expressed as mean and standard 
deviation. Th e independent t-test was used to compare the craniosynostosis with the 
general population. Th e groups were large enough to use this test. Because of the small 
numbers of patients in the OSA subgroups Z-scores were calculated and compared in an 
ANOVA procedure.
Signifi cant diff erences were defi ned as a p-value ≤ 0.05. Pooled eff ect size of the diff e-
rence between craniosynostosis and general population was calculated for each domain. 
Pooled eff ect size is measured by the diff erence between norm scores and patient scores 
divided by the pooled standard deviation15. 
RESULTS
Craniosynostosis population
In total 163 patients with syndromic or complex craniosynostosis and their parents were 
approached, of whom 141 (87%) children and their parents gave informed consent for 
this research project. Of them 119 (73%) returned the questionnaires and underwent a 
polysomnography. Of these 119 parents 34 had children between 12 and 18 years of age and 
29 of them completed the child form themselves and underwent a polysomnography. Th e 
others were unable to do so, due to low mental capacity. 
Th e characteristics of the craniosynostosis population are shown in table 1. Th e median 
age of the parents, who completed the questionnaires, was 39 (23-61) years and 88% of 
them were born in the Netherlands. A sample consisting of 64 out of the 72 (89%) parents, 
who received the OSA-18 twice, completed the survey as retest after a mean time of 6.3 
(sd 3.1) months (range 1-16 months). Th e median age of the children, who completed the 
child form, was 14 (12-18) years. 
General population
After distribution of 1500 questionnaires, parents of 459 healthy children returned the 
questionnaire, the parent form. Th e median age of the respondent, who completed the 
questionnaire, was 41 (17-55) years and 91% were born in the Netherlands. Of these 459 
returned questionnaires children themselves completed also the child form in 162 cases 
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(median age 14 (12-18) years). Th e craniosynostosis and general population were compa-
rable, shown in table 1. However, the educational level of the parents was lower in the 
craniosynososis population with regard to the general population (p = 0.00).
Obstructive sleep apnea
Based on the calculated obstructive apnea hypopnea index (OAHI) 44 patients (37%) were 
diagnosed as having obstructive sleep apnea; 37 mild with a mean OAHI of 2.3 (sd 1.1) and 
7 moderate with a mean OAHI of 9.0 (sd 5.1) with a maximum index of 20. Severe OSA 
was not diagnosed in this craniosynostosis population at the moment of the study.
Internal consistency
With regard to parent-completed questionnaires, in the study and general population the 
Crohnbach’s alpha for almost all domains and for the total OSA-18 score was ≥ 0.70. Th e 
Table 1: Characteristics of the craniosynostosis and general population
Craniosynostosis 
population
n = 119
General 
population
n = 459
p-value
Completed by
Mother
Father
Other
104 (87%) 
  15 (13%)
402 (87%)
  50 (11%)
    7 (2%)
ns
Age respondent   range
(years)                 median
 23-61 
 39 
 17-55 
 41  
ns
Education respondent
Low                                                  
Middle                             
High 
Unknown
    7 (6%)
  78 (65.5%)
  31 (26%)
    3 (2.5%)
    7 (1.5%)
251 (55%)
198 (43%) 
    3 (0.5%)
0.00**
Age child       range
(years)           median
Sex child        boy
                      girl
2-18 
   8 
 56 (47%)
 63 (53%)
2-18
    9 
239 (52%)
220 (48%)
0.04*
ns
Syndrome/ sex (boy/ girl)
Apert 
Crouzon/ Pfeiff er
Muenke 
Saethre-Chotzen 
Complex craniosynostosis
  19 (16%)  (  9/ 10)
  31 (26%)  (14/ 17)
  18 (15%)  (  8/ 10)
  21 (18%)  (  8/ 13)
  30 (25%)  (17/ 13)
Obstructive sleep apnea child
Non
Mild
Moderate
  75 (63%)
  37 (31%)
    7 (6%)
ns not signifi cantly diff erent
* p-value ≤ 0.05
** p-value ≤ 0.01
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exceptions were the domains ‘daytime problems’ in the non OSA craniosynostosis group 
(0.63) and ‘sleep disturbance’ in the general (0.56) and craniosynostosis (0.62) population, 
as shown in table 2. 
With regard to child-completed questionnaires, the Crohnbach’s alpha for three domains 
and for the total OSA-12 score was ≥ 0.70, except for the domain ‘sleep disturbance’. In 
the OSA subgroup (n = 7) the Crohnbach’s alpha was < 0.70 for ‘physical suff ering’, 
‘emotional distress’ and the total OSA-12 score. 
Test-retest reliability in the craniosynostosis population
With regard to parent-completed questionnaires in the craniosynostosis population the 
test-retest reliability was shown in table 3. Th e domains showed no statistically diff erent 
mean scores between the test and retest. Th e intraclass correlations were ≥ 0.70, except the 
domain ‘physical suff ering’ with 0.69. OSA treatment in the interim was only performed 
in two patients.
Table 2: Internal consistency in the craniosynostosis versus general population of the parent and child form
Parent form Items
n
General population
Crohnbach’s α
n = 459
Craniosynostosis 
Total group/
n = 119
population Crohnbach’s α
Non OSA/            OSA 
n = 75               n = 44
Sleep disturbance 4 0.56 0.62 0.73 0.83
Physical suff ering 4 0.83 0.83 0.76 0.89
Emotional distress 3 0.81 0.86 0.79 0.92
Daytime 
problems 
3 0.70 0.70 0.63 0.79
Caregiver 
concerns 
4 0.77 0.91 0.88 0.94
Total OSA-18 
score 
18 0.85 0.89 0.84 0.95
Child form Items
n
General population
Crohnbach’s α
n = 162
Craniosynostosis
Total group/
n = 29
population Crohnbach’s α
Non OSA/          OSA 
n = 22                 n = 7
Sleep disturbance 2 0.25 0.58 0.67 0.29
Physical suff ering 4 0.78 0.79 0.83 0.65
Emotional distress 3 0.74 0.76 0.78 0.65
Daytime 
problems 
3 0.71 0.85 0.79 0.97
Total OSA-12 
score
12 0.81 0.84 0.87 0.60
OSA obstructive sleep apnea
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Table 3: Test-retest reliability of the parent form in a sample of the craniosynostosis population 
Parent form Test
mean (sd)
n = 64
Retest
mean (sd)
n = 64
p-value1 ICC
Sleep disturbance 9.90 (5.81) 9.08 (4.96) 0.49 0.93
Physical suff ering 11.88 (5.77) 12.12 (5.66) 0.86 0.69
Emotional distress 6.67 (3.64) 7.49 (4.02) 0.97 0.82
Daytime problems 7.02 (3.61) 7.73 (3.58) 0.73 0.77
Caregiver concerns 7.98 (5.41) 7.92 (4.88) 0.94 0.71
Total OSA-18 score 42.71 (19.15) 43.51 (16.96) 0.56 0.82
sd standard deviation
ICC intraclass correlation coeffi  cient
¹ 2-sided paired t-test of the mean between the test and retest, time between test and retest: mean 6.3 (3.1) 
months, range 1-16 months
Table 4: Discriminative validity in the craniosynostosis versus general population of the parent and child form
Parent form General 
population
mean (sd) 
n = 459
Craniosynostosis 
population
mean (sd)
n = 119
Cranio vs General
p-value1
Cranio vs General
(pooled) eff ect size2
(d) 
Sleep disturbance 5.8 (2.4) 8.9 (4.8) 0.000** 0.81
Physical suff ering 8.1 (4.3) 11.1 (5.8) 0.000** 0.60
Emotional distress 6.2 (3.1) 6.5 (3.4) 0.35 0.10
Daytime problems 6.2 (3.1) 6.8 (3.5) 0.12 0.17
Caregiver concerns 5.2 (2.4) 7.0 (4.2) 0.000** 0.52
Total OSA-18 score 31.2 (10.4) 39.9 (16.7) 0.000** 0.63
Child form General 
population
mean (sd) 
n = 162
Craniosynostosis 
population
mean (sd)
n = 29
Cranio vs General
p-value1
Cranio vs General
(pooled) eff ect size2
(d) 
Sleep disturbance 3.7 (1.8) 5.6 (3.3) 0.006** 0.71
Physical suff ering 9.0 (4.4) 9.9 (5.3) 0.37 0.19
Emotional distress 5.9 (3.4) 5.4 (2.9) 0.43 0.15
Daytime problems 7.7 (4.0) 7.7 (4.3) 0.99 0.00
Total OSA-12 score 26.4 (9.9) 28.4 (11.6) 0.39 0.19
sd standard deviation
** p-value ≤ 0.01
¹ 2-sided paired t-test of the means between the study population and the norm
² pooled eff ect size d measured the diff erence in mean scores divided by the standard deviations of the study 
group, 0.2 ≤ d < 0.5 indicated a small eff ect, 0.5 ≤ d < 0.8 a moderate eff ect, d ≥ 0.8 a large eff ect, a negative 
eff ect size meant a higher score with regard to the norm group15
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Discriminative validity
With regard to parent-completed questionnaires the mean scores between the general 
and the craniosynostosis population were signifi cantly diff erent in the domains ‘sleep 
disturbance’, ‘physical suff ering’, ‘caregiver concerns’ and total OSA-18 score with higher 
scores, i.e. lower quality of life, in the craniosynostosis population (table 4). Th e ability 
of the OSA-18 to discriminate between the degrees of severity of OSA was signifi cant in 
the fi rst two domains (table 5). Patients with moderate OSA (OAHI ≥ 5) discriminated 
Table 5: Discriminative validity of obstructive sleep apnea in the craniosynostosis population of the parent and 
child form
Parent form Non OSA
mean (sd)
n = 75
Mild OSA 
mean (sd)
n = 37
Moderate OSA 
mean (sd)
n = 7
Mild vs 
Non OSA
p-value1
Moderate vs 
Non OSA
p-value1
Mild vs Non 
OSA
(pooled) 
eff ect size2
Moderate vs 
Non OSA
(pooled) 
eff ect size2
Sleep 
disturbance 
8.1 (4.2) 9.1 (5.0) 15.0 (6.3) 0.34 0.03* 0.21 1.29
Physical 
suff ering 
10.6 (5.1) 10.9 (6.2) 17.7 (6.2) 0.80 0.02* 0.05 1.26
Emotional 
distress 
6.3 (3.1) 6.7 (3.8) 8.5 (4.4) 0.72 0.28 0.07 0.57
Daytime 
problems 
6.6 (3.3) 6.7 (3.6) 8.7 (4.9) 0.89 0.31 0.03 0.50
Caregiver 
concerns 
6.6 (3.8) 7.5 (4.9) 8.2 (4.0) 0.35 0.40 0.20 0.39
Total OSA-
18 score 
38.0 (13.0) 41.0 (20.8) 55.0 (20.4) 0.45 0.10 0.17 0.99
Child form Non OSA
mean (sd)
n = 22
 Mild OSA 
mean (sd)
n = 5
Moderate OSA 
mean (sd)
n = 2
Mild vs 
Non OSA
p-value1
Moderate vs 
Non OSA
p-value1
Mild vs Non 
OSA
(pooled) 
eff ect size2
Moderate vs 
Non OSA
(pooled) 
eff ect size2
Sleep 
disturbance 
5.2 (3.2) 4.8 (2.5) 11.0 (1.4) 0.73 0.04* 0.18 2.30
Physical 
suff ering 
10.0 (5.3) 10.2 (4.9) 9.5 (7.8) 0.90 0.96 0.07 0.05
Emotional 
distress 
5.6 (3.1) 5.2 (1.6) 6.0 (4.2) 0.84 0.88 0.08 0.16
Daytime 
problems 
7.7 (4.1) 7.2 (4.8) 11.5 (7.8) 0.90 0.60 0.07 0.65
Total OSA-
12 score
28.4 (12.1) 25.8 (7.1) 38.0 (9.9) 0.62 0.37 0.23 0.89
OSA obstructive sleep apnea
sd standard deviation
* p-value ≤ 0.05
¹ 2-sided paired t-test of the means between the degrees of severity of OSA
² pooled eff ect size d measured the diff erence in mean scores divided by the standard deviations of the study 
group, 0.2 ≤ d < 0.5 indicated a small eff ect, 0.5 ≤ d < 0.8 a moderate eff ect, d ≥ 0.8 a large eff ect, a negative 
eff ect size meant a higher score with regard to the norm group15
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signifi cantly from the children without OSA on the two domains ‘sleep disturbance’ and 
‘physical suff ering’. Th e total OSA-18 score had a positive trend (p = 0.10) (table 5).
With regard to child-completed questionnaires, the mean scores in the general and the 
study population were signifi cantly diff erent in the domain ‘sleep disturbance’ (table 4). 
Children with moderate OSA (OAHI ≥ 5) discriminated signifi cantly from the children 
without OSA on the domain ‘sleep disturbance’ (table 5). 
DISCUSSION
Until now, the OSA-18 was used for healthy children with OSA due to adenotonsil-
lar hypertrophy without specifi c syndromes. In this study norm scores of the general 
population were provided for clinical studies. We showed that the OSA-18 completed 
by parents is also reliable to measure the quality of life of children with syndromic or 
complex craniosynostosis and to measure the impact of obstructive sleep apnea on the 
health-related quality of life in the craniosynostosis population; the results supported the 
internal consistency and test-retest reliability. Th e results on the test and retest were very 
consistent; the dynamic character of obstructive sleep apnea did not infl uence the scores. 
Th e OSA-18 domains ‘sleep disturbance’, ‘physical suff ering’, ‘caregiver concerns’ and 
the total score discriminated signifi cantly between children with syndromic or complex 
craniosynostosis and the general population independent of the presence of OSA whereas 
the domains ‘emotional distress’ and ‘daytime problems’ did not. Children with syndromic 
or complex craniosynostosis had more sleep related problems and physical symptoms due 
to the severe anatomical malformations of the nasal cavity resulting in nasal obstruction 
and to a higher prevalence of OSA in comparison with the general population. Caregiver 
concerns were probably related to having a child with a syndrome with the additional 
problems. For the child form the domain ‘sleep disturbance’ discriminated between the 
craniosynostosis and the general population. Th is diff erence is mainly based on the fre-
quency of a good bit, most or all of the time (answers 5, 6 or 7 on item 1 of the OSA-18) 
loud snoring during the past 4 weeks: 26% in the craniosynostosis population (n = 29) 
versus 1% in the general population (n = 162). 
In general, parents of children with syndromic craniosynostosis reported a lower quality of 
life compared to parents of children in the general population. But, with the use of the OSA-
18 survey it was possible to discriminate between the presence of moderate OSA and mild 
or no OSA on two domains, ‘sleep disturbance’ and ‘physical suff ering’. Th is means that if 
the child is suff ering from moderate OSA the impact on quality of life is the largest (table 5). 
In the child-completed questionnaires children scored higher than the general popula-
tion on ‘sleep disturbance’, but not on other domains. A reason for these comparable 
scores on the other domains might be that children with syndromic or complex cranio-
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synostosis tend to minimize their concerns about functioning and health16-18, they reported 
their quality of life as better than their parents did. It might also be possible that children 
aged between 12 and 18 in the general population scored higher on diff erent items, due to 
their puberty, more than the children in the craniosynostosis population. In that case the 
general scores were higher than expected resulting in a smaller diff erence in mean scores 
between the general and craniosynostosis population. Another point is the completion of 
the questionnaires; maybe children in the general population really completed the survey 
by themselves and children in the craniosynostosis population talked to their parents 
about some questions, for example about loud snoring, resulting in the diff erent scores on 
the domain ‘sleep disturbance’. 
To unravel diff erences in the scores between parents and children a comparison was 
made using the paired-samples t-test between the scores of the parents about their child 
and the scores of children themselves in the general and the craniosynostosis population 
in the selections in whom the parent and the child form were available. In the craniosy-
nostosis population (n = 29) the answers on all 12 items were comparable (not signifi cantly 
diff erent) between parent and child. In the general population (n = 162) the answers on 6 
items (restless sleep, mouth breathing, frequent colds, nasal discharge, aggressive behavior 
and diffi  culty getting out of bed) were statistically signifi cant diff erent between parent and 
child, the other 6 were comparable. So, in the general population children and parents 
had diff erent views about above-mentioned items in contrast with the craniosynostosis 
population. Th is diff erence may be due to more communication between parents and 
craniosynostosis patients regarding their sleep and health.
Overall, the OSA-18 completed by parents is more reliable and valid than the OSA-12 
child form. We will recommend using the OSA-18 survey anyhow for all children.
A limitation is the small number of moderate OSA patients, and for this reason we 
used the Z-scores for the independent t-test. Th e educational level of the respondents 
was signifi cantly lower in the craniosynostosis population than in the general population, 
which can infl uence the OSA-18 results. However this study showed that the OSA-18 
survey is reliable, also in this population. 
In conclusion, the OSA-18 can be used in future studies to evaluate the disease-specifi c 
impact of obstructive sleep apnea, also in children with syndromic or complex craniosy-
nostosis. 
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APPENDIX 1
OSA-18 Quality of Life Survey
Instructions. For each question below, please circle the number that best describes how 
often each symptom or problem has occurred during the past 4 weeks.  Please circle only 
one number per question. Th ank you.
None
of the 
time
Hardly 
any of
the 
time
A 
little 
of the 
time
Some 
of the 
time
A good 
bit of
the 
time
Most 
of 
the 
time
All 
of 
the 
time
Sleep Disturbance
During the past 4 weeks, how often has your child had…
…loud snoring?
…breath holding spells or pauses in breathing at night?
…choking or gasping sounds while asleep?
…restless sleep or frequent awakenings from sleep?
1
1
1
1
2
2
2
2
3
3
3
3
4
4
4
4
5
5
5
5
6
6
6
6
7
7
7
7
Physical Symptoms
During the past 4 weeks, how often has your child had…
…mouth breathing because of nasal obstruction?
…frequent colds or upper respiratory infections?
…nasal discharge or runny nose?
…diffi  culty in swallowing foods?
1
1
1
1
2
2
2
2
3
3
3
3
4
4
4
4
5
5
5
5
6
6
6
6
7
7
7
7
Emotional Distress
During the past 4 weeks, how often has your child had…
…mood swings or temper tantrums?
…aggressive or hyperactive behavior?
…discipline problems?
1
1
1
2
2
2
3
3
3
4
4
4
5
5
5
6
6
6
7
7
7
Daytime Problems
During the past 4 weeks, how often has your child had…
…excessive daytime drowsiness or sleepiness?
…poor attention span or concentration?
…diffi  culty getting out of bed in the morning?
1
1
1
2
2
2
3
3
3
4
4
4
5
5
5
6
6
6
7
7
7
Caregiver Concerns
During the past 4 weeks, how often have the above problems…
…caused you to worry about your child’s general health?
…created concern that your child is not getting enough air?
…interfered with your ability to perform daily activities?
…made you frustrated?
1
1
1
1
2
2
2
2
3
3
3
3
4
4
4
4
5
5
5
5
6
6
6
6
7
7
7
7
OVERALL, HOW WOULD YOU RATE YOUR CHILD’S QUALITY OF LIFE 
AS A RESULT OF THE ABOVE PROBLEMS?
(Circle one number)
     
0 1 2 3 4 5 6 7 8 9 10
Worst Possible Half-way Between Best Possible
Quality-of-Life    Worst and Best Quality-of-Life
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OSA-18 and behavior in syndromic craniosynostosis
ABSTRACT
Objective 
Th is study aimed at evaluating the impact of syndromic craniosynostosis on quality of life, 
assessing the association between presence of craniosynostosis syndrome and prevalence 
of behavioral problems and assessing the impact of obstructive sleep apnea (OSA) in syn-
dromic craniosynostosis compared to healthy controls and the association with behavior. 
Methods
A prospective study was carried out using the OSA-18 survey and Child Behavior Checklist 
(CBCL) in 119 syndromic craniosynostosis patients and 459 controls. Th e craniosynostosis 
population underwent a ambulatory polysomnography to diagnose OSA. 
Results
Th e domains ‘sleep disturbance’, ‘physical suff ering’, ‘caregiver concerns’ and total OSA-18 
score were signifi cantly higher in the craniosynostosis group than in controls. After sub-
group analysis 67% and 50% of boys with Apert and Muenke syndrome showed behavioral 
problems. Th e correlation between obstructive apnea hypopnea index and total OSA-18 
and CBCL score was signifi cant. Mean scores for the domains ‘sleep disturbance’ and 
‘physical suff ering’ were signifi cantly higher in moderate OSA. 
Conclusion
Children with syndromic craniosynostosis reported lower quality of life measured with 
OSA-18 than controls. Behavioral problems were common in boys with Apert and Muenke 
syndrome. Obstructive sleep apnea reduced the quality of life of craniosynostosis children. 
OSA-18 and CBCL scores are correlated with OSA severity. 
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INTRODUCTION
Apert, Crouzon, Pfeiff er, Muenke and Saethre-Chotzen syndrome are craniosynostosis 
syndromes caused by FGFR (fi broblast growth factor receptor) 1, 2, 3 mutations and 
TWIST gene mutations or deletions. Th ese syndromes are characterized by the premature 
fusion of calvarial sutures, brain anomalies, characteristic facial features, hand and feet 
malformations and hearing defi cits amongst others1, 2. Fusion of two cranial sutures or 
more without a known mutation1, 2 is defi ned as complex craniosynostosis. Patients with 
a syndromic or complex craniosynostosis are at risk for obstructive sleep apnea due to 
midface hypoplasia and collapse of the pharynx, but other factors such as adenotonsillar 
hypertrophy may be involved as well3, 4. Th ey can also have behavioral problems, such as 
attention defi cit hyperactive disorder and autism5, 6. Th e prevalence and severity of the 
behavioral problems among patients with craniosynostosis syndromes are unknown, but 
the problems seem to occur more frequent in comparison with the general population. 
Obstructive sleep apnea (OSA) is characterized by diffi  culties in breathing, snoring and 
apneas during sleep due to a partial or complete obstruction of the upper airway. OSA is 
associated with major physical and functional impairment due to disturbed sleep patterns, 
for instance failure to thrive, recurrent infections, feeding diffi  culties, disturbed cognitive 
functions (attention defi cit, impaired concentration and memory), delay of development, 
cor pulmonale and sudden death7. OSA can be treated pharmacologically (e.g. with 
intranasal corticosteroids or antibiotics), surgically (e.g. with adenotonsillectomy (ATE) 
or midface advancement), or non-surgically (e.g. with nocturnal oxygen or continuous or 
bi-level positive airway pressure (CPAP or BiPAP))3, 8, 9.
Obstructive sleep apnea may aff ect the child’s quality of life because of these physical 
and functional consequences and the treatment. Previously a disease-specifi c quality of life 
survey was developed and validated, the OSA-18, for healthy children who got OSA due 
to adenotonsillar hypertrophy10. 
Th is study aimed (a) at evaluating the impact of syndromic craniosynostosis on quality 
of life, (b) at assessing the association between the presence of a craniosynostosis syndrome 
and the prevalence of behavioral problems and (c) at assessing the impact of obstructive 
sleep apnea on the quality of life in a population of patients with syndromic craniosy-
nostosis compared to healthy controls and the association with the presence of behavioral 
problems. 
METHODS
Authorisation was granted by  the medical ethics committee (MEC-2005-273) of the 
Erasmus Medical Center.
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Craniosynostosis population
A prospective study was carried out in the Erasmus MC-Sophia Children’s Hospital, a 
tertiary care university hospital in Rotterdam. Patients with syndromic (genetically 
confi rmed) or complex craniosynostosis between the age of 2 and 18 years treated at the 
Dutch Craniofacial Center between January 2007 and March 2009 were included (table 
1). Parents were asked to complete the OSA-18 survey and the Child Behavior Checklist 
(CBCL). 
General population
Parents of healthy children between the age of 2 and 18 years were approached at day-
care centers, primary and secondary schools and sports clubs in Rotterdam, Rijswijk and 
Leiden (table 1). Th ey were asked to complete the OSA-18 survey on their child and to 
return this to the hospital. A child with Down syndrome was excluded. No child had 
anamnestic complaints suggestive of OSA. Behavioral problems were not excluded.
Table 1: Characteristics of the craniosynostosis and general population
Craniosynostosis 
population
n = 119
General 
population
n = 459
p-value
Completed by
Mother
Father
Other
104 (87%) 
  15 (13%)
402 (87%)
  50 (11%)
    7 (2%)
ns
Age respondent   range
(years)                 median
 23-61 
 39 
 17-55 
 41  
ns
Education respondent  
Low                                                  
Middle                             
High 
Unknown
    7 (6%)
  78 (65.5%)
  31 (26%)
    3 (2.5%)
    7 (1.5%)
251 (55%)
198 (43%) 
    3 (0.5%)
0.00**
Age child       range
(years)           median
Sex child       boy
                     girl
2-18 
   8 
 56 (47%)
 63 (53%)
2-18
    9 
239 (52%)
220 (48%)
0.04*
ns
Syndrome/ sex (boy/ girl)
Apert
Crouzon/ Pfeiff er
Muenke
Saethre-Chotzen
Complex
  19 (16%)  (  9/ 10)
  31 (26%)  (14/ 17)
  18 (15%)  (  8/ 10)
  21 (18%)  (  8/ 13)
  30 (25%)  (17/ 13)
Obstructive sleep apnea child
Non
Mild
Moderate
  75 (63%)
  37 (31%)
    7 (6%)
ns not signifi cantly diff erent
* p-value ≤ 0.05
** p-value ≤ 0.01
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OSA-18 survey
Th e questionnaire consisted of 18 age-independent items grouped into fi ve domains: ‘sleep 
disturbance’, ‘physical suff ering’, ‘emotional distress’, ‘daytime problems’ and ‘caregiver 
concerns’. Each item had seven optional answers ranging from 1 (never) to 7 (always). Th e 
total OSA-18 score was the sum of the 18 items and ranged from 18 to 126. It also provided 
a 10-point visual analogous scale with specifi c semantic anchors10 (appendix 1). Total scores 
less than 60 suggest a small impact on health-related quality of life, scores between 60 and 
80 a moderate impact and scores above 80 a large impact10. 
Prior to this study the internal consistency, test-retest reliability and discriminative 
validity of the translated OSA-18 survey in healthy children and children with syndromic 
or complex craniosynostosis were demonstrated (Bannink et al., unpublished data, 2010). 
Child Behavior Checklist
Th e standardized Child Behavior Checklist (CBCL) was used to measure the parent-
reported child problem-behavior frequency. Th e CBCL is a widely used norm-referenced 
measure (Rescorla, Manual for the ASEBA Preschool Forms & Profi les11 and Achenbach, 
Manual for the Child Behavior Checklist/4-18 & Profi le12). Th e CBCL 1.5-5 years consisted 
of 100 items and the CBCL 6-18 years of 113 items. Each item is scored as 0, not true; 
1, somewhat or sometimes true; and 2, very true or often true. Th e known Dutch norm 
scores were used as cut-off  values. Scores < 95th percentile are scores in the normal range. 
Scores ≥ 95th percentile but < 98th percentile were defi ned as scores in the borderline and 
≥ 98th percentile as scores in the clinical range, so these scores are considered as abnormal. 
Th e CBCL provided age- (1.5-5, 6-11 and 12-18 years) and gender-specifi c scores for in-
ternalizing, externalizing and total problems. Internalizing scores were based on the three 
domains ‘anxiety’, ‘withdrawal’ and ‘somatic complaints’. Externalizing scores were based 
on ‘rule-breaking behavior’ and ‘aggressive behavior’. Th e total score is a combination of 
the two scores plus ‘social’, ‘thought’ and ‘attention problems’, and ‘other problems’ (e.g. 
overeating, overtired). 
Behavioral problems were defi ned as the presence of scores in the (borderline) clinical 
range11. Th e results were analyzed in the craniosynostosis population and per syndrome. 
Polysomnography
Th e children of the craniosynostosis population underwent a polysomnography, the gold 
standard to diagnose obstructive sleep apnea. Polysomnography was done ambulatory 
with Embletta Portable Diagnostic System and analyzed with Somnologica for Embletta 
software 3.3 ENU (Medcare Flaga, Reykjavik, Iceland). Th oracic and abdominal move-
ments, nasal fl ow, saturation, and pulse were monitored. Th e required minimal total sleep 
time was 360 minutes. Obstructive apnea was defi ned as absence of airfl ow (measured by 
a nasal cannula) or out-of-phase movement of thorax and abdomen (scored as X fl ow) and 
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hypopnea as ≥ 50% reduction in nasal fl ow signal amplitude or X fl ow signal amplitude, 
both for more than two breaths13-15. Th e X fl ow signal was the sum of the amplitudes of the 
thoracic and abdominal movements14, 15 and was used when nasal airfl ow was insuffi  cient. 
Mixed apnea was defi ned as a type of obstructive apnea with a central component that 
mostly preceded the obstructive pattern, for more than two breaths. Central apneas were 
not included in this study. Desaturation was defi ned as ≥ 4% decrease with respect to the 
baseline value. 
Th e degree of OSA was expressed in an obstructive apnea hypopnea index (OAHI), the 
hourly number of obstructive and mixed apneas in combination with the hourly number 
of hypopneas followed by desaturation. A score < 1 is considered to be normal, between 
1 and 5 is defi ned as mild OSA, between 6 and 25 as moderate OSA, and > 25 as severe 
OSA16, 17. 
Statistical analysis
All analyses were performed with SPSS 16.0 for Windows (SPSS, Chicago, IL). Th e analy-
ses were performed in several subgroups, in boys and girls and in each craniosynostosis 
syndrome separately. Th e independent t-test was used to compare the means of the dif-
ferent craniosynostosis syndromes with the general population. Th e correlations between 
OSA-18, CBCL and OAHI were assessed. Signifi cant diff erences were defi ned as a p-value 
≤ 0.05. Th e numbers were given in median and range. 
RESULTS
Craniosynostosis population
A total of 163 patients with syndromic or complex craniosynostosis were approached, of 
whom 141 (87%) children and their parents gave informed consent for this research project. 
Of them 119 (73%) returned the OSA-18 survey and underwent a polysomnography. Out 
of these 119 the parents of two girls did not complete the CBCL, due to very low mental 
capacity of one child (several items could not be answered) and due to a logistic reason in 
the other.  
Most of the questionnaires, namely 87% were completed by mothers compared to 13% 
completed by fathers and 88% of them were born in the Netherlands. Th e craniosynostosis 
group consisted of 56 boys (47%) and 63 girls (table 1).
General population
Parents of 459 healthy children returned the questionnaire. Also in this healthy population 
most of the questionnaires (87%) were completed by mothers and 91% of the respondents 
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were born in the Netherlands. Th e reference group consisted of 239 boys (52%) and 220 
girls (table 1).  
OSA-18 survey
Th e quality of life measured with the OSA-18 in patients with a syndromic or complex cra-
niosynostosis was lower than that measured in the general population (table 2). Th e mean 
total OSA-18 score in the craniosynostosis population was 39.9 (sd 16.7). Th e maximum 
score was 100. A score above 60 was present in 12%, above 80 in 3%. Th e mean OSA-18 
score in the general population was 31.2 (sd 10.4) with a score above 60 in 2% and above 
80 in none of the healthy children.
Th e domains ‘sleep disturbance’, ‘physical suff ering’, and ‘caregiver concerns’ and the 
total OSA-18 score were signifi cantly higher in the craniosynostosis group than in the ge-
neral population (p = 0.000). Specifi cally children with Apert, Crouzon/ Pfeiff er syndrome 
and complex craniosynostosis scored signifi cantly higher than the general population on 
all these domains. Children with Muenke syndrome scored signifi cantly higher on ‘sleep 
disturbance’ (table 2). 
Table 2: Means of the OSA-18 scores in the craniosynostosis population and per syndrome in comparison with 
the general population
General 
population
 
mean (sd) 
n = 459
Craniosynostosis 
population
mean (sd)
n = 119
Apert
mean (sd) 
n = 19
Crouzon/
Pfeiff er
mean (sd) 
n = 31
Muenke
mean (sd) 
n = 18
Saethre-
Chotzen
mean (sd) 
n = 21
Complex
mean (sd) 
n = 30
Sleep 
disturbance 
5.8 (2.4) 8.9 (4.8)** 12.7 (5.2)**+ 9.3 (7.1)** 8.8 (5.3)* 7.8 (5.1) 7.2 (3.1)* 
Physical 
suff ering 
8.1 (4.3) 11.1 (5.8)** 14.7 (6.3)**# 10.8 (6.1)** 8.7 (4.6) 9.7 (5.8) 11.1 (5.1)**
Emotional 
distress 
6.2 (3.1) 6.5 (3.4) 6.7 (3.7) 5.9 (4.1) 6.5 (3.2) 6.1 (2.7) 7.1 (3.4)
Daytime 
problems 
6.2 (3.1) 6.8 (3.5) 7.5 (3.4) 6.0 (3.7) 7.7 (4.6) 7.1 (3.1) 6.3 (3.1)
Caregiver 
concerns 
5.2 (2.4) 7.0 (4.2)** 8.3 (3.9)** 6.9 (5.5)* 6.3 (4.1) 6.2 (2.9) 6.9 (4.1)*
Total OSA-
18 score 
31.2 (10.4) 39.9 (16.7)** 49.8 (16.8)**^ 39.0 (19.0)* 38.2 (19.2) 37.4 (14.4) 37.9 (14.5)*
sd standard deviation
* p-value ≤ 0.05
** p-value ≤ 0.01
+ scores were signifi cantly higher in Apert syndrome in comparison with Muenke, Saethre-Chotzen syndrome 
and complex craniosynostosis
# scores were signifi cantly higher in Apert syndrome in comparison with all other four syndromes
^ scores were signifi cantly higher in Apert syndrome in comparison with Saethre-Chotzen syndrome and complex 
craniosynostosis
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Within the group of children with syndromic or complex craniosynostosis Apert 
syndrome scored signifi cantly higher than the other syndromes on diff erent domains as 
demonstrated in table 2. 
Child Behavior Checklist
Th e prevalence of behavioral problems is 32% in boys with syndromic or complex cranio-
synostosis and 16% in girls (table 3). Th e total CBCL score between 1.5 and 5 years was 31.8 
(sd 17.9) in boys and 28.1 (sd 27.7) in girls and between 6 and 18 years 38.1 (sd 29.6) in boys 
and 28.4 (sd 14.6) in girls. Th e maximum score was 144. 
Table 3 also showed the results of the CBCL scores per syndrome. Of the boys with 
Apert syndrome 67% scored in the (borderline) clinical range in contrast with none of the 
girls. Th is 67% prevalence of behavioral problems in boys is signifi cantly higher than in 
Crouzon/ Pfeiff er syndrome and complex craniosynostosis. Boys with Muenke syndrome 
also scored high (50%) in the (borderline) clinical range. 
Obstructive sleep apnea
Out of the 119 patients 44 (37%) were diagnosed with an obstructive sleep apnea; 37 mild 
with a mean OAHI of 2.3 (sd 1.1) and 7 moderate with a mean OAHI of 9.0 (sd 5.1) with 
a maximum index of 20.
Table 3: Th e numbers and percentages of the CBCL scores in the (borderline) clinical range in the 
craniosynostosis population and per syndrome in boys and girls
Craniosynostosis 
population
 (borderline) 
clinical range 
n (%)
Apert
 (borderline) 
clinical range 
n (%)
Crouzon/
Pfeiff er
 (borderline) 
clinical range 
n (%)
Muenke
  (borderline) 
clinical range 
n (%)
Saethre-
Chotzen
 (borderline) 
clinical range 
n (%)
Complex
 (borderline) 
clinical range 
n (%)
Boy n = 56 n = 9 n = 14 n = 8 n = 8 n = 17
Internalizing 
score 
14 (25) 4 (44) 3 (21) 3 (38) 1 (13) 3 (18)
Externalizing 
score
12 (21) 4 (44)- 1 (7) 3 (38) 1 (13) 3 (18)
Total score 18 (32) 6 (67)# 3 (21) 4 (50) 2 (25) 3 (18)
Girl n = 61 n = 10 n = 16 n = 10 n = 12 n = 13
Internalizing 
score 
12 (20) 0 (0) 2 (13) 4 (40)^ 4 (33)+ 2 (15)
Externalizing 
score
5 (8) 0 (0) 1 (6) 1 (10) 3 (25) 0 (0)
Total score 10 (16) 0 (0) 1 (6) 3 (30) 3 (25) 3 (23)
- scores were signifi cantly higher in Apert syndrome in comparison with Crouzon/ Pfeiff er syndrome 
# scores were signifi cantly higher in Apert syndrome in comparison with Crouzon/ Pfeiff er syndrome and 
complex craniosynostosis
^ scores were signifi cantly higher in Muenke syndrome in comparison with Apert syndrome 
+ scores were signifi cantly higher in Saethre-Chotzen syndrome in comparison with Apert syndrome 
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Obstructive sleep apnea in the patients with syndromic or complex craniosynostosis 
had impact on the quality of life. Th ere was a signifi cant positive correlation between 
the total OSA-18 score and the OAHI (r = 0.34, p = 0.000), also after exclusion of the 
patients without OSA (r = 0.40, p = 0.009) (fi gure 1). Patients without OSA had a mean 
total OSA-18 score of 38.0, with mild OSA 41.0 and with moderate OSA 55.0 (fi gure 2). 
All patients with a total OSA-18 score above 80 had OSA, and 9 out of 14 (64%) with a 
total score above 60. 
Th e domains ‘sleep disturbance’ and ‘physical suff ering’ were signifi cantly higher in the 
moderate OSA group than in the non OSA and than in the mild OSA group (p ≤ 0.05), 
but not in the mild OSA group in comparison with the non OSA group. 
Th e degree of obstructive sleep apnea also has impact on behavior. Th e correlation 
between the total CBCL score in children between 6 and 18 years and the OAHI was 
signifi cant (r = 0.38, p = 0.001), also after exclusion of the patients without OSA (r = 0.55, 
p = 0.008) (fi gure 3). 
Overall, there is a signifi cant correlation between the total OSA-18 score and the total 
CBCL score in children between 1.5 and 5 years and 6 and 18 years (fi gure 4), also after 
exclusion of the patients without OSA (r = 0.73, p = 0.000). 
 
S 
U 
Figure 1: Correlation between total OSA-18 score and the OAHI in the total group after exclusion of children 
without obstructive sleep apnea 
OAHI obstructive apnea hypopnea index
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Figure 2: Mean total OSA-18 scores with standard deviation over three groups with no, mild and moderate 
obstructive sleep apnea 
sd standard deviation
S 
U 
Figure 3: Correlation between total CBCL score and the OAHI in the children between the age of 6 and 18 after 
exclusion of children without OSA 
OAHI obstructive apnea hypopnea index
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DISCUSSION
Th is is the fi rst study using a disease-specifi c quality of life score (OSA-18) in which com-
parison is made between children with syndromic or complex craniosynostosis suff ering 
from obstructive sleep apnea and a general healthy population of Dutch children. Th e 
total OSA-18 score was signifi cantly higher in the syndromic craniosynostosis population 
than in the general population (table 2), which meant a lower quality of life. Explanations 
can be the higher prevalence of OSA in this group compared to the low prevalence (2-5%) 
in the general population15 and the impact of having syndromic or complex craniosynos-
tosis independent of the presence of OSA18. In the craniosynostosis population the total 
OSA-18 score (mean 43.4) of the OSA group was higher in comparison with the non OSA 
group (mean 38.0). Per domain the scores on ‘sleep disturbance’, ‘physical suff ering’, and 
‘caregiver concerns’ were signifi cantly higher in the craniosynostosis than in the general 
population. 
Within the group of children with syndromic or complex craniosynostosis, children 
with Apert syndrome showed the highest total OSA-18 score (table 2). Th is is in accordance 
with the lowest health-related quality of life in comparison with the other syndromes18 and 
a high prevalence of OSA (42%) seen in Apert syndrome. 
S 
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Figure 4: Correlation between the total CBCL score of the children between the age of 6 and 18 and the total 
OSA-18 score 
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Th ere was a signifi cant positive correlation between the total OSA-18 score and the 
OAHI. However, within the group of children with mild OSA a considerable number of 
children had a high OSA-18 score. Th is could be due to high scores on some specifi c items 
within the domains, which can be related to syndromic craniosynostosis. Th ese items are 
snoring, mouth breathing, nasal discharge, aggressive or hyperactive behavior and poor 
attention span or concentration. Th ese items were also higher scored in children with 
syndromic craniosynostosis without OSA. Overall the domains ‘sleep disturbance’ and 
‘physical suff ering’ were scored signifi cantly higher in children with moderate OSA and 
these two domains might be used in clinical practice for evaluating the severity of OSA. A 
signifi cant correlation between the mean OSA-18 score and the severity of OSA was also 
found in healthy children with OSA due to adenotonsillar hypertrophy10. 
We found a high prevalence of behavioral problems, especially in boys with syndromic 
or complex craniosynostosis. Furthermore we found a positive correlation between the 
total CBCL score and the OAHI and the total OSA-18 score. Within the group of chil-
dren with syndromic or complex craniosynostosis it was remarkable that boys with Apert 
and Muenke syndrome showed the highest prevalence of behavioral problems, whereas 
none of the girls with Apert syndrome scored these problems. In Apert syndrome OSA 
is much more present in boys (78%) than in girls (10%) and the intelligence of boys with 
Apert syndrome is signifi cantly lower than that of girls, which can infl uence the behavior 
(Maliepaard et al., unpublished data). In Muenke syndrome the behavioral problems may 
be more intrinsic and possibly related to their P250R mutation than be associated with 
OSA. Th e prevalence of OSA in Muenke syndrome is with 28% low in comparison with 
the other syndromes. Previously, studies on behavioral problems were mostly performed 
in children with isolated craniosynostosis. Boltshauser et al.19 reported in 30 children with 
isolated sagittal craniosynostosis a normal behavior whereas Kelleher et al.20 reported in 
63 children with trigonocephaly that 37% of the parents expressed concerns about their 
child’s behavior. In children with Apert syndrome Sarimski et al.5, 6 reported in the majo-
rity of the children clinically signifi cant social problems and attention defi cit, the total 
CBCL scores were only in 8 out of 25 children with Apert in the clinical range. 
In this study it can be questioned what the additional infl uence of OSA is next to 
having syndromic craniosynostosis on the presence of behavioral problems in the diff erent 
syndromes. Goldstein et al.9 reported that non-syndromic healthy children with OSA 
demonstrated a high prevalence of behavioral and emotional problems measured by the 
standardized CBCL, which changed after adenotonsillectomy. A positive correlation was 
found between the OSA-18 total scores and the CBCL scores9. After adenotonsillectomy 
both scores improved21. In children with the diagnosis ADHD in combination with mild 
OSA the apnea hypopnea index, the OSA-18 ‘sleep disturbance’ domain and the ADHD-
rating scale total and inattentive scores improved signifi cantly more in the group treated 
for OSA by adenotonsillectomy than the group treated for their ADHD by methylphe-
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nidate22. Concerning children with syndromic or complex craniosynostosis future studies 
have to elaborate the impact of OSA treatment on the OSA-18 score and CBCL score for 
each specifi c syndrome separately.  
In conclusion, children with syndromic craniosynostosis reported a lower quality of life 
measured with the OSA-18 compared to healthy controls. Behavioral problems were highly 
prevalent and most common in boys with Apert and Muenke syndrome. Obstructive sleep 
apnea reduced the quality of life of children with syndromic craniosynostosis. Th e OSA-18 
and CBCL scores are correlated with the severity of OSA, but the additional infl uence of 
OSA on behavior is unclear in craniosynostosis. 
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APPENDIX 1
OSA-18 Quality of Life Survey
Instructions. For each question below, please circle the number that best describes how 
often each symptom or problem has occurred during the past 4 weeks.  Please circle only 
one number per question. Th ank you.
None
of the 
time
Hardly 
any of
the 
time
A 
little 
of the 
time
Some 
of the 
time
A good 
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time
Most 
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time
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time
Sleep Disturbance
During the past 4 weeks, how often has your child had…
…loud snoring?
…breath holding spells or pauses in breathing at night?
…choking or gasping sounds while asleep?
…restless sleep or frequent awakenings from sleep?
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Physical Symptoms
During the past 4 weeks, how often has your child had…
…mouth breathing because of nasal obstruction?
…frequent colds or upper respiratory infections?
…nasal discharge or runny nose?
…diffi  culty in swallowing foods?
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Emotional Distress
During the past 4 weeks, how often has your child had…
…mood swings or temper tantrums?
…aggressive or hyperactive behavior?
…discipline problems?
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Daytime Problems
During the past 4 weeks, how often has your child had…
…excessive daytime drowsiness or sleepiness?
…poor attention span or concentration?
…diffi  culty getting out of bed in the morning?
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Caregiver Concerns
During the past 4 weeks, how often have the above problems…
…caused you to worry about your child’s general health?
…created concern that your child is not getting enough air?
…interfered with your ability to perform daily activities?
…made you frustrated?
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OVERALL, HOW WOULD YOU RATE YOUR CHILD’S QUALITY OF LIFE AS A 
RESULT OF THE ABOVE PROBLEMS?
(Circle one number)
     
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DISCUSSION
Th e main aim of this thesis was to assess the importance and impact of obstructive sleep 
apnea (OSA) in children with syndromic or complex craniosynostosis. Main fi ndings are:
·  Th e prevalence of obstructive sleep apnea in children with syndromic or complex cra-
niosynostosis is 42%.
·  When parents do not notice diffi  culty in breathing of their child during sleep the pre-
sence of moderate or severe obstructive sleep apnea can almost be excluded. 
·  Home cardiorespiratory monitoring is feasible to diagnose obstructive sleep apnea; 
nevertheless there are concerns about the nasal fl ow recordings. Analysis of the X fl ow 
signal gives additional information. 
·  Endoscopy before midface advancement in patients with obstructive sleep apnea is 
recommended to identify level of airway obstruction and to help predict respiratory 
improvement after midface advancement.
·  Th ere is a high (52-56%) prevalence of functional problems such as refractive errors and 
hearing loss in all types of syndromic or complex craniosynostosis. Th e prevalence of 
papilledema in Crouzon/ Pfeiff er syndrome is 53%; in Apert syndrome it is 33%.
·  Syndromic craniosynostosis has a large impact on the health-related quality of life of 
these children and their parents, both physical and psychosocial. 
·  Th e OSA-18, a disease-specifi c quality of life questionnaire, has good reliability and 
validity for patients with syndromic craniosynostosisis. Obstructive sleep apnea reduced 
the quality of life of children with syndromic craniosynostosis and the OSA-18 scores are 
correlated with disease severity. 
·  Th e prevalence of behavioral problems in boys with syndromic or complex craniosy-
nostosis is 32%; in girls it is 16%. Boys with Apert syndrome (67%) or Muenke syndrome 
(50%) had more behavioral problems than children with the other syndromes. 
COMMENTS ON FINDINGS
Th is thesis describes a large study in children with syndromic or complex craniosynostosis, 
who were treated by the multidisciplinary team at the craniofacial center in Rotterdam. 
It is divided into a retrospective and prospective part. Prospectively, 190 children and 
their parents were approached consecutively, and 164 gave informed consent. Th us the 
participation rate was 86%. Th is high rate made it possible to diff erentiate the outcomes 
per syndrome. Th e records of 167 children with syndromic craniosynostosis were reviewed 
retrospectively regarding the presence of elevated intracranial pressure (ICP), obstructive 
sleep apnea, functional problems and the diff erent treatments. 
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
150
Discussion and future perspectives
Prevalence of obstructive sleep apnea
Obstructive sleep apnea is an important feature in children with syndromic craniosy-
nostosis. On the basis of an obstructive apnea hypopnea index ≥ 1 the prevalence of OSA 
was 42% in the total prospective study group, 47% in Apert syndrome, 42% in Crouzon/ 
Pfeiff er, 35% in Muenke, 28% in Saethre-Chotzen syndrome, and 50% in complex cra-
niosynostosis. Th is is in accordance with the 40% risk to develop OSA in children with 
Apert, Crouzon and Pfeiff er syndrome reported in the literature1-3. Of the OSA patients 
82% had mild and 18% had moderate OSA. Apert syndrome occurred in half of those with 
moderate OSA; each of the other syndromes in 12.5% of the other half. Th e prospective 
study revealed no new cases with severe OSA. On the other hand, some cases of severe 
OSA were described in the group of patients studied retrospectively in chapter 4. Th e 
latter patients were older than 18 years at the time of the study and therefore not included 
in the prospective study. 
Polysomnography in the prospective study resulted in a higher prevalence of OSA than 
that found previously in the retrospective analyzed patients, of whom the majority had 
undergone nocturnal pulse oximetry only (chapter 6). Obstructive and mixed apneas 
without desaturation were not registered with pulse oximetry, as this technique only re-
cords desaturation.
After informed consent all children aged between 0 and 18 years underwent a polysom-
nography. Th e mean age at inclusion and thus the age at OSA diagnosis with polysom-
nography diff ered between the children with OSA and the children without OSA: 5.5 and 
9.7 years, respectively. Th is would seem to imply that in the majority of children with 
syndromic craniosynostosis OSA will develop at a young age. Th e older patients did not 
develop OSA or had already been treated. Th e exact age of OSA onset is currently not clear; 
yearly follow up from the fi rst year of life during at least six years might provide a clue.
Screening tool
In the past, parents and physicians of children with syndromic or complex craniosynos-
tosis did not recognize respiratory diffi  culties as separate entity. Parents or caregivers did 
not report and physicians did not ask for breathing problems at the outpatient clinic. We 
evaluated the use of an established screening tool for OSA, the Brouillette score, which is 
based on three questions4 (chapter 2). Th is study showed that informing of diffi  culty in 
breathing in itself is sensitive to screen for moderate or severe OSA. Th is single question 
is a simplifi cation of the Brouillette score. Information about snoring is not specifi c due 
to its high prevalence (77%). Th e question about presence of apneas is specifi c but not 
sensitive and thus may result in missing cases. 
In conclusion, if the child has no diffi  culty in breathing moderate or severe OSA is not 
very likely to be present. If diffi  culties in breathing are reported a polysomnography is 
recommended. 
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
151
C
hapter 10
Diagnostic method
Polysomnography
Th ere are four levels of polysomnography5, 6. 
Level 1, full polysomnography, is the gold standard and this is performed in a sleep 
laboratory with a technician in attendance. It records sleep stages (REM and non-REM 
sleep and arousals), respiratory eff ort, airfl ow, oxygen saturation, electrocardiogram, body 
position and limb movements. 
Level 2 records the same variables, but can be performed outside of the sleep laboratory 
without a technician. 
Level 3 is the method used in the prospective study described in this thesis. A portable 
monitor records four physiologic variables, i.e. two respiratory variables (respiratory 
movement and airfl ow), a cardiac variable (heart rate or an electrocardiogram), and arte-
rial oxyhemoglobin saturation via pulse oximetry. Sleep stages and arousals cannot be 
recorded5, 6. 
Level 4 is the simplest portable monitor, which records arterial oxyhemoglobin satura-
tion and/ or airfl ow5, 6. Brouillette et al.7 used nocturnal pulse oximetry to diagnose OSA 
in healthy children with a high positive predictive value, but a negative oximetry result 
could not rule out the presence of OSA. In children with syndromic craniosynostosis 
moderate or severe OSA is almost unlikely with a negative oximetry. 
Chapter 3 described the use of level 3 polysomnography in children with syndromic or 
complex craniosynostosis. OSA was diagnosed with 40.5% successful recordings (minimal 
total sleep time of 360 minutes with artefact-free signals). Th is is a better result than that 
of a previous study performed in children who snore, in whom only 29% of the home 
cardiorespiratory recordings were successful8. Moss et al.9 studied the use of abbreviated 
home polysomnography in 50 primary school children. In 89% of the recordings the total 
sleep time without movement or artifacts was at least four hours. However, it is two hours 
less than our defi nition of a successful measurement. In general, a polysomnography las-
ting a minimum of six hours is advocated for the accurate diagnosis of OSA. 
Limitations in the use of ambulatory polysomnography 
- Use of nasal cannula
Th e nasal cannula is the most important limitation of polysomnography in children 
with syndromic craniosynostosis. Shifting during sleep or intolerance may cause failure. 
Another causative factor is the absence of nasal passage when the nasal cavity is severely 
malformed10. 
- X fl ow as alternative for nasal fl ow
We showed that the X fl ow can be helpful to diagnose OSA in the absence of nasal fl ow. We 
were the fi rst to report this use of the X fl ow in ambulatory polysomnography in children. 
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Discussion and future perspectives
A limitation of this method is underestimation of the degree of OSA by missing a part of 
the obstructive apneas, possibly due to shifting of the trace belts. Th is method should be 
properly validated in comparison with level 1 polysomnography. An alternative solution to 
bypass the nasal obstruction is the use of a mouth thermistor to record oral airfl ow. 
- Additional measurements
Guilleminault et al.11, 12 recommended to measure esophageal pressure (indirect measure 
of the intrathoracic pressure, which gives information on respiratory eff orts) and the 
transcutaneous or end tidal CO2 next to arousal and sleep stages detection. Th is method 
allows to distinguish OSA from upper airway resistance syndrome (UARS)12. Furthermore 
the relation between elevated intracranial pressure and OSA or UARS can be determined 
more accurately.
- Uniform defi nitions for polysomnography in children 
Another limitation in children is the lack of a uniform defi nition to analyze a polysomno-
graphy (table 1)7, 8, 13-15. Th e common defi nition of OSA is an AHI ≥ 1 based on the number 
of obstructive apneas and hypopneas followed by desaturation for at least two breaths. In 
our studies this defi nition was used as well. Th ere is less consensus about the defi nitions 
of mild, moderate and severe OSA (table 2). In our study we used the defi nition of Guil-
leminault et al.16 Children were classifi ed as having mild obstructive sleep apnea if they 
had an AHI of 1 to 5 events per hour of sleep, as moderate OSA with an AHI of between 6 
and 25 events per hour of sleep, and as severe with more than 25 events per hour.
Central apneas were not included in the AHI, because many children, especially the 
very young, show central irregularity of breathing17, 18, which has no association with OSA. 
Another defi nition is the lowest observed saturation in addition to the number of apneas 
and hypopneas per hour19, 20. Th ere are however no studies in children who showed a 
higher morbidity using these criteria. It might be argued that very low saturations warrant 
more or earlier treatment than mild desaturations, but this has to be determined.
Treatment 
Patients who underwent a polysomnography are discussed by a multidisciplinary team 
consisting of a pediatrician, plastic surgeon, otorhinolaryngologist, oral and maxillofacial 
surgeon, and nurse specialist. If OSA is not diagnosed, a strategy of annual screening is 
decided on, unless symptoms of OSA developed in between.
If OSA is diagnosed, the otorhinolaryngologist is asked to inspect the adenoid and 
tonsils. In mild or moderate cases conservative medical therapy (e.g. xylometazolin, anti-
biotics, nasal corticosteroids) or adenotonsillectomy (ATE) are the fi rst treatment options. 
If these do not improve OSA or in severe OSA, continuous or bi-level positive airway 
pressure (CPAP or BiPAP) can be initiated. In some children oxygen therapy might be 
helpful. A tracheostomy might be necessary in very young children with severe OSA who 
present with breathing problems throughout the day.
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Discussion and future perspectives
Surgical treatment to enlarge the upper airway with midface advancement can also 
be valuable to treat OSA. Patients with Apert, Crouzon and Pfeiff er syndrome have an 
intrinsic growth retardation of the maxilla21 and restriction of normal transverse growth 
of the mandible, possibly secondary to cranial base abnormalities22. However, midface 
advancement does not always result in improvement of OSA21, 23, 24. 
Chapter 4 showed a favorable short-term eff ect of monobloc or le Fort III with distrac-
tion in only six of eleven (55%) patients with Apert, Crouzon or Pfeiff er syndrome. In a 
study by Witherow et al.24, severe OSA treated with tracheostomy or CPAP was resolved 
after monobloc with external distraction in six of fourteen (43%) patients suff ering from 
Apert, Crouzon or Pfeiff er syndrome. Th e other eight patients remained dependent on 
tracheostomy or CPAP. Arnaud et al.21 showed that removal of tracheostomy was possible 
after monobloc with internal distraction in four of six (67%) severe cases with Apert, 
Crouzon or Pfeiff er syndromes. Nelson et al.23 studied eighteen patients with syndromic 
bilateral coronal synostosis and OSA; respiratory support was discontinued after midface 
advancement in eleven patients (73%). Five patients were decanulated and CPAP was 
stopped in six. With a monobloc the midface (including the maxilla) and the forehead are 
advanced; with a le Fort III the midface is advanced, which resulted in improvement of the 
naso- and oropharynx (fi gure 1)25. A lower obstruction at the level of the hypopharynx may 
be responsible for unsuccessful midface advancement. Other treatment modalities should 
be considered as well, such as an advancement of the mandible. 
Endoscopy of the upper airways by the otorhinolaryngologist before starting OSA treat-
ment is recommended. In adults endoscopy is possible under propofol to induce the obstruc-
tive sleep situation. Children need to be in lying position at the outpatient clinic. When this 
is not possible, usually in very young children, it might be done under general anesthesia. 
Table 2: Overview of diff erent studies about the severity of OSA
Mild (events/hour) Moderate (events/hour) Severe (events/hour)
Guilleminault et al.16, 1995
AHI 1-5 6-24 >25
Guideline New Zealand*, 2005 
Apnea index 1-4 5-9 >10 
Saturation in association with 
obstruction
Nadir 87-91% Nadir 76-85% Nadir <75%
Hypoventilation 10-24% of total sleep 
time
25-49% of total sleep time >50% of total sleep time
Goroza et al.16, 2009
AHI 5-15 16-30 >30 
Lowest saturation Nadir 81-90% Nadir 71-80% Nadir ≤ 70%
Th is study, Bannink et al, 2010
AHI 1-5 6-25 >25
* best practice evidence based guideline, assessment of sleep disordered breathing in childhood, 2005, Pediatric 
Society of New Zealand
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
155
C
hapter 10
Furthermore, the age at which the midface is advanced is essential, seeing that due to 
persistent maxillar growth retardation this intervention has only a temporary eff ect when 
performed at young age26. Th en, at the age of 18, a second but simpler advancement (le Fort 
I) is needed. During adolescence it will be better to postpone the midface advancement if 
possible, because of the psychological consequences of this large surgical intervention, the 
period of distraction and the change of the child’s face. 
Other treatment options for OSA are a mandibular repositioning appliance (MRA), a 
surgically assisted rapid maxillary expansion (SARME) or a correction of the nasal septum. 
Th e treatment of OSA must be individualized, dependent on age, severity of OSA, cranio-
facial syndrome and level of obstruction (table 3).
Multidisciplinary approach 
In this prospective study all children underwent at least one polysomnography; children 
below the age of seven more frequently on a yearly basis. In 35 multidisciplinary meetings 
321 polysomnographies were evaluated. In 246 polysomnographies (77%) no or mild OSA 
without clinical symptoms was diagnosed and follow-up was arranged. In 78 polysom-
nographies (24%) mild OSA with clinical symptoms or moderate OSA was diagnosed and 
treatment was scheduled (table 4). Treatments were mostly (81%) needed in patients with 
Apert, Crouzon or Pfeiff er syndrome. Th is study also includes patients who were treated 
for OSA in the past and underwent a PSG in the follow-up program. In the past few years 
a new treatment was needed in 24% of those.
Airway volume measurements
In chapter 4 we showed that it was possible to analyze computed tomography (CT) 
scans and measure volumes of two separate anatomical defi ned areas, the nasal cavity and 
rhinopharynx, and the oro- and hypopharynx. Th ese airway volume measurements can 
show the improvement in airway after midface advancement and can determine the nar-
rowest point of the airway. Volume changes in the pharyngeal airway were also found after 
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Figure 1: Le Fort III and monobloc as treatment modalities to improve the upper airway volume
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mandibular advancement27. Per surgical treatment this method can reproduce the level of 
improvement in the upper airway and it will be possible to choose the best treatment for 
each patient individually. 
Functional problems
In chapters 5 and 6 functional problems in syndromic craniosynostosis were discussed. 
Th e prevalence of papilledema in patients with Apert, Crouzon, or Pfeiff er syndrome is 
high, not only before but also after vault expansion. From 4% of patients with Muenke 
syndrome to 53% of patients with Crouzon/ Pfeiff er syndrome showed a fi rst, preoperative 
episode of elevated intracranial pressure. It can be related to craniocerebral dispropor-
tion and can be adequately treated or prevented with early vault expansion. However, 
Table 4: Treatment protocol of obstructive sleep apnea
Policy after 321 polysomnographies n (%)
Follow-up 246 (76.6)
Consultation of otorhinolaryngologist 17 (5.3)
Endoscopy of upper airways 20 (6.2)
Nasal corticosteroids 7 (2.2)
Adenotonsillectomy 11 (3.4)
CPAP 4 (1.2)
Midface/ mandibular advancement 7 (2.2)
Correction of nasal septum 1 (0.3)
Diagnostics for elevated ICP 8 (2.5)
Table 3: Policy of the multidisciplinary team after performing a polysomnography
Age Mild OSA Moderate/ severe OSA Remarks
0-1 yr Conservative medical 
therapy
Nasal corticosteroids, nocturnal 
oxygen, NPT, tracheostomy
1-6 yrs Conservative medical 
therapy
ATE, nasal corticosteroids, nocturnal 
oxygen, CPAP/ BiPAP, monobloc (as 
fi rst vault expansion or in presence of 
elevated ICP)
PSG 6 weeks post ATE, 3 
months post monobloc, repeat 
PSG yearly
6-12 yrs Conservative medical 
therapy
ATE, nasal corticosteroids, nocturnal 
oxygen, CPAP/ BiPAP,
monobloc (in presence of elevated 
ICP)/ le Fort III
PSG 6 weeks post ATE, 3 
months post advancement, 
repeat PSG yearly
12-15 yrs Conservative medical 
therapy
Nasal corticosteroids, nocturnal 
oxygen, CPAP/ BiPAP, monobloc* (in 
presence of elevated ICP)/ le Fort III*, 
other options
PSG 3 months post 
advancement, repeat PSG yearly
15-18 yrs Conservative medical 
therapy
Nasal corticosteroids, nocturnal 
oxygen, CPAP/ BiPAP, monobloc 
(in presence of elevated ICP)/ le Fort 
III, mandibular advancement, other 
options
PSG 3 months post 
advancement, repeat PSG yearly
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the second episode is also frequently seen at the age of about 4 years, but its causative 
factors are less clear. It can be related to OSA, hydrocephalus or venous hypertension28-30. 
Th e prevalence of papilledema after the fi rst vault expansion was 17% in Saethre-Chotzen 
syndrome, 20% in Crouzon/ Pfeiff er and 35% in Apert syndrome. Marucci et al.31 reported 
the same prevalence in Apert syndrome. Only in Muenke syndrome there is a low risk 
of papilledema, i.e. 4%. Annual fundoscopy is recommended to screen for papilledema. 
If found present, a CT angiography can be performed to evaluate the ventricles and the 
venous outfl ow. A polysomnography to exclude OSA is needed to explore the possible 
cause of elevated ICP. Fundoscopy is of particular importance given the low reliability of 
clinical symptoms related to elevated ICP32.
Other functional problems, such as refractive errors and hearing loss, should be diag-
nosed early, through screening. Treatment of hearing loss is necessary for an adequate 
development of speech.
Quality of life 
Syndromic craniosynostosis has a large impact on the health-related quality of life of 
the children and their parents, both physical and psychosocial. Th is phenomenon was 
explored in chapter 7. Apert syndrome has the largest impact. But also patients with 
Muenke syndrome scored signifi cantly lower than the norm, despite the lower risk for 
elevated ICP and OSA in comparison with Apert and Crouzon or Pfeiff er syndrome. 
OSA was an independent predictor for the domain ‘change in health’ on the Child Health 
Questionnaire (CHQ) only, possibly associated with the improvement after OSA treat-
ment. Furthermore, elevated ICP was an independent predictor for lower scores on several 
domains: ‘parental impact: emotional’, ‘family activity’ and ‘change in health’ on the 
Infant Toddler Quality of Life questionnaire (ITQoL) and ‘physical functioning’, ‘general 
behavior’, ‘general health perceptions’, ‘parental impact: time’ and ‘family activity’ on the 
CHQ. Th is might be explained by the fact that elevated ICP could result in behavioral 
changes that infl uence these scores. 
Chapter 8 showed the reliability and validity of the OSA-18, a disease-specifi c quality 
of life questionnaire, in children with syndromic or complex craniosynostosis. Its use 
is described in chapter 9. OSA seems to have consequences for quality of life. In these 
patients the OSA-18 score is also correlated with the severity of OSA. Th e domains ‘sleep 
disturbance’ and ‘physical suff ering’ can be used to evaluate the impact of OSA on quality 
of life. In future research we will ask parents to complete the OSA-18 before and after 
treatment. Comparing these scores with polysomnography results we could measure the 
exact impact of OSA in syndromic craniosynostosis. 
Th e OSA-18 showed no correlation with the presence of elevated ICP. Patients with 
papilledema scored not signifi cantly higher at the diff erent domains than those without 
papilledema.
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Behavior
Behavioral problems were common in children with syndromic or complex craniosynos-
tosis, as presented in chapter 9. Th e prevalence of behavioral problems is 32% in boys and 
16% in girls. Sixty-seven percent of the boys with Apert syndrome scored in the (borderline) 
clinical range versus none of the girls. In Muenke syndrome also half of the boys scored in 
the (borderline) clinical range. In Apert syndrome OSA occurs more in boys (78%) than 
in girls (10%). Further the intelligence of boys with Apert syndrome is signifi cantly lower 
than that of girls with Apert syndrome (Maliepaard et al., unpublished data); this can 
infl uence behavior. In Muenke syndrome the behavioral problems may be more intrinsic 
and are possibly related to the P250R FGFR3 mutation rather than associated with OSA. 
Previous studies were mostly performed in isolated craniosynostosis, only Sarimski33, 34 
reported behavioral problems in patients with Apert syndrome. 
Th e total Child Behavior Checklist (CBCL) score of the children between the ages 
of 6 and 18 clearly correlated with the total OSA-18 score (p = 0.000). Boys aged 2-18 
years with total CBCL scores in the abnormal range had signifi cantly higher mean scores 
(p < 0.05) on all domains of the OSA-18 and the total OSA-18 score, girls only on the 
domains ‘emotional distress’ and ‘daytime problems’. In boys the same was found for 
the externalizing CBCL scores in the abnormal range and for internalizing CBCL scores 
in the abnormal range: signifi cantly higher means were found on the domains ‘sleep 
disturbance’, ‘emotional distress’, ‘caregiver concerns’ and the total OSA-18 score. In girls 
with abnormal internalizing and externalizing CBCL scores only the domain ‘emotional 
distress’ had signifi cantly higher scores. 
From the above results we may deduce that the ‘emotional distress’ domain can serve 
as a fi rst screening for the presence of behavioral problems in children with syndromic or 
complex craniosynostosis. Dependent on age and sex we can formulate cut-off  points for 
the ‘emotional distress’ score. Only above these points the complete CBCL questionnaire 
is needed. Setting a cut-off  point of 6, for example, would imply that 45 CBCLs were 
indicated in this study population, of which 24 were scored in the (borderline) clinical 
range. Th e negative predictive value is 93% in boys and 91% in girls; six were missed. For 
externalizing scores in the abnormal range the domain ‘emotional distress’ had a negative 
predictive value of 100% in both boys and girls. Seventy-seven questionnaires could have 
been saved, and thus effi  ciency at the outpatient clinic in tracing behavioral problems 
could have been higher.
Th e CBCL showed no correlation with the presence of elevated ICP. Only one of seven 
boys and one of twelve girls with papilledema scored in the (borderline) clinical range on 
the total CBCL score. After this analysis with a small number of patients with papilledema 
we cannot confi rm that elevated ICP resulted in behavioral problems. 
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Overall, obstructive sleep apnea in children with syndromic or complex craniosynostosis 
is characterized by diffi  culty in breathing during sleep and an obstructive apnea hypopnea 
index (OAHI) ≥ 1. But complaints during the day, such as frequent colds, and the conse-
quences for behavior and quality of life are also important for evaluation of the severity in 
specifi c patients and for the decision how to treat.
FUTURE PERSPECTIVES
- Improved recognition of the clinical symptoms of mild obstructive sleep apnea
Th e presence of OSA must be suspected in each child with syndromic or complex cranio-
synostosis. Information from parents about diffi  culty in breathing is a good screening tool 
to exclude moderate or severe OSA in these children, but not mild OSA. Th ere is a need 
for a screening tool that can be used to detect mild OSA. 
- Better defi nition of mild, moderate and severe obstructive sleep apnea
Th e clinical consequences of mild obstructive sleep apnea are not well understood in chil-
dren with syndromic and complex craniosynostosis. To gain more insight into the (patho)
physiologic consequences of OSA, future studies should address the relations of OSA 
severity with heart rate variability, pulse transit time, sleep quality and arousal detection. 
Furthermore, markers of infl ammation and oxidative stress will have to be determined to 
fi nd a relation with the severity of OSA. 
- Improvement of ambulatory polysomnography as diagnostic method
Polysomnography carried out at home is a great step forward. However, nasal fl ow is 
diffi  cult to register. As alternative methods may serve the X fl ow or a mouth thermistor for 
recording of oral airfl ow. In ambulatory polysomnography, professionals could remotely 
monitor parents attaching the sensors with the use of a webcam rather than going to the 
patients’ home themselves to attach the sensors. In case monitoring raises doubt about the 
procedure or when the diagnosis OSA is made, a full polysomnography in the hospital is 
necessary. 
- Further determination of the relation between obstructive sleep apnea, elevated intra-
cranial pressure and functional problems
Th e detection of elevated intracranial pressure is diffi  cult. Papilledema is a late sign32. 
Transorbital sonography of the optic nerve can show dilatation of the optic nerve sheath 
diameter. A rise in ICP directly aff ects the perioptic nerve space resulting in an increase 
of the diameter35-37. Ultrasounds were performed in the craniosynostosis group and these 
will be analyzed in relation to the presence of papilledema. We will study the value of 
this method to detect elevated ICP more early in comparison with the development of 
papilledema. 
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Th e cause for elevated ICP is not only craniocerebral disproportion. Th e possible 
relationship between elevated ICP and Chiari malformation or ventricular dilatation is 
evaluated in these children with syndromic or complex craniosynostosis. To explore the 
venous hypertension hypothesis the size of the jugular foramen38 will be measured on 
CT angiography scan in our study population. In addition, the natural course of ICP 
in craniosynostosis and the exact relationship with OSA will be studied by combining 
polysomnography with intracranial pressure monitoring. 
- Further evaluation of the relation between physical sequelae, obstructive sleep apnea, 
elevated intracranial pressure and quality of life and behavior
Quality of life was measured using the Child Health Questionnaire Parental Form 50 
(CHQ-PF50) above the age of 4 and the Infant Toddler Quality of Life questionnaire 
below 4 years. To compare the health-related quality of life in these children after a few 
years and to evaluate the impact of momentous events such as going to school we will 
ask the parents, who completed the ITQoL in this study, to complete the CHQ-PF 50. 
As teachers may note problems from comparison with classmates, parents are unaware of 
before. Teachers will also be asked to complete the CBCL to compare behavioral problems 
reported by parents and teachers.
Muenke syndrome is not well understood. Th is syndrome was recognized recently. Until 
now it was seen as a mild anomaly, but our studies brought out many problems in these 
children. Not all persons with the P250R FGFR3 mutation have craniosynostosis and it 
is not clear if they have the same problems as the patients with craniosynostosis. Maybe 
we can use them as controls to see the impact of the premature fusion of the calvarial 
sutures. Th e health-related quality of life of children with Muenke syndrome is lower and 
behavioral problems were frequently seen. Perhaps there is a relation between these two 
fi ndings. Th e risk for elevated ICP is very low, but a third of patients will develop OSA in a 
mild form. It might well be that the behavioral problems are intrinsic. On the other hand 
mild OSA might be underestimated and the condition could then also result in behavioral 
problems and a lower quality of life. Psychological tests will help to unravel the sort of 
behavioral problems and the need for treatment.
Mental development in all children with syndromic or complex craniosynostosis will 
be determined by psychological tests. More attention to quality of life and behavior is 
needed at the outpatient clinic and support of children and their parents is necessary. 
Each child with syndromic or complex craniosynostosis should be seen by a psychologist 
minimally once. Th e best age for testing seems to be eight years; at that age accurate tes-
ting is possible. Furthermore, in most children any problems, such as anxiety, behavioral 
problems and learning disabilities will have developed before that age, so there is time for 
intervention.
- Longitudinal follow-up of treatment for OSA 
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Treatment should be individualized and the level of obstruction must be the determining 
factor. Th e eff ect of each treatment should be analyzed by change and hopefully improve-
ment of the OAHI, the functional outcome and quality of life measured by the ITQoL 
or CHQ and by the OSA-18. Enlargement of the upper airway volume after surgical 
treatment, such as midface advancement, should be evaluated with three dimensional 
volume measurements before and after surgery. 
With the initiation of this large prospective study in 2006, a lot of these future aims 
can be explored as part of the ongoing research in our center. Th e aim of this study 
and the ongoing studies is to improve the care of patients with syndromic and complex 
craniosynostosis. Th e early recognition of possible problems related to their syndrome is 
important. Th is enables to start with treatment as soon as possible, thus diminishing the 
negative consequences and off ering these children optimal chances in life.
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SUMMARY
Th e aim of this thesis is to assess the importance and impact of obstructive sleep apnea in 
children with syndromic or complex craniosynostosis. Th e topics of interest are the preva-
lence, diagnostics and treatment outcome of obstructive sleep apnea and the infl uence on 
prevalence of papilledema, health-related quality of life and general behavior. 
Background information on syndromic craniosynostosis is given in chapter 1. Cranio-
synostosis is characterized by the premature fusion or agenesis of calvarial sutures and in 
about 40% of the cases (1:6.250) the craniosynostosis is part of a syndrome, such as Apert, 
Crouzon, Pfeiff er, Muenke or Saethre-Chotzen syndrome. Complex craniosynostosis is 
defi ned as fusion of two or more cranial sutures without known FGFR (fi broblast growth 
factor receptor) or TWIST mutation. 
Patients with syndromic and complex craniosynostosis are at risk for elevated intracra-
nial pressure (ICP) and obstructive sleep apnea (OSA). Factors suggested to contribute 
to elevated ICP in craniosynostosis are craniocerebral disproportion, ventriculomegaly or 
hydrocephalus, venous hypertension and obstructive sleep apnea. In craniosynostosis the 
fi rst treatment or prevention of elevated ICP is surgical decompression to expand the skull 
within the fi rst year of life.
Obstructive sleep apnea is a clinical syndrome due to partial or complete upper airway 
obstruction characterized by diffi  culty in breathing, snoring and apneas during sleep 
resulting in sleep fragmentation, hypoxia and hypercapnia. A questionnaire on presence 
of symptoms can be helpful to screen for OSA, but the gold standard to diagnose presence 
and severity of OSA is polysomnography (PSG). Th e obstructive apnea hypopnea index 
(OAHI) is used to diff erentiate in severity. OSA treatment is dependent on its severity, 
cause and level of obstruction. 
Chapter 2 described the prediction of the presence of OSA in children with syndromic 
or complex craniosynostosis by their parents. Th e OSA score, known as Brouillette score, 
can be used to screen for the presence of OSA and consists of the three items: breathing 
diffi  culty, apnea and snoring. Th e single question ‘diffi  culty in breathing during sleep’ 
showed a sensitivity of 64% and a high negative predictive value of 91% in comparison with 
polysomnography. So, if the child has no diffi  culty in breathing during sleep, the presence 
of moderate or severe OSAS can almost certainly be excluded and polysomnography is not 
necessary. Th e question about snoring does not have any additional value, because it was 
shown that 77% of the children snore. Th is is mainly due to a narrow nasal cavity. 
Th e feasibility of a home cardiorespiratory monitor in these children to diagnose OSA at 
home is presented in chapter 3. Overall, 40.5% of the recordings were suitable for calcula-
ting an OAHI with all signals being present. Th e most important limitation is the absence 
of nasal fl ow. In children with syndromic or complex craniosynostosis we speculate that 
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the main reason for the failing signal of the nasal cannula is the absence of nasal passage 
due to the severe anatomical malformations of the nasal cavity, leading to almost complete 
obstruction of the upper airway and as a consequence preferred mouth breathing. Another 
important reason for absence of nasal fl ow is that not all children accept the nasal cannula. 
Th e sum of the amplitudes of the thoracic and abdominal movements (X fl ow) seems a 
valuable alternative assessment, when complete recording of the nasal fl ow signal was not 
achieved. Using X fl ow as screening method raised the overall success rate from 40.5% to 
75%. 
Th e long-term respiratory outcome of midface advancement in patients with Apert, 
Crouzon or Pfeiff er syndrome suff ering from moderate or severe OSA, requiring oxygen, 
continuous positive airway pressure (CPAP), or tracheostomy is assessed in chapter 4. 
Despite midface advancement, long-term respiratory support (dependency on CPAP or 
tracheostomy) was maintained in fi ve of the eleven studied patients. In all patients without 
respiratory improvement or with relapse after surgery, endoscopy showed obstruction 
at the level of the rhino- or hypopharynx. Dynamic pharyngeal collapse can aff ect the 
respiratory outcome of midface advancement. Th erefore endoscopy of the upper airway 
before midface advancement is recommended to identify any level of airway obstruction 
that may interfere with respiratory improvement after midface advancement. 
Th e prevalence of functional problems in children with syndromic craniosynostosis 
is reported in chapter 5 and 6. Th e prevalence of papilledema in patients with Apert, 
Crouzon or Pfeiff er syndrome is high (51%), not only before cranial decompression (38%) 
but also after surgery (43%). Clinical symptoms, such as headache and vomiting, were 
poor predictors for the presence of papilledema. Complex craniosynostosis, exorbitism 
and ventricular dilatation were factors associated with papilledema. Given the high 
prevalence of papilledema annual fundoscopy is highly recommended (chapter 5). Other 
functional problems such as refractive errors and hearing loss are highly prevalent (52-56%) 
in all types of syndromic or complex craniosynostosis. Genetic analysis is necessary for 
counseling and screening on syndrome specifi c anomalies and functional defi cits. Follow-
up by a multidisciplinary team is needed till the age of 18 years to obtain the best possible 
outcome. A diagnosis-specifi c screening and treatment protocol is given (chapter 6). 
Chapter 7 describes the health-related quality of life in children and adolescents with 
syndromic or complex craniosynostosis. Parents’ scores for these patients were signifi cant 
lower than those for the norm population; syndromic craniosynostosis has a large impact 
on the health-related quality of life, both physical and psychosocial. Apert syndrome had 
the largest impact on the diff erent domains. 
To evaluate the disease-specifi c impact of obstructive sleep apnea in the general popula-
tion and also in children with syndromic or complex craniosynostosis, a disease-specifi c 
quality of life questionnaire, the OSA-18 survey, is tested. Th e internal consistency, test-
retest reliability and discriminative validity of the OSA-18 in the craniosynostosis popula-
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tion are assessed in chapter 8. Th e OSA-18 was found to be a reliable and valid method. 
It can be used in future studies. 
Chapter 9 reports the impact of OSA on quality of life in syndromic and complex cra-
niosynostosis and the prevalence of behavioral problems. Th e correlation between OAHI 
and the total OSA-18 and CBCL scores was signifi cant. Th e domains ‘sleep disturbance’ 
and ‘physical suff ering’ were signifi cantly higher in patients with moderate OSA and can 
be used to evaluate the impact of OSA on their quality of life. Within the craniosynostosis 
group children with Apert syndrome showed the highest total OSA-18 score. A high 
prevalence of behavioral problems was found, especially in boys with Apert and Muenke 
syndrome.
Th e main fi ndings of this thesis and comments on these fi ndings are discussed in chap-
ter 10, including future perspectives on research. Future studies are needed to improve 
the recognition of the clinical symptoms of mild, moderate and severe OSA and the 
consequences of the severity of OSA on growth and development, intracranial pressure, 
behavior and quality of life. Concerning ambulatory polysomnography the use of X fl ow 
should be validated in comparison with full polysomnography in the hospital. 
A multidisciplinary team should take care of all the diff erent clinical features known in 
these craniosynostosis patients and centralization of care is highly recommended.
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Het doel van dit proefschrift betreft het in kaart brengen van het belang en de impact 
van het obstructief slaap apneu syndroom bij kinderen met een syndromale of complexe 
vorm van craniosynostose. Aandachtsgebieden zijn prevalentie, diagnostiek en behande-
lingsuitkomst van het obstructief slaap apneu syndroom (OSAS) en de invloed van OSAS 
op de prevalentie van papiloedeem, de gezondheidsgerelateerde kwaliteit van leven en het 
gedrag. 
Achtergrondinformatie over syndromale craniosynostose wordt gegeven in hoofdstuk 1. 
Craniosynostose wordt gekenmerkt door vroegtijdige sluiting of agenesie van de sche-
delnaden en is in 40% van de gevallen (1:6.250) onderdeel van een syndroom, zoals het 
syndroom van Apert, Crouzon, Pfeiff er, Muenke of Saethre-Chotzen. Complexe cranio-
synostose wordt gedefi nieerd als sluiting van twee of meer schedelnaden zonder bekende 
mutatie in de fi broblast groeifactor receptor (FGFR) of in het TWIST gen.
Patiënten met een syndromale en complexe craniosynostose hebben een verhoogd risico 
op de ontwikkeling van verhoogde intracraniële (hersen)druk (ICP) en van het obstruc-
tief slaap apneu syndroom. Mogelijke factoren die bijdragen aan de verhoogde ICP bij 
craniosynostose zijn craniocerebrale disproportie, ventriculomegalie of hydrocephalus, 
veneuze hypertensie en OSAS. De eerste behandeling of preventie van verhoogde ICP bij 
deze kinderen betreft een operatie in het eerste levensjaar waarbij de schedel groter wordt 
gemaakt. 
Het obstructief slaap apneu syndroom is een klinisch syndroom waarbij een gedeelte-
lijke of complete obstructie van de bovenste luchtweg optreedt, die wordt gekenmerkt 
door moeilijkheden met ademhalen, snurken en apneus (stoppen met ademhalen) tijdens 
de slaap en die leidt tot slaapfragmentatie, hypoxie (zuurstoftekort) en hypercapnie (teveel 
koolstofdioxide). Een vragenlijst over de aanwezigheid van symptomen kan handig zijn 
in de screening naar OSAS, maar de gouden standaard om de aanwezigheid en de ernst 
van OSAS vast te stellen is polysomnografi e (PSG). De obstructieve apneu hypopneu 
index (OAHI) wordt gebruikt om te diff erentiëren in ernst. De behandeling van OSAS is 
afhankelijk van de ernst, de oorzaak en het niveau van obstructie. 
Hoofdstuk 2 beschrijft de vraag of ouders de aanwezigheid van OSAS bij hun kinderen 
met een syndromale of complexe craniosynostose kunnen voorspellen. De OSAS score, 
bekend als Brouillette score, kan gebruikt worden bij de screening op de aanwezigheid van 
OSAS en bestaat uit drie items, namelijk ademhalingsmoeilijkheden, apneus en snurken. 
In de craniosynostose populatie heeft de vraag naar moeilijkheden met ademhalen tijdens 
de slaap een sensitiviteit van 64% en een hoge negatief voorspellende waarde van 91% in 
vergelijking met polysomnografi e. Kortom, als het kind geen moeilijkheden met ademha-
len tijdens de slaap heeft kan de aanwezigheid van matige en ernstige OSAS zo goed als 
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zeker uitgesloten worden en is een polysomnografi e onnodig. De vraag over snurken heeft 
geen toegevoegde waarde, daar vastgesteld is dat 77% van de kinderen snurkt. Dit komt 
voornamelijk door een nauwe neusholte. 
Het gebruik van een cardiorespiratoire thuismonitor (polysomnograaf ) voor het stellen 
van de diagnose OSAS bij deze kinderen wordt besproken in hoofdstuk 3. Totaal is 40.5% 
van de registraties te gebruiken om een OAHI te berekenen aan de hand van alle signalen. 
De belangrijkste beperking is de afwezigheid van de neusfl ow, geregistreerd door de neus-
bril. Bij kinderen met een syndromale of complexe craniosynostose lijkt de belangrijkste 
reden voor het ontbreken van het neusfl owsignaal de afwezigheid van neuspassage te zijn. 
Dit laatste komt door de anatomische afwijkingen van de neusholte, die leiden tot een 
bijna complete obstructie van de bovenste luchtweg met als gevolg mondademhaling. 
Een andere belangrijke reden voor de afwezigheid van de neusfl ow is het feit dat niet alle 
kinderen de neusbril accepteren. De som van de amplitudes van de borst- en buikademha-
lingsbewegingen (X fl ow) lijkt een waardevol alternatief, wanneer complete registratie van 
de neusfl ow niet gelukt is. Het gebruik van de X fl ow als screeningsmethode zorgt voor een 
stijging van het succespercentage van 40.5% naar 75%. 
De respiratoire uitkomst van een aangezichtscorrectie op de lange termijn bij patiënten 
met het syndroom van Apert, Crouzon of Pfeiff er met matige of ernstige OSAS, waarvoor 
ze zuurstof, neuskapbeademing (CPAP) of een tracheacanule nodig hebben, wordt bespro-
ken in hoofdstuk 4. Ondanks de aangezichtscorrectie bleef respiratoire ondersteuning 
(afhankelijkheid van CPAP of een tracheacanule) op de lange termijn gehandhaafd bij 
vijf van de elf onderzochte patiënten. Bij alle patiënten zonder respiratoire verbetering of 
met een recidief na chirurgie toonde de endoscopie een obstructie op het niveau van de 
rhino- of hypopharynx (neus-keelholte of het onderste deel van de keelholte). Een dyna-
mische collaps van de pharynx kan de respiratoire uitkomst van de aangezichtscorrectie 
beïnvloeden. Daarom wordt voor deze operatie een endoscopie van de bovenste luchtweg 
geadviseerd om elk niveau van luchtwegobstructie vast te stellen, dat invloed kan hebben 
op de respiratoire verbetering na de correctie. 
De prevalentie van functionele problemen voorkomend bij kinderen met een syndro-
male craniosynostose komt aan de orde in hoofdstuk 5 en 6. De prevalentie van papiloe-
deem bij patiënten met het syndroom van Apert, Crouzon of Pfeiff er is hoog (51%), niet 
alleen voor de chirurgische decompressie (38%), maar ook na de operatie (43%). Klinische 
symptomen, zoals hoofdpijn en braken, zijn slechte voorspellers voor de aanwezigheid van 
papiloedeem. Complexe craniosynostose, exorbitisme en ventrikeldilatatie zijn factoren 
die geassocieerd zijn met papiloedeem. Jaarlijkse funduscopie is sterk aan te raden gezien 
de hoge prevalentie van papiloedeem (hoofdstuk 5). Andere functionele problemen, zoals 
refractieafwijkingen en gehoorverlies komen veel voor (52-56%) bij alle typen syndromale 
en complexe craniosynostose. Genetische analyse is noodzakelijk voor counseling en scree-
ning op syndroom-specifi eke afwijkingen en functionele stoornissen. Follow-up door een 
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multidisciplinair team is nodig tot de leeftijd van 18 jaar om de best mogelijke uitkomst 
te bieden. Een voorstel voor een diagnose-specifi eke screening en een behandelprotocol 
wordt gedaan (hoofdstuk 6). 
Hoofdstuk 7 beschrijft de gezondheidsgerelateerde kwaliteit van leven van kinderen 
en adolescenten met syndromale of complexe craniosynostose. De door ouders gerappor-
teerde scores voor deze patiënten waren signifi cant lager dan die voor de normpopulatie; 
syndromale craniosynostose heeft een grote impact op de gezondheidsgerelateerde kwali-
teit van leven, zowel fysiek als psychosociaal. Het syndroom van Apert heeft de grootste 
impact op verscheidene domeinen. 
Om de ziekte-specifi eke impact van het obstructief slaap apneu syndroom in de gewone 
populatie en bij kinderen met een syndromale of complexe craniosynostose te evalueren, 
is een ziekte-specifi eke kwaliteit van leven vragenlijst, de OSA-18, getoetst. De interne 
consistentie, de test-hertest betrouwbaarheid en de discriminatieve validiteit van de OSA-
18 in de craniosynostose populatie zijn onderzocht in hoofdstuk 8. De OSA-18 vragenlijst 
is als een betrouwbaar en valide instrument getest en kan in toekomstige studies gebruikt 
worden. 
Hoofdstuk 9 rapporteert de impact van OSAS op de kwaliteit van leven bij syndromale 
en complexe craniosynostose en de prevalentie van gedragsproblemen. De correlatie tussen 
de OAHI en de totale OSA-18 en CBCL scores is signifi cant. De domeinen ‘slaapproble-
men’ en ‘lichamelijke verschijnselen’ scoren signifi cant hoger bij patiënten met matige 
OSAS en kunnen gebruikt worden om de impact van OSAS op hun kwaliteit van leven 
te bepalen. Binnen de craniosynostose groep wordt bij kinderen met het syndroom van 
Apert de hoogste totale OSA-18 score gemeten. De prevalentie van gedragsproblemen is 
hoog, voornamelijk bij jongens met het syndroom van Apert en Muenke.
De belangrijkste bevindingen van dit proefschrift en opmerkingen naar aanleiding van 
deze bevindingen worden bediscussieerd in hoofdstuk 10, dat ook de toekomstplannen 
op onderzoeksgebied bespreekt. Toekomstige studies zijn nodig om de herkenning van 
klinische symptomen van milde, matige en ernstige OSAS en de consequenties van de 
mate van ernst op groei en ontwikkeling, hersendruk, gedrag en kwaliteit van leven te 
verbeteren. Wat de ambulante polysomnografi e betreft, het gebruik van de X fl ow behoeft 
validatie in vergelijking met volledige polysomnografi e uitgevoerd in het ziekenhuis. 
Een multidisciplinair team dient zorg te dragen voor alle verschillende klinische aspec-
ten voorkomend bij deze craniosynostose patiënten en centralisatie van de zorg wordt 
sterk aangeraden.
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ABBREVIATIONS
ATE  adenotonsillectomy
BiPAP  bi-level positive airway pressure
Br score  Brouillette score
CBCL  child behavior checklist
CHQ-PF child health questionnaire parent form
CHQ-CF child health questionnaire child form
CI  confi dence interval
CPAP  continuous positive airway pressure 
CT scan  computed tomography scan
FGFR  fi broblast growth factor receptor
ICP  intracranial pressure
ITQoL  infant toddler quality of life questionnaire
MRA  mandibular repositioning appliance 
NPT  nasopharyngeal tube
NPV  negative predictive value
OAHI  obstructive apnea hypopnea index
ODI   oxygenation desaturation index
OSA  obstructive sleep apnea
PSG  polysomnography
SARME  surgically assisted rapid maxillary expansion 
Sens  sensitivity
sd  standard deviation
VP  ventriculoperitoneal
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Nu mijn proefschrift bijna voltooid is, is het tijd om stil te staan bij de afgelopen vier 
jaar. Allereerst wil ik mijn co-promotoren, dr. Irene M.J. Mathijssen en dr. Koen F.M. 
Joosten enorm bedanken, want zonder hen was dit onderzoek niet tot stand gekomen. 
Het moment dat ik in het trappenhuis van Koen hoorde dat ik was aangenomen voor dit 
promotieonderzoek kan ik me nog goed herinneren, de weg naar de kindergeneeskunde 
lag gelukkig nog steeds voor me open. Irene, wat een gedrevenheid en passie heb jij voor 
je werk. Je werk is je leven en wat heb ik veel van je geleerd, niet alleen het schrijven van 
de METC aanvraag en de diverse artikelen, het nadenken over verschillende problemen, 
maar ook het stukje meer assertiviteit dat je me hebt bijgebracht. Koen, wat is het prettig 
samenwerken met jou. Je bent altijd vriendelijk, geduldig, hebt een groot hart voor je vak, 
maar ook aandacht voor de dingen eromheen. Jullie zijn een perfect stel begeleiders dat 
elkaar goed aanvult en me altijd weer vol enthousiasme op de juiste weg kon brengen. 
Zonder wie ik dit onderzoek ook niet had kunnen doen zijn de 164 zeer gemotiveerde 
kinderen en hun ouders die hebben willen meewerken aan mijn onderzoek. Bedankt! Wat 
ongeloofl ijk om te zien hoe bereid ieder was om vragenlijsten in te vullen, een slaapmeting 
en echo te ondergaan en elke keer te meten en te wegen. Daarnaast heb ik de interesse in 
mij als persoon zeer gewaardeerd. Het waren vier mooie jaren. Ik wens jullie het allerbeste 
toe en wie weet tot ziens.
Prof. dr. S.E.R. Hovius wil ik bedanken dat hij mijn promotor wilde zijn en me heeft 
gesteund op de weg die ik heb bewandeld. Ook de andere leden van de kleine commissie, 
prof. dr. D. Tibboel, prof. dr. F.C. Verhulst en prof. dr. H.A.M. Marres wil ik natuurlijk 
bedanken voor hun tijd en moeite die het beoordelen van mijn proefschrift heeft gekost. 
Prof. dr. K.G.H. van der Wal, prof. dr. J.C. de Jongste, prof. dr. P.J. van der Spek, dr. 
H. Raat en drs. J.M. Vaandrager wil ik bedanken voor het plaatsnemen in mijn grote 
commissie. Wat een eer om straks tegenover deze geleerde mensen te mogen staan.
Mijn paranimfen wil ik bedanken dat ze straks op 1 september naast mij willen staan en 
me willen helpen met de voorbereiding. Ten eerste Germaine Liebrechts-Akkerman, mijn 
vriendin vanuit de collegebank en practica en degene die me voorging op vele vlakken, 
beginnen als AIOS, trouwen en moeder worden en daarnaast Marianne Maliepaard, in 
het begin mijn steun als researchverpleegkundige en later mijn directe collega binnen het 
craniofaciaal team als psycholoog-onderzoeker. Germaine, bedankt voor je gezelligheid 
tijdens de lunch en binnenkort moeten we weer eens gaan wandelen, met z’n zevenen. En 
daarna is het jouw beurt om te promoveren. Marianne, wat fi jn dat je me wilde helpen 
met het invoeren van de kwaliteit van leven vragenlijsten, het vergaren van de OSA-18 
bij de gezonde kinderen en de analyses van de laatste drie stukken. Veel succes met je 
promotietraject.
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De collega’s van het craniofaciaal team, Hansje Bredero-Boelhouwer, Léon van Adrichem, 
Jacques van der Meulen, Marie-Lise van Veelen, Eppo Wolvius, Hans Hoeve, Edwin Ong-
kosuwito, Inge Balk-Leurs, Jeannette Hoogeboom, Jolanda Okkerse en Francien Meertens 
wil ik bedanken voor hun hulp bij het uitvoeren van mijn onderzoek. Hansje, ik wil jou 
ook even apart noemen, bedankt voor onze goede samenwerking, het gezellige lunchen en 
je luisterend oor. En natuurlijk onze reizen naar Montréal, Luxemburg, Antwerpen, Lille 
en Seoul niet te vergeten, wat hebben we veel geleerd en gezien samen!
Anderen die betrokken waren bij mijn onderzoek en die ik wil danken voor hun inzet 
en ideeën zijn Hein Raat, Maarten Lequin, Yolanda de Rijke, Erik Nout, Sandra van 
den Berg, Marjolijn Bartels en Marcel van Rijn. Tim de Jong mag ook niet onvermeld 
blijven, hij is als gemotiveerde geneeskunde student bij mij terechtgekomen en heeft een 
groot deel van de statussen doorgenomen en het retrospectieve deel van mijn onderzoek 
compleet gemaakt. 
Bij klinisch onderzoek is ook de samenwerking met de poliassistenten, de radiologie 
medewerkers, de anesthesie en de afdeling van groot belang. Marloes, Conny, Annemarie, 
Irma, Dorien, Margreet, Roland, Edith en de verpleegkundigen van 1 Noord jullie inzet 
was fantastisch, wat een mooie werkomgeving.
Voor mijn vragen kon ik altijd terecht op het secretariaat, Maaike, Perlita, Joan en in de 
eerste jaren Karin hartelijk bedankt voor jullie hulp.
Ik was in de luxe positie dat ik collega’s had bij de plastische chirurgie en bij de kin-
dergeneeskunde. Mijn collega-onderzoekers hebben bijgedragen aan een onvergetelijke 
tijd, van terechtkunnen met allerlei vragen en samen op congres gaan tot het organiseren 
van het onderzoekersweekend, het bijwonen van de borrels en het jaarlijkse diner. Joyce, 
Marijke, Sarah, Dirk-Jan, Caroline, Raúl, Mirjam, Femke, Idse, Denise, Petra, Sandra, 
Marjolein en Nanda bedankt voor de gezelligheid. Joyce, succes met je artikelen, straks 
mag jij. Caroline, goed dat je het stokje van me hebt overgenomen. Marijke, de kaft en 
titelpagina’s zijn super geworden! Mirjam, wat leuk dat we elkaar weer treff en tijdens de 
opleiding en samen in het Maasstad zitten.
In mijn onderzoekstijd heb ik gelukkig ook tijd gehad voor kletsen, uiteten gaan, 
wandelen en volleyballen. Sylvia, Christine, Iris, Anouk, Lisette, Daniëlle, Mirjam, Lotte, 
Merel en Judith bedankt voor jullie betrokkenheid en hopelijk zien we elkaar straks ook 
nog regelmatig!
Tot slot zijn er mensen die al jaren zo niet mijn gehele leven achter me staan, mijn 
(schoon)familie. Het is bijzonder om te merken dat sommigen zo met mij mee leven, 
wat ben ik dankbaar voor jullie interesse en steun! Een paar van jullie wil ik nog extra 
in het zonnetje zetten. Bas en Barbara wat fi jn dat jullie zo vaak voor me klaar staan. Ik 
zal niet vergeten dat jullie me hoogzwanger naar het Sophia hebben gebracht zodat ik 
kon solliciteren en wat een dag later bleek ook aangenomen werd. Sanne, mijn lieve zus, 
bedankt voor de kleine dingen die zoveel voor me betekenen! Lieve mamma, wat kan ik 
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me nog meer wensen, je weet hoe belangrijk je voor me bent. Bedankt dat je altijd naar me 
wilt luisteren, ook als het even niet loopt zoals ik wil. 
Lieverd, mijn Arno, jij bent altijd zo rustig en voelt gewoon dat alles goed komt. Nu je 
hebt gelijk gekregen. Wat hadden we een topweek, op dinsdag werd ik aangenomen voor 
de opleiding kindergeneeskunde en op zaterdag werd Nouschka geboren! En dan nu nog 
mijn promotie. Bedankt voor je steun en liefde de afgelopen elf jaar! Nouschka, je hebt 
mijn leven nog mooier gemaakt.
Natalja
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Natalja Bannink was born on 1st January 1980 in Th e Hague. She fi nished high school at 
the Gymnasium Haganum in Th e Hague in 1998. From her youngest years she knew she 
wanted to become a pediatrician. She obtained her medical degree at the Erasmus Uni-
versity in Rotterdam in 2004 (cum laude). At the outpatient clinic of the Erasmus MC-
Sophia Children’s Hospital in Rotterdam she fi nished her research project about learning 
problems in children with Neurofi bromatosis type 1 in 2002. She worked as a pediatric 
resident (ANIOS) at the department of pediatrics in the Albert Schweitzer Hospital in 
Dordrecht during six months. In March 2005 she worked for a year in the Erasmus MC-
Sophia Children’s Hospital at the medium care unit and the neonatal intensive care unit. 
Between March 2006 and April 2010 she performed her PhD on ‘Obstructive sleep 
apnea in children with syndromic craniosynostosis’ at the Dutch Craniofacial Center 
in the Erasmus MC-Sophia Children’s Hospital under the supervision of dr. Irene M.J. 
Mathijssen and dr. Koen F.M. Joosten (promoter prof. dr. S.E.R. Hovius).
In April 2010 she started as a pediatric resident (AIOS) at the Maasstad Hospital in 
Rotterdam (dr. C.R. Lincke) and at the Erasmus MC-Sophia Children’s Hospital in Rot-
terdam (dr. M. de Hoog and prof. dr. A.J. van der Heijden).  
Natalja lives with her husband Arno and daughter Nouschka in Rijswijk.
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PHD PORTFOLIO SUMMARY
Summary of PhD training and teaching activities
Erasmus MC Department: Pediatrics/ Plastic Surgery
PhD period: 01-03-2006 – 01-04-2010
Promoter: Prof. dr. S.E.R. Hovius
Supervisor: Dr. I.M.J Mathijssen/ Dr K.F.M. Joosten
1. PhD training
Date Workload
(ECTS)
General academic skills 
- Introduction for beginning PhD candidates 
- How to write and read a medical paper? 
- Biomedical English Writing and Communication
08-06-06
12-08-06, 19-08-06
04-09-07 – 18-12-07,
15-01-08
0.1
0.7
4.0
Research skills
- Statistics
  Introduction to data-analysis 
  Regression analysis 
- Methodology
   Minicursus Methodologie van patiëntgebonden onderzoek 
Rotterdam 
07-08-06 – 11-08-06
14-08-06 – 18-08-06
16-03-06
0.9
1.3
0.3
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Oral presentations
-  Obstructive sleep apnea and intracranial pressure in children with 
syndromic craniosynostosis. Meeting Tyco Healthcare Rotterdam
-  Obstructief slaap apneu syndroom en intracraniële drukverhoging 
bij kinderen met een syndromale craniosynostosis. Onderzoeksdag 
Sophia Kinderziekenhuis Rotterdam
-  De eff ecten van chirurgische behandeling van het obstructief slaap 
apneu syndroom bij kinderen met een syndromale craniosynostosis. 
Vergadering Nederlandse Vereniging van Schisis en Craniofaciale 
Afwijkingen Zwolle
-  Obstructive sleep apnea and intracranial pressure in children with 
syndromic craniosynostosis. Craniofacial Meeting Rotterdam
-  Obstructief slaap apneu syndroom en verhoogde intracraniële druk 
bij kinderen met syndromale craniosynostosis. Refereerbijeenkomst 
Plastische Chirurgie Rotterdam
-  Lange termijn resultaat van midface advancement voor obstructief 
slaap apneu syndroom bij kinderen met syndromale craniosynostosis. 
Vergadering Nederlandse Vereniging van Plastische Chirurgie Zeist
-  Obstructive sleep apnea in children with syndromic craniosynostosis: 
unsatisfactory long-term respiratory outcome of midface 
advancement. European Society of Craniofacial Surgery Lille, France 
-  Kunnen ouders van kinderen met syndromale craniosynostosis de 
aanwezigheid van obstructief slaap apneu syndroom voorspellen? 
Vergadering Nederlandse Vereniging van Schisis en Craniofaciale 
Afwijkingen Nijmegen
-  Obstructive sleep apnea in children with syndromic craniosynostosis: 
respiratory outcome of midface advancement. 9th World Congress on 
Sleep Apnea Seoul 
-  Health-related quality of life in children with syndromic or complex 
craniosynostosis and obstructive sleep apnea. 9th World Congress on 
Sleep Apnea Seoul 
-  Gezondheids gerelateerde kwaliteit van leven van kinderen met een 
syndromale of complexe craniosynostosis. Vergadering Nederlandse 
Vereniging van Plastische Chirurgie Utrecht 
19-04-07
18-10-07
17-11-07
18-01-08
02-04-08
24-04-08
20-09-08
15-11-08
26-03-09
28-03-09
03-04-09
1.4
1.4
1.4
1.4
1.4
1.4
1.4
1.4
1.4
1.4
1.4
Poster presentations
-  Elevated ICP in patients with Apert, Crouzon and Pfeiff er syndrome. 
Wetenschapsdag Erasmus MC Rotterdam
-  Kunnen ouders van kinderen met syndromale craniosynostosis de 
aanwezigheid van obstructief slaap apneu syndroom voorspellen? 
Dag voor de jonge onderzoeker Nederlandse Vereniging 
Kindergeneeskunde Veldhoven 
-  Kunnen ouders de aanwezigheid van obstructief slaap apneu 
syndroom voorspellen? Posterprijs 30e congres Nederlandse 
Vereniging voor Kindergeneeskunde Veldhoven 
-  Can parents predict the presence of obstructive sleep apnea in 
children with syndromic or complex craniosynostosis? 9th World 
Congress on Sleep Apnea Seoul 
01-02-07
04-11-08
07-11-08
26-03-09
1.0
1.0
1.0
1.0
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International conferences
- Sleep and the cardiovascular system Marburg, Germany
- 8th International Neurotrauma Symposium Rotterdam 
- 8th World Congress on Sleep Apnea Montréal, Canada 
- Benelux Sleep Congress Mondorf-les-Bains, Luxembourg 
- European Society of Craniofacial Surgery Lille, France 
-  Benelux meeting Nederlandse Vereniging van Plastische Chirurgie/ 
Royal Belgian Society for Plastic Surgery Den Bosch 
-  Symposium on sleep-disordered breathing in children Antwerpen, 
Belgium
- 9th World Congress on Sleep Apnea Seoul, Korea 
07-04-06
23-05-06
28-09-06 – 30-09-06
11-05-07
19-09-08 – 20-09-08
04-10-08
21-11-08 – 22-11-08
25-03-09 – 28-03-09
0.3
0.2
0.7
0.2
0.4
0.3
0.4
1.0
Seminars and workshops
- INVOS Paediatric Master Class Paris, France 
- Wetenschapsdag Erasmus MC Rotterdam
- Embletta trainingsdag Embla/ Medcare Amsterdam
-  Brain RT klinische polysomnografi e trainingsdag Universitair 
Ziekenhuis Antwerpen, Belgium 
-  Onderzoeksdag Kindergeneeskunde Sophia Kinderziekenhuis 
Rotterdam
-  Najaarsvergadering Nederlandse Vereniging van Schisis en 
Craniofaciale Afwijkingen Zwolle
- Craniofacial Meeting Rotterdam
- Wetenschapsdag Erasmus MC Rotterdam
- Refereerbijeenkomst Plastische Chirurgie Rotterdam
-  Voorjaarsvergadering Nederlandse Vereniging van Plastische 
Chirurgie Zeist
-  Th e Generation R Symposium Imaging and early brain development 
Rotterdam
-  Najaarsvergadering Nederlandse Vereniging van Schisis en 
Craniofaciale Afwijkingen Nijmegen
- Refereerbijeenkomst Plastische Chirurgie Rotterdam 
-  Dag voor jonge onderzoekers Nederlandse Vereniging voor 
Kindergeneeskunde Veldhoven
-  30e congres Nederlandse Vereniging voor Kindergeneeskunde 
Veldhoven
-  Symposium Cognitive defi cits in children with Neurofi bromatosis 
type 1: from recognition to treatment Rotterdam
- Symposium Quality of life and quality of care Rotterdam
-  Onderzoeksdag Kindergeneeskunde Sophia Kinderziekenhuis 
Rotterdam
- Refereerbijeenkomst Plastische Chirurgie Rotterdam
- Workshop grant writing Nijmegen
- Workshop TULIPS subsidieaanvraag schrijven Rotterdam
-  Voorjaarsvergadering Nederlandse Vereniging van Plastische 
Chirurgie Utrecht
-  Seminar Epidemiology Success in research: learn from the experts 
Rotterdam
-  Symposium Infant feeding, early growth patterns, and long-term risk 
for metabolic and cardiovascular disease Rotterdam
10-04-06 – 11-04-06
01-02-07
14-02-07
02-07-07
18-10-07
17-11-07
18-01-08
07-02-08
02-04-08
24-04-08
19-06-08
15-11-08
17-09-08
04-11-08
07-11-08
26-11-08
02-12-08
18-12-08
21-01-09
29-01-09
02-03-09
03-04-09
15-04-09
06-05-09
0.3
0.2
0.2
0.1
0.2
0.3
0.3
0.2
0.1
0.3
0.1
0.3
0.1
0.3
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.3
0.1
0.2
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2. Teaching activities
Lecturing
-  Wetenschappelijk onderzoek OSAS en ICP bij syndromale 
craniosynostosis. Kinderartsenweek Sophia Kinderziekenhuis 
Rotterdam 
-  Het obstructief slaap apneu syndroom bij kinderen. Keuzeonderwijs 
plastische chirurgie studenten geneeskunde Rotterdam
29-01-07
12-02-07, 30-01-08,
26-01-09, 28-01-10
1.4
2.8
Supervising Master’s theses
-  Supervising Tim de Jong, medical student, retrospective research and 
article writing
2008 3.6

